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I. INTRODUCTION 
A. What Are Allophenic Mice? 
Allophenic mice are chimeras. The term chimera is used to describe 
a composite plant or animal in which the different cellular populations 
are derived from more than one fertilized egg or the union of more than 
two gamates (McLaren, 1976). Plants or animals in which the tissues are 
combined from two or more adult individuals or from embryos after the 
period of organogenesis are referred to as secondary chimeras while pri­
mary chimeras are individuals in which genetically different cell popu­
lations coexist from a very early stage of embryogenesis (Ford, 1969; 
McLaren, 1976). A different term, mosaic, is used to describe a composite 
individual derived from a single fertilized egg (McLaren, 1976). Second­
ary chimeras are chimeric in only one tissue or organ. On the other hand, 
all primary chimeras may be chimeric in any or all of their tissues or 
organs. Allophenic mice are primary chimeras. The preparation of these 
mice was first described by Tarkovski (1961) and shortly thereafter modi­
fied by Mintz (1962a,b). In the Mintz procedure, allophenic mice are 
formed by the aggregation of two embryos at the 8-cell stage of develop­
ment subsequent to removal of the zona pellucida by pronase. After 24-
36 hours in culture, the double-sized blastocysts are Lransferred to a 
pseudopregnant foster female and allowed to come to term. Allophenic 
mice derived from the aggregation of two embryos are designated as strain 1 
4—> strain 2 mice. 
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An alternate method for making allophenic mice is the injection 
technique (Gardner, 1968). In this technique, cells from a dissociated 
blastocyst are injected singly or in groups into the blastocoele of an 
intact blastocyst and become incorporated into the inner cell mass of the 
recipient embryo, giving rise to an injection chimera (McLaren, 1976). 
Allophenic mice derived from the injection procedure are designated 
strain 1 .—> strain 2 mice, where strain 1 is the donor and strain 2 is 
the recipient blastocyst. Both the aggregation and injection techniques 
of making allophenic mice are shown in Figure 1. 
Other terminology is often used synonymously with allophenic mice 
(Mintz, 1967). These terms include quadriparental (Mintz, 1965), tetra-
parental (Wegmann and Oilman, 1970), ovum fusion derived (Barnes and Tuffrey, 
1972), and early embryo aggregation (EEA) derived chimeras (Barnes, 1976). 
Allophenic mice have been used extensively as laboratory test systems 
in the scientific fields of experimental embryology, genetics, and immun­
ology. Some of the markers used to identify the different cell popula­
tions in an allophenic mouse include cell surface antigens (Mintz and 
Palm, 1969; Mintz and Silvers, 1970; Bona et al., 1974; Festenstein et 
al., 1975; Warner et al., 1976, 1977a,b,c,d; and Stephens et al., 1977), 
hemoglobin 3-chain differences (Wegmann and Gilraan, 1970; Stephens et al., 
1977; and Warner et al., 1977d), biochemical variations of the enzymes 
glucose phosphate isomerase (GPI) and isocitrate dehydrogenase (IDH) 
(Gearhart and Mintz, 1972; Chapman et al., 1972; Mintz and Baker, 1967; 
and Ansell et al., 1974), and chromosomal markers such as the T6 chromo­
some translocation (Mystkowska and Tarkowski, 1968; Ford et al., 1975). 
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Figure 1. Diagram to show the essential steps involved in making 
aggregation chimeras (on the left) and injection chimeras 
(on the right). [For both, the procedures represented in 
in the outer columns are carried out vitro (McLaren, 
1976),1 
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B. Phenotypic Sex in Allophenic Mice 
Since attempts to sex living embryos at the 8-cell or blastocyst 
stages of development have not been successful, allophenic mice are syn­
thesized without regard to the sex of the component strains comprising 
the mice (McLaren, 1976). As a result, allophenic mice tend to distribute 
themselves into populations consisting of 25% males (XY <—>XÏ), 25% female 
, (XX <—>XX) and 50% male or female (XX > XY). Experiments in chromosomal 
sexing of mice has consistently agreed with this ratio (Mystokowska and 
Tarkowski, 1970; Milet et al., 1972; McLaren, 1975; and Ford et al., 1975). 
XX <—>XY allophenic mice may show varying degrees of dominance of 
either sex, ranging from 100% development as phenotypic males or females 
to an equal ratio of males to females in some strain combinations (McLaren, 
1976). The expression of this dominance is thought to reflect the rela­
tive distribution of XY and XX cells in the primordial gonads (McLaren, 
1976). Whether phenotypic sex is determined by the somatic or germ cell 
componenta of tuc gonads is still ccntrcversial. Arguing In favor of 
the somatic cells is the investigation of Ford (1970) who observed that 
in XO/XY human mosaics the more masculinized gonad is usually character­
ized by a higher proportion of XY cells in cultures grown from its somatic 
tissue and that the genital ridge undergoes its initial sexual differen­
tiation even when germ cells are absent (Coulombre and Russell, 1954). 
In disagreement and in favor of the germ cells is Mintz (1969a) who 
examined fertile male XX <—> XY chimeras with functional germ line cells 
of XY when 95% of the somatic tissue of the gonad was made up of XX cells. 
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The role of both types of tissue are supported by the work of Milet 
et al. (1972) who examined four XX <—>XY chimeras and found no relation­
ship between the phenotypic sex of the animal and the proportion of XY 
cells in skin, spleen, kidney, bone marrow, or cornea. They suggest that 
phenotypic sex is determined jointly by the somatic component and pri­
mordial germ cells but give no explanation of their hypothesis (McLaren, 
1976). 
In conclusion, the phenotypic determination of sex in allophenic 
mice is influenced by the sex of component strains, and the distribution 
of these components into the somatic and germ cells of the gonads. 
C. Hair Pigmentation in Allophenic Mice 
Coat color in allophenic mice offers a visible genetic marker for 
evaluating external chimerism, but has been found to be very unreliable 
for estimating the internal composition of the mice (Warner et al., 1976). 
Coat color is determined by the two cell types that make up the hair fol­
licles of the animal. Coat color can be influenced by genes active in 
the melanocytes that determine the type and quantity of pigment in the 
hair shaft. It is also influenced by the genes of the epidermal cells 
that determines the pattern of how the hair is laid down (McLaren, 1976). 
In allophenic mice, chimerism can exist at the level of individual hairs 
(McLaren and Bowman, 1969). 
Coat color chimeras are classified as melanocyte chimeras, and hair 
follicle chimeras, depending upon the appearance of the animal (McLaren, 
1976). In the melanocyte chimeras, coat color patterns tend to distribute 
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themselves in broad transverse bands of color over the head, body and 
tail of the mice. At the mid-dorsal line there appears to be a sharp 
discontinuity, so that each side appears to be independently determined 
(Mintz, 1967). 
Mintz (1967, 1970, 1971b) hypothesized that the most frequent 
standard pattern in melanocyte chimeras was three bands over the head, 
six on the side and eight on the tail. Based on these observations, she 
suggested that there must be 34 primordial melanoblasts in the neural 
crest, with each arising from a single progenitor cell that was responsi­
ble for each of the transverse bands. This orientation reflected the 
route of cellular migration from the neural crest, at 8-12 days of gestation. 
The mid-dorsal line of discontinuity was the result of clones of melano­
blasts migrating before the neural crest had a change to fuse, thereby giving 
the appearance that each side is independently determined (McLaren 
1976). West (1975) has verified the accuracy of this hypothesis by 
showing mathematically that 34 clones would be required to produce 17 
bands on each side. However, McLaren and Bowman (1969) when examining the 
transverse bands characteristic of melanocyte chimeras, observed the 
most frequent banding pattern was one band over the head, five bands over 
the body, and one band over the tail. They concluded that the distribu­
tion of bands observed by Mintz (1967) was not the most frequent, but 
the maximum number of bands possible. 
Hair follicle chimeras, like melanocyte chimeras, show transverse 
bands, with a mid-dorsal discontinuity, except the bands are of a much 
finer nature (Mintz, 1970, 1971b). Coat color in these animals is 
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influenced by the hair follicle itself either through modifying the 
activity of melanocytes or by altering the structure of the hair (McLaren, 
1976). Mintz (1969b, 1970, 1971b) has postulated that in agouti <—^ 
nonagouti mice where the hair follicles were predominantly of one compo­
nent, the pattern of banding may directly reflect the clonal history of 
the tissue and that each narrow band represents a single hair follicle 
clone and correlates with the number of somites in the area. She further 
suggested that coat color in these mice is of mesodermal origin and not 
ectodermal since mesoderm is known to contribute to the hair follicle in 
the form of the dermal papilla (McLaren, 1976). 
In contrast, McLaren (1976) has suggested that hair follicle bands 
do not represent localized clones of progenitor cells, but instead some 
developmental phenomenon superimposed on a systemic wave pattern which 
arises from the presence of two genetically distinct cell populations. 
This theory would explain why the agouti locus is responsive to positional 
effects which result in hair of identical genotype producing different 
phenotypes. The same genotype produces yellow hairs on the stomach, 
agouti hairs on the side, and black hairs in the middle of the back 
(McLaren, 1976). 
The dynamic nature of pigment patterns was shown by Warner et al. 
(1976) when characterizing the coat color of 17 pigmented <—> nonpigmented 
C57BL/6<—> (A X SJL)F^ mice at two time points. They observed 5 out of 
17 or 29% of the population showed significant change in their coat color 
composition» In A out of 5 mice, the shift was in the direction of the 
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C57BL/6 phenotype, while one mouse shifted to the (A x SJL)F^ phenotype. 
Changes in the relative proportion of parental cells with time were termed 
chimeric drift (Stephens et al., 1977; Warner et al., 1977c,d). Although 
no attempt was made to quantitate bands, evidence presented was not con­
sistent with the single clone theory of Mintz (1969b, 1970, 1971b) which 
suggests the possibility of a developmental and(or) environmental phenom­
enon being exerted on these mice. 
D. Stability of Allophenic Mice 
It was first suggested by Mintz and Palm (1969) that allophenic mice 
may not be completely stable chimeras but may show changes in their cel­
lular composition with age. In an extensive study, they examined the 
erythrocyte H-2 type and serum gamma globulin allotype in 34 adult 
C3H(f) <—>C57BL/6 mice. Of the 34 mice tested, 18 mice appeared to have 
only C3H(f) or C57BL/6 erythrocytes while 16 mice gave evidence of pos­
sessing erythrocytes of both strains, as detected by antibody dependent 
agglutinination and absorption tests. The presence of hybrid red blood 
cells in these chimeric mice was excluded based on previous direct ex­
amination of allophenic mice, using the T6 translocation marker and 
electrophoretically distinct forms of isocitrate dehydrogenase or malate 
dehydrogenase of which each parental strain showed a homozygous allelic 
variant genotype (Mintz and Palm, 1969). Red blood cells and serum allo­
type of 7S gamma globulins (subclass IgG2a) showed some concordance to 
the erythrocyte composition in all but one of the mice, with half of the 
mice showing a single red blood population and a serum allotype 
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corresponding to a single parental strain. The results also suggested 
that the C57BL/6 erythropoietic tissue might have a selective advantage 
over the C3H(f) strain and that time dependent shifts in the direction 
of only the C57BL/6 phenotype occurred. This advantage seemed greater 
with respect to the erythrocytes than the gamma globulin producing cells. 
Wegmann and Oilman (1970) also examined a series of C3H/He <—> 
C57BL/6 mice using the hemoglobin beta-chain marker and allotype analysis 
of IgG2a gamma globulin. Of the nine mice judged chimeric from coat 
color analysis, all contained hemoglobin and gamma globulin of both pa­
rental types, with no evidence of a selective advantage of the C57BL/6 
red blood cells. Results further indicated no time dependent changes in 
the direction of either parental strain, but instead concordance between 
red blood cell and white blood cell (i.e., gammaglobulin producing cells) 
populations at all time points sampled. 
West (1977) investigated the relative proportions of the two red 
blood cell populations of eight C3K/BiMcL i—^ C57BL/McL mice and ten 
(C57BL/McL x C3H/BiMcL)F^ <—> Recessive (Recessive is a multiple recessive 
stock previously described by McLaren and Bowman, 1969) by using the 
hemoglobin beta-chain marker and electrophoretically distinct forms of 
CPI of which each parental strain showed a homozygous allelic genotype. 
Analysis of a large number of tissues and organs from the eight C3H/BiMcL 
<—>C57BL/MCL aggregation chimeras suggested that the C57BL/McL red 
blood cell population predominates, whereas in other tissue the propor­
tions of the two genotypes are nearly equal. Similar results were 
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obtained with the ten (C57BL/McL x C3H/BiMcL)Fj^ <—> Recessive chimeras. 
Further analysis of this data suggests that a temporal shift in the pro­
portions of the two component red blood cell populations occurs in some 
adult chimeras and results eventually in an unbalanced phenotype. This 
has been claimed in the case of some spontaneous chimeric cattle twins 
(Stone et al., 1964;, artificial sheep chimeras (Tucker et al., 1974), 
and other allophenic mice (Mintz and Palm, 1969). Although temporal 
shifts of this nature are difficult to explain, it has been suggested 
(Mintz and Palm, 1969; West, 1977) that time dependent changes in erythro­
poietic tissue may be the result of differential rates of mitotic activity 
that contributes to strain-dependent, tissue-specific selective pressures 
in allophenic mice. One of the major goals of the work reported in this 
thesis was the quantitative evaluation of time-dependent changes in the 
red blood cell and white blood cell populations of allophenic mice. 
E. The Immune System of 
Allophenic Mice 
Studies characterizing the immune system (bone marrow, spleen, 
thymus, Peyer's patches, lymph nodes, and circulating lymphocytes) of 
allophenic mice indicate that the lymphomyeloid system can be chimeric, 
but the ratio of the two parental strains in different tissues and organs 
is not uniform (McLaren, 1976). Cornish et al. (1972) examined five allo­
phenic mice—three C3H/He<—>(C3H/He x CBA/H-T6)F^ and two C57BL/10 
<—>(C57BL/10 X CBA/H-T6)F^ — produced by the aggregation of two 8-cell 
embryos according to Mintz (1962a,b). From a karylogical analysis of the 
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mice, they concluded that the percentage of cells carrying the T6 
chromosome marker was the same for bone marrow, spleen, and thymus. Their 
results have been taken as support for the view that lymphomyeloid tissue 
throughout the body arises from a single stem cell pool (McLaren, 1976). 
In another study Ford et al. (1975) characterized two allophenic 
mice which were produced by the injection of three to five cells into the 
inner cell mass of recipient blastocysts according to the method of 
Gardner (1968), The mice were of the type PDE —> (PDE x CBA/H-T6)Fj^ 
where the PDE is a random-bred albino strain. Their results indicated 
that the population of T6 containing cells was similar in bone marrow, 
thymus, and Payer's patches, but different from the proportion of T6 
containing cells in a second group of tissues, the spleen and lymph nodes. 
Attempts to explain the inconsistencies between these two sets of find­
ings are difficult because of technical difficulties in both studies. 
In the Cornish et al. (1972) study, there appears there might have been 
a selective advantage of cells over C3H. cells, thereby accounting for 
some of the uniformity seen in tissue analysis. This is particularly 
true in chimeras such as AKR <—)CBA/H-T6T6 mice where coat color and 
germ line analysis of the component strains are more or less equal, while 
in the lymphomyeloid system, AKR appears to have a selective advantage 
(Tuffrey et al., 1973; McLaren, 1976). In the Ford et al. (1975) investi­
gation, observations are complicated by the fact that blood was cultured 
in the presence of phytohemagglutinin (PHA) and the two genetic popula­
tions of lymphocytes could react differently to In. vitro conditions or to 
stimulation with PHA. 
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Bona et al. (1974) analyzed the parental distribution of theta 
antigens in eight AKR<—>CBA/H-T6T6 chimeras using immunoautoradiography. 
When the two lymphocyte populations were distinguished by their theta 
antigens, the proportions of cell types were almost equal, ranging from 
24% to 76% AKR; with a mean of 46%. In contrast to control animals, 
no cells in the chimeras carried both antigens implying that cell hybrid­
ization seldom if ever occurs. This latter observation is consistent 
with the studies of Mintz and Palm (1969). 
In contrast, cell hybridization of lymphocytes in allophenic mice 
has been reported by other investigators (Munro et al., 1974a), In exper­
iments designed to test if genetic information for immunoglobulin synthesis 
is transferred between cells as part of the normal vivo response to 
d 3-
antigen, allophenic mice of the combination BALB/c<'H-2 , Ig ) -—> 
C57BL (H-2^, Ig^) were constructed between the two strains by transfer­
ring the inner cell masses of BALB/c blastocysts into C57BL blastocysts 
accordiûg tû Garuûer (1968). The surface antigens were detected by rear-
ting suspensions of cells with appropriate anti H-2 serum followed by C6-
deficient rabbit complement and fluorescently labeled sheep anti rabbit C3. 
After the treatment, viable cells were fluorescently stained and able 
to secrete immunoglobulins. Indirect plaque forming cells were detected 
by mixing cells with anti-IgM antiserum in agar and spreading the mixture 
on glass slides. The agar-covered slides were then treated with anti-
allotype serum and complement, specific for one of the parental cell 
types in the population. By combining the indirect plaque assay with 
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immunofluorescence it was possible to estimate the number of cells of 
a haplotype making antibodies of the wrong allotype. In the majority 
of the nine chimeras analyzed, no apparent gene transfer occurred, but 
this was not true for two mice. No further attempts have been made to 
characterize other parental combinations of allophenic mice for hybrid 
cells. 
F. Allophenic Mice as Test Systems for 
Cellular Cooperation Across H-2 Barriers 
In recent years, the immune response of mice to synthetic polypeptide 
antigens, alloantigens and isoantigens and limiting doses of complex 
foreign proteins has been demonstrated to be under the control of a num­
ber of specific immune response (Ir) genes within the major histocompati­
bility (H-2) complex (Klein, 1975). However, the nature of the Ir gene 
products and their functions remain unknown. They may be expressed in T 
cells, B cells or macrophages and may be involved in cell-cell interac­
tions among these cell types. 
In attempting to answer these questions, investigators have constructed 
chimeric mice between two inbred strains, one of which was capable of 
producing antibody to a particular antigen and the other which was not. 
The antigens which have been used include (poly-L tyrosine, L glutamic 
acid)-poly D,L alanine—poly L lysine [(T,G)-A—L], (Freed et al., 1973; 
Bechtol et al., 1974; Bechtol and McDevitt, 1976; Press and McDevitt, 
1977); 2,4-dlnitrophenyl L-glutamic acid^^, L-lysine^^, L-alanine^ 
(DNP-GLA^); (Warner et al., 1973); L-glutamic acid^^, L-alanine^^, 
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L-tyrosine^^ (GAT^^) (Warner et al., 1973) and poly(glutamic acid^^, 
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lysine , phenylalamine ) (GL0) (Warner et al.. 1976. 1977a). 
Katz et al. (1973) first demonstrated a restriction in lymphycyte 
cell interaction to an antigen under immune response (Ir) gene control 
by using an adoptive transfer system. T cells from (low responder x 
high responder)mice previously primed to the terpolymer GLT can col­
laborate with (DNP)-primed B cells from the high responder strain but 
not a low responder strain in response to DNP-GLT. In other studies 
(von Boehmer et al., 1975b) with bone marrow reconstituted tetraparental 
mice have demonstrated that T cells can interact with H-2 histoincompati-
ble B cells in response to antigens not under ^  gene controls. 
In similar experiments by Sado and Kamisaku (1975) the antibody 
response to sheep red blood cells of syngeneic B cell-bearing radiation 
chimeras receiving syngeneic, semiallogeneic or allogeneic macrophages 
and T cells in various combinations were analyzed. Results indicated 
that histoincompatible T and B cells would not cooperate successfully for 
antibody production, while semiallogeneic T cells cooperated successfully 
with B cells in the chimeras. 
Other investigators (Munro et al., 1974b; Munro and Taussig» 1975; 
Taussig et al., 1974, 1976; Mozes et al., 1975; Waldmann et al., 1975) 
characterizing the immune response to the synthetic polypetides (T,G)-A—L, 
(T,G)-P—L, and (Phe,G)-A—L have shown that specific soluble T cell 
factors from vitro culturing of thymocytes can replace T cells vitro 
and can cooperate with H-2 histoincompatible B cells in producing direct 
plaques. Their results indicate that defects in responsiveness to an 
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antigen can be found at the level of the B cell (lacks genes coding for 
an acceptor for a class of T cell factors), T cell (lacks a gene coding 
for a specific binding site for antigen) or in both cell types depending 
upon the strain of mice used. 
The vivo response of tetraparental mice immunized with 
(T,G)-A—L has been investigated by Bechtol et al. (1974) and Bechtol 
and McDevitt (1976). In their studies several tetraparental mice pro­
duced anti-(T,G)-A—L antibody of the low responder strain gamma globulin 
allotype- Their data implied that the Ir-IA gene controlling the response 
to (T,G)-A—L was not expressed in B cells and suggested that cellular 
interactions among genetically dissimilar cell populations could occur 
when tolerance existed to both cell types. Attempts to clarify these 
observations by using bone marrow cell chimeric mice (presumed tolerant 
to H-2 histoincompatible cells) to examine antigen specific and 
allotype specific antibody suggests that low responder B cells cannot in­
teract with chimeric histcinccmpatible high responder T cells and macro­
phages in an antigen under ^  gene control (Press and McDevitt, 1977). 
Thus, the bone marrow and allophenic mouse data on the (T,G)-A—L system 
are conflicting. However, Press and McDevitt (1977) now claim that at­
tempts to repeat the original observations on the allophenic mouse sera 
have given no evidence of antibody of the low responder allotype. 
Warner et al. (1978) when examining the antibody response of 13 
C57BL/6 <—>A mice immunized to DNP^^BGG confirmed these results. They 
observed that none of the mice, in spite of the presence of a significant 
16 
proportion of low responder cells in some mice, produced any significant 
antibody of the low responder allotype. Their conclusion was that two 
histoincompatible cell types in allophenic mice, one from a high responder 
strain and one from a low responder strain to DNP^^BGG is not sufficient 
to allow the low responder cells to produce anti-DNP antibody. 
G. Transplantation and Immunological 
Tolerance 
1. The H-2 complex 
Transplantation or grafting is defined as the transfer of living 
cells, tissues, or organs from one part of the body to another, or from 
one individual to another (Klein, 1975). The success of the graft is 
primarily determined by the genetic relationship between the donor and 
the host. The immunological basis of rejection of normal tissue was 
first demonstrated by Medawar and his colleagues (Billingham et al., 
1954). In general, their investigations indicated that grafts (isografts) 
between genetically identical individuals (syngeneic) would succeed, 
while grafts (allografts) between genetically different individuals (allo­
geneic) would not succeed. Rejection was typically characterized by dila­
tion of the blood vessels with erythrocytes, followed by hemorrhages 
and the invasion of a mixed population of lymphoid cells into the grafted 
area. This inflaaimatory reaction spread upward through the dermis and 
epidermis until edema, necrosis, and tissue breakdown ultimately resulted 
in a sloughing off of the graft (Klein, 1975). The complex physiological 
phenomenon associated with graft rejection in the unsensitized individual 
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is referred to as a first set reaction, while the response of a sensitized 
individual to a graft is referred to as a second set reaction (Klein, 
1975). The success of transplantation can be summarized into five laws 
(Snell and Stimpfling, 1966; Klein, 1975); 
1. Grafts within an inbred strain (syngeneic grafts) succeed. 
2. Grafts between different inbred strains (allografts) fail. 
3. Grafts from either inbred parent strain to the hybrid succeed, 
but grafts in the reverse direction fail. 
4. Grafts from or subsequent F generations to F^ succeed. 
5. Grafts from either inbred parent strain succeed in some members 
of an F2 generation but fail in others. Also, grafts from one inbred 
parental strain succeed in some members and fail in others of a backcross 
produced by crossing the F^ hybrid to the opposite parental strain. 
The factors responsible for tissue compatibility were previously 
identified by Snell et al. (1948, 1953) as histocompatibility antigens and 
the genes coding for these structures as histocompatibility genea. la the 
mouse, the histocompatibility genes involved in governing transplantation 
and graft rejection are called the H-2 complex and can be mapped to a 
segment of chromosome 17 (Klein, 1975). The particular combinations of 
H-2 antigens coded by this segment of chromosome 17 are called the H-2 
haplotype and is typically designated by small letters in the superscript 
position (e.g., H-2^)(Klein, 1975). 
However, only in recent years have investigators appreciated the 
serological and genetic complexity of the H-2 complex and its antigens. 
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The current working model is that the antigens are encoded by two loci 
situated at either end of the major histocompatibility complex, the H-2K 
and H-2D regions (Snell et al., 1971) (see Table 1 for a map of the H-2 
complex). The ^  region was originally defined by the immune response 
genes controlling the response to thymus-dependent antigens (McDevitt et 
al., 1972) discussed in the previous section. However, it has recently 
been found that the antigens in this area stimulate a variety of cell 
mediated responses such as mixed lymphocyte culture (MLC) and graft-
versus-host response (GVH)(Klein, 1975; Brent et al, 1976). Also immune 
functions such as the generation of cytotoxic T cells iji vitro not only 
depend upon differences between responder and stimulator cells in the 
H-2K and H-2D ends, but also in the I region (Cantor and Boyse, 1975a,b). 
The cytotoxic cells themselves are directed against the H-2K and H-2D 
ends but for optimal response they require the help of cells that recog­
nize I region antigens and proliferate in response to them (Schendel and 
Bach, 1974; CauLoi" and Boyse, 1975a,b; Brent et al., 1976). The cells 
generated by immune functions can often be separated based upon different 
surface antigens such as the ^  differentiation antigens (Cantor and 
Boyse, 1975a,b) and the la antigens (Shreffler and David, 1975). 
The I regions consist of five subregions designated lA, IB, IJ, IE, 
and 2 subregion antigens are selectively expressed on helper and 
suppressor T cells and play a role in the regulation of humoral responses. 
A new subregion, ^  has been found to control a determinant found on al­
lotype suppressor and normal T lymphocytes (Murphy et al., 1976). 
Table 1. Genetic nomenclature of tfie H-2 complex^ 
Complex H-2 
Ends 
Regions 
K D 
K I S G D 
Subregions (I) A B J E C 
Lymphocytes and 
Factors Carrying 
la Determinants° References 
Suppressor T 
allotype (Ig-Ib) . . Murphy et al. (1976) 
idiotype (A5A)^ Murphy et al. (1977) 
carrier (KLH) j j Tada and Taniguchi (1976) 
Suppressor factor 
carrier (KLH) j ^ Tada et al. (1976) 
acceptor for KLH 
suppressor 
factor^ Tada and Taniguchi (1976) 
Con-A promoter T ^ j Shreffler et al. (1977) 
Fc-receptor-
bearing T I 1 McDevitt et al. (1976) 
Helper T (IgG resp) Okumura et al. (1976) 
Helper factors 
(T,G)—A—-L 
(IgM resp) J I Taussig et al. (1976) 
acceptor for 
(Ï,G)-A~L 
helper factor. ^ Taussig et al.(1976) 
KLH (IgG resp) ^ ^ Tada and Taniguchi (1976) 
allogenic (IgG 
resp) Armerding et al. (1974); McDevitt et al. 
(1976) 
B lymphocytes I 1 \ 1 Sachs and Cone (1973); Hammerling et al. 
(1974); Gb'tze (1975); David et al. (1975); 
Shreffler et al, (1977) 
^From Klein (1975); Murphy et al. (1977). 
subregions localization of loci controlling determinants present on different lymphocyte 
subpopulations and Immune factors. 
''Not mapped to a subregion. 
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The ^  region, located between the ^  region and the region contains 
two loci which code for serum proteins (Shreffler and Owen, 1963). The 
Ss locus controls the levels of serum complement, particularly C4, while 
Sip locus controls the expression of a sex limited testosterone dependent 
allotypic marker present on the serum substance (Ss) (Shreffler and 
Passmore, 1970). This dominant trait is expressed on some, but not all, 
Ss proteins (Klein, 1975). The G region contains the H-2G locus which 
controls erythrocyte antigens (Shreffler and David, 1975). The K and D 
regions are considered peripheral regions of the H-2 complex while the 
1, ^  and G regions are central regions (Klein, 1975). 
2. Tolerance 
Under certain conditions, the transplant recipient may be rendered 
unresponsive to foreign grafts. The state of unresponsiveness is called 
immunological tolerance (Klein, 1975). In self-tolerance, all reactive 
lymphoid cells to self-components are passively eliminated or actively 
suppressed. 
a. The forbidden clone theory Although several theories have 
postulated the mechanism of self-tolerance, only one has accurately ac­
counted for both immune responsiveness and tolerance. The forbidden 
clone theory (Burnet, 1959; Jerne, 1971) postulates that self-tolerance 
is induced by specific deletion or irreversible inactivation of potenti­
ally reactive clones to self-antigens during ontogeny. This is based 
on the premise that each lymphoid cell carries one immunological pattern 
expressed as a receptor which is passed on to its clonal descendants. 
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Clonal deletion of cells carrying receptors for self are absent for as 
long as the antigen which induces deletion is present. However, removal 
of the tolerizing antigen may then allow the generation of new precursor 
cells from noncommitted stem cells. This observation is supported by 
numerous reports of the absence of specific GVH and MLC reactive cells 
in mice and rats made tolerant by the neonatal injection of a large num­
ber of foreign cells (Gowens et al., 1963; Schwarz, 1968; Atkins and 
Ford, 1972; Brent et al., 1972; Brooks, 1975; Brent et al., 1976). When 
suboptimal dosages of foreign cells were given to recipients, residual 
T cells are thought to be present and give rise to low but detectable 
GVH and MLC reactions (Gowens et al., 1963; Bernstein, 1975; Brooks, 
1975). Evidence has shown that tolerance in these neonatal chimeras was 
not caused by the active suppression of host T cell reactivity (von 
Boehmer and Sprent, 1976). Autoimmunity according to the clonal selection 
theory is thought to result from either the somatic mutation and prolif­
eration of lymphocytes into self-reacting clones; changes in the nature 
of the autoantigen perhaps due to viral infection; exposure to antigens 
hidden from the immune system during ontogeny; immunization to antigens 
cross reactive to autoantigens or from intense stimulation of lymphocyte 
proliferation (Talal et al., 1976). 
Zinkernagel and Doherty (197Aa,b,c) have shown for T cell mediated 
cytotoxicity reactions that T lymphocytes from lymphocytic choriomenin­
gitis (LCM)-infected mice could lyse LCM-infected targets only if they 
expressed the same H-2 haplotype as the donor of the effector cells. In 
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their model, they hypothesize the viral immune effector T cells express 
two variable region (V) genes, one specific for self and the other for 
virus-induced changes. Virus-induced cytotoxic T cells generated in a 
mouse which is heterozygous at the H-2 complex would, therefore, express 
one of four self-reactive 2 genes specific for each of the alleles at 
H-2K or H-2D. In self-tolerance, clones that express two y_ genes specific 
for self would be deleted or suppressed whereas those which possess recog­
nition structures for self or nonself (surveillance T cells) or two com­
ponents for nonself (alloreactive T cells) will enter the recirculating 
pool. Autoimmunity or altered self is the result of changes in H-2 anti­
gens induced by the process of virus synthesis or as some complex of 
viral and H-2 antigens. This suggests that both the infecting or modi­
fying agent is in close association with the self H-2 products, and are 
recognized by the cytotoxic T lymphocytes as a single receptor (Zinker-
nagel 1976a,b,c; Zinkernagel and Doherty, 1974a,b,c, 1975, 1976; Zinker-
nagel and Welsh. 1976). However, an altered self model and a dual 
recognition model cannot be distinguished yet. Similar results have been 
obtained with a chemically modified cell mediated lympholysis model 
(Shearer and Schmitt-Verhulst, 1977). Cells modified by TNP separated 
from the cell surface by a tripeptide did not act as targets for effec­
tors generated by sensitization against TNP-modified cells (Rehn et al., 
1976). If T cell recognition occurs by two independent receptors, one 
recognizing the TNP group and the other recognizing self H-2 coded prod­
ucts, either or both of the targets modified by these slight variations in 
TNP presentation on the cell surface should have been recognized by 
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effector cells specific for TNP-self. These findings are compatible 
with recognition of single or double receptors and an altered self model 
or dual recognition model (Shearer and Schmitt-Verhulst, 1977). 
However, the H-2 restriction requirement for viral infected T cell 
mediated cytotoxic reactions has recently been reexamined (Zinkernagel 
et al., 1978). Using lethally irradiated bone marrow reconstituted 
chimeras (F^ >parent), they found tolerance alone was not sufficient 
to generate both virus specific and TNP-specific cytotoxic T cells against 
antigen in association with the tolerated H-2 types. In their experiments 
adult thymectoraized irradiated C57BL/6 were reconstituted with bone mar­
row of (BALB/c X C57BL/6)F^ origin and transplanted along with two irradi­
ated thymus lobes of the hybrid. The thymus lobes were transplanted 
under the kidney capsule, immediately following bone marrow reconstitu­
tion. The reconstituted mice were infected with vaccinia virus. After 
5-10 days, hybrid cytotoxic T cells were formed against virus infected 
parental target cells of either H-2 type. In contrast, control nonthymec-
tomized irradiated bone marrow chimeras (F^ -—^ parent), reconstituted 
with bone marrow of F^ origin but not receiving a F^ thymus prior to in­
fection with vaccinia virus, formed cytotoxic T cells whose specificity 
of killing was limited to virus infected target cells of the same H-2 
haplotype as the parental recipient component of the reconstituted mice. 
There are a number of conclusions that can be drawn from these 
experiments. First, it appears the thymus plays an important role in 
the differentiation of H-2 restricted killer T cells. Their capacity 
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for self-recognition or recognition of modified target cells is determined 
primarily by the radioinsensitive portion of the thymus, the thymus epi­
thelium. Second, these findings are more compatible with a dual recog­
nition model, where the antigen specific cytotoxic T cells recognize two 
receptors on target cells. The two receptors would consist of a virally 
modified H-2 determinant and a second separate receptor whose recognition 
by educated killer T cells is determined during the course of their mat­
uration in the thymus. The biochemical and serological nature of this 
latter receptor presently remains unknown. Finally, there are some data 
which support a dual recognition model and other data which support an 
altered-self model. The controversy is unresolved. 
b. Other theories of tolerance In contrast to the forbidden 
clone theory, other investigators have hypothesized that neonatally 
Induced tolerance is mediated through the action of serum blocking fac­
tors (Voisin et al., 1972; Hellstrom et al., 1970, 1971; Wegmann et al., 
based upon numerous reports that self-reactive clones of lymphocytes are 
retained in fully tolerant mice and rats (Hellstrom et al., 1971; 
Wegmann et al., 1971; Phillips et al., 1971; Phillips and Wegmann, 1973; 
Bansal et al., 1973a; Wright et al., 1974a,b; and Festenstein et al., 
1975). The blocking factor is thought to be either an antibody or an 
antibody-antigen complex that might be directed specifically against the 
relevant receptor sites on the surface of immunologically competent cells 
(McLaren, 1976). The presence of serum blocking activity has been reported 
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in allograft tolerant chickens containing cells with GVH reactivity 
against the tolerant strain (Droege and Mayor, 1975). Contrary to these 
observations, other studies have shown tolerant serum to have no effect 
on either GVH or MLC reactivity of normal cells (Ceppellini, 1971; Atkins 
and Ford, 1972; Brent et al., 1972; Crone, 1973; Meo et al,, 1973; 
Festenstein et al., 1975). It has also been demonstrated that tolerance 
can be induced in agammaglobulinemic chickens just as easily as in nor­
mal chickens (Rouse and Warner, 1972; Crone, 1973; Nowygrod et al., 1974). 
Another theory of tolerance is based on the observation that T 
lymphocyte receptors and IgG molecules share similar idiotypic determinants 
(Binz and Wigzell, 1975; Brent et al., 1976). Anti-T cell receptor anti­
bodies can be raised to the variable portion because of the idiotypic 
determinants which are in effect a protein new to the organism; with its 
determinant group as an antigen being its idiotype. Anti-recognition 
structure (anti-RS) can be raised by injecting semi-allogeneic cells into 
recipients of one or the other parental strains; with donor cells form­
ing anti-RS against host lymphocyte receptors for alloantigens of the 
opposite parental strain (Ramseier, 1973a,b; Binz and Wigzell, 1975). 
Such anti-RS antibodies have been shown to selectively destroy the ability 
of recipient strain lymphocytes to mount GVH reactions (Binz, 1975) and 
to inhibit cell mediated cytotoxicity and the mixed lymphocyte reaction 
(Kimura, 1974; Binz and Askonas, 1975). However, no direct evidence has 
shown that anti-RS antibodies play a role in neonatally induced tolerance. 
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Suppressor cells have recently been described as mediating neonatal 
self-tolerance. One of the best examples of T cell suppressor cells is 
the experiments of Pinto et al. (1974). In their experiments recipient 
mice given an i.v. injection of donor strain liver extract, followed by 
an i.v. injection of B pertussis were grafted and treated with anti-
lymphocyte serum for three days. Recipient mice were found to maintain 
healthy grafts for months after transplantation while maintaining a re­
active population of lymphoid cells to donor antigens as determined by 
GVH, MLC and cell mediated lympholysis assays (CML) (Brooks et al., 1975). 
This tolerance can he passively transferred to syngeneic donor mice 
pretreated with sublethal irradiation or antilymphocyte serum after trans­
fer. Pretreatment of the population of cells with anti-theta serum and 
complement before transfer, abolishes the effect (Kilshaw et al, 1975; 
Brent et al., 1976). Recently it has been shown that recirculatory 
suppressor T cells play an important role in transplantation tolerance 
in rats (Dorsrh And Rnser. 1Q77). 
In chickens pretreated with a sublethal dosage of irradiation, prior 
injection of syngeneic thymus cells prolonged the survival of skin 
allografts (Droege, 1975). This population of suppressor cells have been 
characterized as being found predominantly in the thymus of young chicks 
and are bursa dependent. These thymus cells after exposure to the anti­
gen can lead to the formation of specific suppressor cells that can medi­
ate long term tolerance to that antigen (Droege, 1976). An earlier study 
by Rouse and Warner (1974) has shovm that chickens made tolerant in early 
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embryonic life possess suppressor cell activity, but no attempt was made 
in the identification of the effector population. In contrast, several 
other groups of workers have shown that lymphoid cells from tolerant 
rats and mice do not suppress normal syngeneic lymphocytes (Atkins and 
Ford, 1972; Meo et al., 1973; Brooks, 1975; Festenstein et al., 1975). 
H. Tolerance in Allophenic Mice 
Allophenic mice provide an unique model for the study of 
immunological tolerance. We have seen that allophenic mice, although 
chimeric for lymphoid cell populations, appear mutually tolerant to the 
other component strain cells. Although a number of experiments have been 
performed trying to elucidate the mechanism of this tolerance, there is 
no consensus of opinion at the present time on the true mechanism. Sim­
ilarly, very little is known about the cellular composition of the immune 
system of allophenic mice. Previous studies characterizing the immune 
system of allophenic mice have been plagued by a number of difficulties. 
Among the problems commonly seen is the application of qualitative tech­
niques for quantitative data collection, the use of small numbers of mice 
with no parental strain combination diversity, and the employment of 
techniques leading to biased estimation of the relative proportions of 
the two cell types in a tissue or organ. In spite of the lack of under­
standing of the immune system of allophenic mice, these mice have been 
and currently are being used in a number of important immunological 
studies (McLaren, 1976). 
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The work described in this dissertation was undertaken to characterize 
and quantitate the hematopoietic and immune systems of a large, diverse 
population of allophenic mice. Techniques were developed to examine 
erythrocyte, peripheral white blood cell, spleen white blood cell and 
thymocyte compositions of the mice. This approach was accomplished by 
using polyacrylamide gel isoelectric focusing (PAGIF) and antibody medi­
ated cytotoxicity. Mice were analyzed for changes in their peripheral 
white blood cell composition and hemoglobin composition as a function of 
time. Spleen white blood cell and thymocyte compositions were analyzed 
at the time of sacrifice. These studies were carried out concomitantly 
with a project that was aimed at evaluating the possible role of serum 
blocking factors as a mechanism of tolerance in allophenic mice. 
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II. EXPERIMENTAL PROCEDURES 
A. Experimental Animals 
1. Mice 
All inbred strains of mice were obtained from the Jackson Laboratory, 
Bar Harbor, Maine. The strains used in these studies were C57BL/6, 
C57BL/10Sn, CBA, CBA/H-T6, DBA/1, and SJL. The hybrids (CBA x CBA/H-T6) 
and (A x SJL) were bred in our laboratory. The choice of inbred strains 
and hybrids was based on genetic differences at the major histocompat­
ibility (H-2) complex, and at the gene for the chain of hemoglobin. 
This information is summarized in Table 2 . Inbred mice of the same sex 
were kept in metal cages in groups of eight and were given mouse chow and 
water ad libitum. The room was kept light from 7 a.m. to 9 p.m. and dark 
from 9 p.m. to 7 a.m. 
2. Allophenic mice 
Allophenic mice used for these studies were constructed in our 
laboratory by J. Mclvor, C. Tollefson, and C. Warner. The allophenic mice 
were produced by the techniques of Tarkowski (1961) and Mintz (1962a,b, 
1971b) as modified by Warner et al. (1973). Mature female mice were 
superovulated by an iutraperiLoneal injection of 5-10 I.U. of pregnant 
mare serum (Organon)(PMS), followed 48 hours later by 5-10 I.U. of human 
chorionic gonadotropin (Nutritional Biochemical, Cleveland, Ohio) (hCG). 
Both injections were at about 4 p.m. Females were then mated with males 
Table 2. Description of inbred, hybrid and allophenic mice^ 
Mouse Hemoglobin^ H-2 Tla 
Strain Type Haplotype Haplotype 
Inbred Strains 
C57BL/6 single b b 
C57BL/10Sn single b b 
DBA/1 diffuse (double) q b 
CBA diffuse (double) k b 
CBA/H-T6 diffuse (double) k b 
A diffuse (double) a a 
SJL single s a 
B. Hybrids 
(CBA X CBA/H-T6)F^ diffuse (double) k b 
(A X SJL)F^ diffuse (double)- as a 
single 
*Based on Klein (1975). 
^This refers to the genetic polymorphism in Hbb (Oilman, 1972; 
Hutton et al., 1962a,b). Electrophoresis shows Hbb either as a "single" 
or as a "diffuse" species. In our study, isoelectric focusing further 
defines the diffuse Hbb as two bands, which we have referred to as 
"double" hemoglobin. 
= Unknown. 
= absence of antigen. 
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Thy-1 Ly 2 Ly 4 LzJ 
2 2 2 
2 2 2 
1 1 
2 11 
2 11 
2 2 2 
• 2 2  
2 2 1 
2 2 ^ 1 
2 —— • 
• • • 
* • • 
2 — 1 
2 — 2 
2 
2 / '  
1 
2 1/2 
Table 2. (continued) 
Mouse 
Strain 
Hemoglobin 
Type 
Haplotype 
H-2 Tla 
C. Allophenlc Mice 
C57BL/6 4^ (AxSJL)Fj 
DBA/1 i->(A X SJL)F^ 
DBA/lt-f A 
(CBA X CBA/H-T6)F 
4-» DBA/1 
(CBA X CBA/H-T6)F 
<->C57BL/6 
(CBA X CBA/H-T6)F^ 
4->A 
C57BL/6 <-> DBA/1 
C57BL/6 4 y A 
C57BL/10Sn A 
single <—> diffuse x single b4r->as b 4-^ a 
(double) 
diffuse <-> diffuse x single q 4r^ as b a 
(double) (double) 
diffuse diffuse 
(double) (double) 
diffuse 4~^ diffuse 
(double) (double) 
diffuse 4-t single 
(double) 
diffuse 4-> diffuse 
(double) (double) 
single <-> diffuse 
(double) 
single diffuse 
(double) 
single diffuse 
(double) 
q 4-> a b<-> a 
k.<->q b b 
k ^  y b b b 
k 4-> a b <-> a 
b q b <r^  b 
b 4 ^  a b X y a 
b 4—) a b 4-^  a 
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Haplotype 
Thy-1 Ly 1 Ly 2 Ly 3 Ly 4 Ly 5 
2 2 / .  2 < - >  2  2 < - > 2  2 < - t 2  2 < - > —  l < - > l / 2  
•<-»2/. l<->2 14->2 2<r-t2 —<r^—" •<->1/2 
• <->2 l<->2 l<->2 2 <-» 2 —<->— ••->1 
2 1<-»1 1 1 * ^  2 •<->— 
2^2 l*-»2 14-^2 .4-^ 2 »t-»2 #6-^1 
2*->2 14r»2 l<->2 *4-^2 • <-> *t^l 
2<->* 2<->l 2 4-^1 2 4-^2 2<-> 1<-^* 
24-^2 2<-^2 2<-^2 2<r^2 2<-^ Kr^l 
2<->2 2 4-^2 2<r^2 2<r4 2 2 •<-> 14^ 1 
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and checked for vaginal plugs the next morning. Collection of 8-cell 
embryos from plug-positive mice was begun 64 hours after hCG administra­
tion. The 8-cell embryos were flushed from the oviducts using Whitten 
and Diggers (1968) medium. The zona pellucida was removed with the enzyme 
pronase and the embryos were mechanically bumped together. The embryos 
were allowed to culture for 24-36 hours at 37° C in an atmosphere of 
5% CO^ in air. The blastocysts were then transferred to a pseudopregnant 
CFl female (Charles River, Portage, Michigan), previously mated to a 
vasectomized male. Mice were allowed to come to term. 
The choice of inbred strains for allophenic mouse production was 
based on the hemoglobin and major histocompatibility (H-2) type of the 
parental strains comprising an allophenic mouse. The allophenic mice used 
for these studies and their pertinent genetic markers are listed in Table 2., 
B. Buffers and Culture Media 
The various buffers and culture media used can be found in Table 3. 
All solutions were routinely prepared every 7-10 days. 
C. Sera 
1. Normal sera 
Normal sera from inbred strains and allophenic mice were obtained by 
bleedings from the orbital venus sinus. Approximately 0.30 ml of whole 
blood was collected (Beckman Microfuge; 0.4 ml tube) and samples were per­
mitted to stand at room temperature until the sera began to separate from 
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Table 3. Buffers and culture media 
A. Isoelectric Focusing Buffers 
1. 2X Hemoglobin Reducing Buffer pH 8.7 
0.2M boric acid 12.40g 
0.08M NAOH 3.20g 
O.OIM EDTA 2.92g 
0.02M 2-mercaptoethanol 1.08ml 
distilled H^O to 1000ml 
2. Sucrose-Cyanide Diluting Buffer pH 8.7 
O.IM boric acid 6.20g 
0.04M NAOH 1.60g 
0.005M EDTA 1.46g 
0.04M KCN 2.60g 
sucrose 50g 
distilled H^O to 1000ml 
3. Electrolytes 
Catholyte 
Q.02M HjPO^ 1.96g 
distilled H^O to 1000ml 
4. 10% TCA Solution (w/v) 
trichloroacetic acid lOOg 
distilled H.O lOOOml 
Anolyte 
O.OIM NAOH 0.4g 
distilled H^O to lOOOmI 
B. Cytotoxicity Assay Solutions 
1. RPMI 1640 with F.C.S. 
RPMI 1640 with 25 mM Hepes buffer 
heat inactivated fetal calf serum 
millipore 
90ml 
10ml 
.45 pm filter 
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Table 3. (continued) 
L-15 with F.C.S. 
L-15 culture medium 
heat inactivated fetal calf serum 
millipore 
90ml 
10ml 
.45 pm filter 
3. Saline pH 7.0 
0.15M NaCL 
distilled H^O to 
4. EDTA Saline pH 7.0 
8.50g 
1000ml 
O.OOIM EDTA .29g 
0.15M NaCl 8.50g 
distilled H^O to 1000ml 
5. Phosphate buffered saline (PBS) pH 7.0 
0.003M NaHzPO, • H2O 
0.007M Na2HP07 • 12H 0 
0.13M NaCl 
distilled HgO to 
0.45g 
2.40g 
7.40g 
1000ml 
C. RNA Synthesis Assay Buffers 
1. Supplemented RPMI 1640 
RPMI 1640 with 25mM Hepes buffer 90ml 
penicillin 1000 lU 
streptomycin 100 Mg 
200mM L-glutamine 1.0ml 
heat inactivated fetal calf serum 10ml 
millipore .45 pm filter 
2. Carrier RNA (CRNA) 
yeast ribonucleic acid 0.80g 
distilled H„0 100ml 
heat to 40° G and filter 
38 
Table 3. (continued) 
3. Deoxycholate Solution 
deoxycholate 
distilled H2O 
heat to 40-45° C 
12g 
100ml 
4. Tris-BSA Washing Solution 
Tris - HCl 0.33g 
O.OIM Tris 
Tris Base 0.049g 
0.5% bovine serum albumin 1.25g 
distilled H^O to 1000ml 
5. Sodium Phosphate pH 9.2 
0.5M Na^HPO^ (anhydrous) 70.98g 
distilled H^O to 1000ml 
D. Cell Freeze-Thawing Solution 
1. 14% DMSO pH 7.0 (w/v) 
Phosphate buffered saline 
PES pH 7.0 88ml 
14% dimethylsulfoxide 12ml 
(p = 1,096) 
2. Cell Washing Solution 
RPMI 1640 with 25niM Hepes buffer 50ml 
heat inactivated human AB normal serum 50ml 
penicillin 
streptomycin 
200mM L-glutamine 
1000 lU 
100 ng 
1.0ml 
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the clot. The blood samples were then placed in the refrigerator for 5-10 
hours. Blood clots were removed from sera with a disposable applicator 
stick and samples were centrifuged for 5 minutes in a Beckman Microfuge B 
(Beckman Instruments, Chicago, Illinois). Samples were pooled, if approp­
riate, heat inactivated, coded, and stored at a -70° C until needed. 
2. Preparation of antlsera 
Antisera were produced against whole spleen cells according to the 
method of Batchelor (1973). Single cell suspensions were prepared by 
flushing spleens with 1.0 ml RPMI 1640 medium (Gibco, Grand Island, New 
York, or ISI Biologicals, Cary, Illinois) followed by pressing through 
a 40 or 50 mesh stainless steel screen. Each recipient mouse received 
20-40 mg wet weight of the spleen cell suspension in 0.2 ml of RPMI 1640. 
This usually consisted of two donor spleens per eight recipient mice. 
Females were always used as donors and either males or females as recipi­
ents. Therefore, no anti-HY antibody was produced. Weekly injections 
(usually at least 10) were given until high titer antisera wête prouuceu. 
The recipient mice were alternately bled and boosted and finally exsan­
guinated. The serum from each bleeding was pooled, heat inactivated and 
stored either at -20° C or -70° C. Reciprocal immunizations were performed 
to eliminate cross-reacting antibodies. For example, to produce antlsera 
for usage on C57BL/6 <—> A mice, C57BL/6 mice were injected with A spleen 
cells and A mice were injected with C57BL/6 spleen cells. 
Antisera to thymocytes were produced by performing similar reciprocal 
immunizations with thymocytes from each of the strains used in the 
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production of the allophenic mice. All antisera were appropriately coded 
and stored in various-sized aliquots at a -70° C. 
3. Commercial antisera 
Specific anti-H-2 sera prepared in congenic lines were obtained from 
the Research Resources Branch, National Institutes of Health. Single vials 
containing the lyophilized antiserum were reconstituted with 1.0 ml de-
ionized distilled water and stored in aliquots of 100 yl at -70° C. The 
sera used included anti-^o)^(D-2A-T), anti-K^D^ (D-36A-R) and anti-K^o)^ 
(D-3bA-Q). 
4. Guinea pig serum 
Normal guinea pig serum obtained from Miles Laboratory (Elkhart, 
Indiana) was used as a source of complement in antibody mediated cyto­
toxicity assays. Lyophilized serum was reconstituted with 25 ml of sup­
plied diluent (sterile distilled water) and aliquoted and stored in 200 
and 500 pi amounts at -70° C. 
Occasionally, to remove natural antibodies to murine spleen cells 
and thymocytes, the guinea pig serum was absorbed with agarose using the 
modified procedure of Cohen and Schlesinger (1970). Briefly, 30 mg of 
dry agarose were added to 1.0 ml of reconstituted guinea pig serum 
(Beckman Microfuge; 1.5 ml tube) on ice. Samples were gently vortexed 
every 3 minutes. Absorption was complete within 10 minutes (Cohen and 
Schlesinger, 1970). Supernatants were then collected by a 5-minute cen-
trifugation and the absorbed serum aliquoted. 
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D. Antibody Mediated Cytotoxicity Testing 
1. Cell preparation 
The antisera produced by immunization with spleen cells were tested 
against both peripheral white blood cells and spleen white blood cells. 
The antisera produced against thymocytes were tested against thymocytes. 
All antisera were evaluated using the trypan blue dye exclusion assay 
(Warner et al., 1976) or the RNA synthesis assay (Stephens and 
Warner, 1978). Cells were isolated from the thymus or spleen by injecting 
1.0 ml of either L-15 medium (Gibco) containing 10% heat inactivated fetal 
calf serum or RPMI 1640 with 25 mM hepes buffer (ISI Biologicals or Gibco) 
into their respective capsules and forcing the thymic or splenic contents 
through a 40 or 50 mesh stainless steel screen. Single cell suspensions 
were prepared by passing clumps through a 1.0 ml sterile plastic tuberculin 
syringe equipped with a 26-gauge needle or by repeated pipetting with a 
Pasteur pipet. 
Peripheral white blood cells were obtained by bleeding mice from the 
orbital venous sinus using four 75 (il heparinized capillary tubes (Sherwood 
Medical Industries, St. Louis, Missouri). Approximately 0.30 ml of col­
lected whole blood were rapidly mixed with 0.70 ml of a O.OOIM EDTA saline 
solution (pH 7.0)(See Table 3). 
All three cell types were prepared for cytotoxicity testing by the 
Ficoll-Hypaque density gradient centrifugation method (Boyum, 1968). The 
method of preparation of Ficoll-Hypaque solution is shewn in Tabic 4 . 
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Table 4. Ficoll-Hypaque density gradient solution 
A. 
9% (w/v) Ficoll (Pharmacia, Piscataway, N.J.)—dissolve 9 grams 
flcoll powder in 100 ml distilled water. 
34% (w/v) Hypaque (Winthrop Laboratory, N. Y.)—dissolve 34 grams 
Hypaque powder into 100 ml distilled water. 
B. 
Specific Gravity Parts 9% Parts 34% 
of F-H (25° C) Ficoll Hypaque 
1.076 65.3 34.7 
1.078 64 36 
1.080 62.7 37.3 
1.084 60 40 
1.090 56 54 
C. 
Check specific gravity with a hydrometer. 
Aliquot and store in the freezer. 
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Depending on the source of the white blood cells, the density of the 
Ficoll-Hypaque used varied. Optimal separation of spleen cells and thymocytes 
was achieved using a density equal to 1.080, while best results for 
peripheral white blood cells were obtained with a density of 1.084. 
Roughly, one part cell suspension was layered over two parts Ficoll-
Hypaque solution in either 0.4 ml or 1.5 ml polyethylene microfuge tubes. 
Tubes were centrifuged for three minutes in a Beckman Microfuge B (Beckman 
Instruments, Chicago, Illinois). Cells were then washed with tissue 
culture medium (spleen cells and thymocytes) or with O.OOIM EDTA saline 
solution (PWBC), and centrifuged for five seconds. The cells (1-6 x 10^ 
cells/ml) were resuspended in L-15 with F.C.S. or RPMI 1640 with F.C.S. 
(see Table 3). 
In experiments evaluating RNA synthesis as a probe of antibody 
mediated cytotoxicity, unfractionated single spleen cell suspensions con­
taining both red blood cells and white blood cells were prepared as above, 
by passage through a stainless steel screen and the cells were washed once, 
counted, and resuspended in RPMI 1640 with 25mM hepes buffer (ISI Biologi­
cal or Gibco) supplemented with heat inactivated 10% fetal calf serum, 
1000 lu/ml penicillin, 100 vig/ml streptomycin (Sigma Chemical Company, 
St. Louis, Missouri) and 1% of 200 mM glutamine (Gibco Company)(see Table 
3), The final white blood cell concentration was adjusted to 6.0 x 10^ 
cells/ml. Each assay tube received 20 yl of this suspension to give 
4 
12 X 10 spleen white blood cells per assay. 
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2. Trypan blue dye exclusion assay 
Two types of protocols were employed in the trypan blue dye exclusion 
assay, with selection depending upon the purpose of the experiment. These 
are summarized in Figure 2. 
In routine histocompatibility typing, 10 yl of the Ficoll-Hypaque 
isolated cell suspension (6 x 10^ cells/ml) were mixed with 10 y1 of the 
appropriate antiserum dilution. Then 10 yl of a 1:2 dilution of guinea 
pig serum (Miles Laboratory) were added as the source of complement. The 
mixture was allowed to incubate at 37° C for one hour after which time 
10 yl of a 0.4% filtered trypan blue solution was added (Gorer and 0'Gorman, 
1956). 
A modified version of the protocol previously described was designed 
to compare the sensitivity and accuracy of the trypan blue dye exclusion 
assay with the EUJA synthesis assay (described below)(Stephens and Warner, 
1978). 
In each assay, 20 yl of the cell suspension (6.0 x 10^ cells/ml) 
were mixed with 20 y 1 of the appropriate serum dilution and 20 y 1 of a 
1:4 dilution of fetal calf serum in 12 x 75 mm glass tubes. Then 20 y 1 
of a 1:2 dilution of guinea pig serum (Miles Laboratory) were added as 
the source of complement. The guinea pig serum had been absorbed previously 
with agarose (Cohen and Schlesinger, 1970). The mixture was allowed to 
incubate at 37° C for one hour in 7% CO^ in air, after which 20 yl of a 
0.4% filtered trypan blue solution were added to each tube. After three 
to five minutes, a minimum of 200 cells was assessed microscopically for 
viability. Samples were counted using a hemocytometer (American Optical 
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Protocol 1 
10 ul 1:2 guinea pig serum 
10 yl antiserum 
10 yl target cells 
1 hour incubation at 37° C 
Add 10 lil of 0.4% trypan blue dye solution and score microscopically. 
Protocol 2 
20 pi 1:2 guinea pig serum 
20 ijl 1:4 fetal calf serum 
20 yl antiserum 
20 yl target cells 
1 hour incubation at 37° C 
(7% CO. in air) 
Add 20 yl of 0.4% trypan blue dye solution and score microscopically. 
Figure 2• The trypan blue dye exclusion assay 
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Corporation, Buffalo, New York) and a binocular microscope (Wild, Heers-
brugg, Switzerland or American Optical Corporation) adjusted to low power 
phase-contrast or bright field. Each assay was performed in duplicate. 
3. RNA synthesis assay 
Antibody mediated cytotoxicity to spleen cells was evaluated by 
measuring RNA synthesis in target cells after treatment with antiserum 
and complement. The protocol is summarized in Figure 3. In each assay, 
20 yl of the 6.0 x 10^ cells/ml suspension were combined with 20 ul of the 
appropriate serum dilution, 20 ul of a 1:4 dilution of heat-inactivated 
fetal calf serum, and 20 pi of a 1:2 dilution of absorbed guinea pig 
serum. The assays were performed in 12 x 75 mm culture tubes fitted with 
caps (Falcon, Oxnard, California). If the procedure were automated, using 
an automatic cell harvester, the assays could be performed in 96-well 
microtiter plates. Tubes were incubated at 37° C in 7% CO^ in air for one 
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hour. After this one hour preincubation, 25 yl (500 y Ci/ml) of a [ H]-
uridine (26.7 Ci/mmole, New England Nuclear, Boston, Massachusetts) solu­
tion were added. The radioactive solution was prepared prior to addition 
3 
by diluting the [ H]-uridine stock solution (1.0 mCi/ml) with an equal 
volume of culture medium. Simultaneously, 20 yl of supplemented culture 
medium were added to each tube. The supplemented culture medium served 
to maximize viability during labeling, and also to ensure a final volume 
of 150 yl for spotting on filter papers, as described below. 
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After addition of the [ H]-uridine, the cells were cultured for an 
additional five hours, after which 25 yl of a solution containing yeast 
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RNA (8 mg/ml) and 12% (w/v) deoxycholate in PBS or water (45° C) (See 
Table 3) were added. The contents of the tubes were vigorously vortexed 
and spotted in 75 fil aliquots on DEAE-cellulose paper discs (Whatman DE81, 
23 mm diameter, Clifton, New Jersey). Each tube was washed twice with 75 
pi of a 0.01 M Tris, pH 7.4, 0.5% BSA solution (Table 3) and the washings 
spotted on two additional filter papers. Duplicate blanks consisted of 
tubes containing all ingredients, except spleen cells. 
The filters were then processed in a batch (the filters were numbered 
in pencil for identification) by the method of Litman (1968) as modified 
by Versteegh et al. (1975). The principle of the procedure is that DEAE-
filter papers retain RNA by electrostatic attraction and matrix effects, 
while low molecular weight material (less than 10 nucleotides) is easily 
removed by extensive washing in phosphate buffer. The advantages of this 
procedure over conventional trichloroacetic acid precipitation on glass 
filter papers are that blank values can be reduced to less than 0.1% of 
the added radioactivity. Also, no unincorporated label is occluded by a 
large precipitate, and no high molecular weight material is removed by 
extensive washing. This means that recovery of small samples is quanti­
tative and highly reproducible. 
Thus, the filters were washed extensively in 0.5 M sodium phosphate, 
pH 9.2 (Table 3), to remove unincorporated uridine. Following the final 
wash, the filters were quickly rinsed twice with distilled water, twice with 
95% ethanol, once with ether, and finally air dried. They were counted in a 
Packard 2405 Liquid Scintillation counter (Downer Grove, Illinois) using 
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Step 1 Step 2 
Step 4 
(1 hour incubation at 37°C 
(.7% COg in air)) 
20 yl 1:2 guinea pig serum 
20 yl 1:4 fetal calf serum 
20 yl antiserum 
20 yl target cells 
80 yl 
DEAE-81 Filter Paper 
75 yl 75 yl 
75 yl 
Wash 1 
75 yl 
Wash 2 
Step 5 
i 
Step 3 
80 yl Step 1 
20 yl culture medium 
25 yl ^[H]uridine 
125 yl 
125 yl from Step 2 
25 yl (8 mg/ml) RNA and 
(12% w/v) DOC 
150 yl 
Process Filter Papers 
Step 6 
Count in Scintillation Counter 
Figure 3. The RNA synthesis assay 
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10 ml of a toluene counting solution containing 18.6 g 2,5-diphenyloxazole 
(PPO) and 0.94 g p-bis-[2-(5-phenyloxazolyl)]-benzene (POPOP) per gallon 
of toluene. The filter papers may be removed from the vials and the fluor 
reused several times. 
a. Cytotoxic quantitation The percentage of dead cells was 
calculated using the following formula: 
1 - S-B L t-B J 
P = X 100 
1 1 - C-B I L J 
where; 
P = percentage of dead cells in an assay; 
B = average cpm in blank tubes containing no spleen cells; 
S = average cpm in tubes containing an unknown sample of spleen 
cells and antiserum; 
C = average cpm observed in tubes with a theoretical 100% killing 
with antiserum. If the antiserum actually gives 100% killing 
of cells, then C = B, and the denominator drops out of the 
equation; and 
T = average cpm in control tubes containing spleen cells and normal 
mouse serum. 
b. Experimental protocols To compare the sensitivity and accuracy 
of the RNA synthesis assay to the trypan blue dye exclusion assay, two 
types of experiments were designed. In the first type, the five antiserum 
samples were titered using a constant number of target cells. Supplemented 
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culture medium was used as diluent for the antiserum samples. Increasing 
serum dilutions were chosen to reflect changes in cytotoxicity and to per­
mit the contruction of cytotoxic killing curves for each of the antiserum 
samples. Cytotoxicity was monitored using both the RNA synthesis assay 
and the trypan blue dye exclusion assay. 
In the second type of experiment, the antiserum concentration was 
kept constant, and the target cell concentration was varied. It should 
be noted that the RNA synthesis assay measures the number of live cells 
in a population directly, regardless of the number of dead cells present. 
Therefore, various dilutions of spleen white blood cells were made with 
supplemented RPMI 1640. Cells were treated with normal serum and comple­
ment for one hour and the RNA synthesis activity measured, as previously 
described. The observed counts per minute were used as an index of the 
number of live spleen white blood cells in a culture. In contrast, the 
trypan blue dye exclusion assay measures the number of dead (or live) 
spleen white bleed cells relative tc the total number of cells present. 
Thus, to get directly comparable results between the two assay procedures, 
the trypan blue dye exclusion assay was set up as a series of mixing ex­
periments. For example, A spleen white blood cells and C57BL/6 spleen 
white blood cells were mixed in varying proportions so that the total cell 
number in each assay would be constant. Thus, a culture tube might con­
tain 9.6 X 10^ A cells and 2.4 x 10^ C57BL/6 cells, while another might 
4 4 
contain 6.0 x 10 A cells and 6.0 x 10 C57BL/6 cells. The total cell 
number in each assay was 12 x 10 . Cells were treated with the appropriate 
antiserum and complement and the percentage of dead cells determined. 
51 
The cells selected for mixing experiments were chosen to minimize 
nonspecific cytotoxicity of each antiserum sample with the other cell type. 
The percentage of dead cells killed by a specific antiserum would reflect 
the number of cells of one type in a mixture at the beginning of the ex­
periment, and the results would be directly comparable to the viable cell 
number determined by the RNÂ synthesis assay. Various cell numbers of 
five different inbred strains of mice were analyzed using both the RNA 
synthesis assay and the trypan blue dye exclusion assay. 
E. Analysis of Hemoglobin 
1. Preparation of hemoglobin 
Hemoglobins from the inbred strains and allophenic mice (Table 2) 
were collected using the modified method of Clegg and Schroeder (1959). 
The procedure is diagrammed in Figure 4. In the experiments, 0.10 ml 
of whole blood was collected from the orbital venous sinus of each mouse 
using a 5 3/4-inch pasteur pipet and rapidly mixed with 0.05 ml of 3.2% sodium 
citrate (pH 5.5) at 4° C. Murine erythrocytes were then washed in 0.85% 
saline (pH 7.0) and centrifuged (Beckman Microfuge, 0.4 ml tubes) for one 
minute. After three successive washings and centrifugations, cells were 
lysed with distilled water and centrifuged for two five-minute Intervals, 
discarding pelleted cell stroma between centrifugatlons. Hemoglobins 
were treated with carbon monoxide (5-10 psig) for one and one-half minutes 
and stored at -70° C (Beckman Microfuge, 0.4 ml tubes) or -196° C (Provial 
Cooke Laboratory Products, Alexandria, Virginia, 2.0 ml tubes). 
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Figure 4, Flow diagram of the modified procedure of CI egg and 
Schroeder (1959) used for the preparation and storage 
of hemoglobin 
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Hemoglobins were prepared for polyacrylamide gel isoelectric 
focusing (PAGIF) by coupling an S-ethylamine group to the accessible 
sulfhydryl groups, thus effecting resolution of the structurally 
different hemoglobins (Smithies, 1965; Wegmann and Oilman, 1970). 
First, hemoglobin concentrations were determined by diluting 10 yl ali-
quots of samples with 0.99 ml distilled water in 12 x 75 mm glass test 
tubes. Samples were vortexed and concentrations determined spectrophoto-
metrically inaBeckman D.U. spectrophotometer by reading absorbance at 576 
nm (Figure 5). The samples were diluted with distilled water to a concen­
tration of 20 mg/ml. To this was added an equal volume of reducing buffer 
(See Table 3). Modification of the hemoglobin was caused by the addition 
of dry cystaminé dihydrochloride (Sigma Chemical Company, St. Louis, Mis­
souri) to a final concentration of 0.25 M. Samples were diluted to a final 
concentration of 5.0 mg/ml with an equal volume of sucrose-cyanide dilut­
ing buffer pH 8.7 (see Table 3). The exact concentration of the hemo-
4 -1 -1 
globins was verified by the absorption at 576 nz (e = 3.77 x 10 M ce ) 
previous to sample application to gels. When artificial mixtures of the 
structurally different hemoglobins were used, the mixtures were prepared 
before application to the gels. 
2. Polyacrylamide gel isoelectric 
focusing (PAGIF) 
The technique of polyacrylamide gel isoelectric focusing was a 
modification of a previously described method (Drysdale et al. , 
1971; Righetti and Drysdale, 1972) using a Buchler Polyanalyst equipped 
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Figure 5. Standard curve used to determine protein concentration of 
hemoglobin samples from inbred, hybrids, and allophenic 
mice. (The accuracy of the curve was verified by Lowry et 
al. procedure of protein determination (1951)2 
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with a Lauda circulator pump (West Germany) preset at 4° C and a Buchler 
regulated power supply. 
The gels were prepared as follows. In a 50 ml beaker, 8.17 ml of 
an acrylamide and methylene-bis-acrylamide (Bio-Rad, Richmond, California) 
stock solution (292.5 g/1 acrylamide and 14.6 g/1 methylene-bis-acrylamide) 
were mixed with 1.40 ml of glycerol, 22.2 ml of distilled water, and 0.53 
ml of ampholytes (3-10) (Bio-Rad), 0.53 ml of either ampholytes (6-8) 
(Bio-Rad) or ampholytes (5-8) (LKB), and 2.24 ml of a solution containing 
1% (v/v) TEMED (Bio-Rad) and 0.01% (w/v) riboflavin 5'phosphate (Bio-Rad). 
After mixing, gel tubes (12 x 0.5 cm) were filled within 2 cm of the top, 
after which water was carefully layered on top of the gel solution. Any 
occasional inconsistencies in gel polymerization, when using different 
preparations of ampholytes, were corrected by increasing the volume of the 
(3-10), (6-8) ampholytes to 1.0 ml, respectively, while decreasing the 
volume of distilled water to 21.2 ml. The volume of other gel components 
remained unchanged. Gels were phoLopolymeLized for 10 hours and cxccss water 
removed before sample application. Three hundred fifty milligrams of arti­
ficial mixtures of mouse hemoglobins or allophenic mouse hemoglobins were 
applied to the surface of the gels. To safeguard against possible denatur-
ation of proteins at the interface by the catholyte, 100 fil of 20% and 
100 p.1 of 10% sucrose were overlayed on the sample. Solutions (300 ml) 
of 0.02M phosphoric acid (pH 2.2) and O.OIM sodium hydroxide (pH 12.0) were 
used as anolyte and catholyte, respectively, with the catholyte uppermost 
(see Table 3). A current of 1 mA/tube was established until the voltage 
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rose to 500 V. Thereafter, the voltage was maintained at this level for 
the duration of the experiment. Isoelectric focusing was complete within 
four hours (Dale and Latner, 1968; Righetti and Drysdale, 1972). Gels were 
then removed from their tubes and washed in 10% TCA (See Table 3) for one 
and one-half hours, to fix the protein and remove the ampholytes (Dale and 
Latner, 1968). The procedures of hemoglobin modification and polyacryla-
mide gel isoelectric focusing are diagrammed in Figure 6. 
3. Hemoglobin quantitation 
Gels were scanned at a wavelength of 576 nm using either a Zeiss 
Spectrophometer and Strip Chart Recorder (Oberkochen, Germany) or a Beck-
man ACTA Spectrophotometer (Fullerton, California) and a Heath Strip 
Chart Recorder (Model EU-200-01) (Benton Harbor, Michigan) preset at a 
IQ mV with a chart speed of 15 sec/cm. Total area under the curves was 
established by tracing with a polar planimeter (K and E, New York) or by 
cutting out and weighing recorded gel scans. Areas under individual peaks 
were resolved using the following formula (Disc Instruments, 1973). 
P- = X (Total Area) 
P2 + P3 = Total Area -
where ? 
P^ = area under largest peak; 
Pg = area under Intermediate peak: 
P^ = area under smallest peak; 
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Figure 6. Flow diagram of hemoglobin modification technique (Smithies, 
1965; Wegmann and Oilman, 1970) and PAGIF procedures (Drys-
dale at al,, 1971; Righetti and Drysdale, 1972) used to 
resolve artificial mixtures of allophenic mouse hemoglobins 
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= height of largest peak; 
hg = height of intermediate peak; and 
h^ = height of smallest peak. 
Composition of unknown mouse hemoglobin was estimated relative to 
artificial parental strain hemoglobin mixtures. To overcome differences 
among strains of the proportionality of the area of each peak to its height, 
a set of at least four artificial mixtures was included with each set of 
allophenic mouse hemoglobins for the C57BL/64—> (AXSJL)F^, (CBA x CBA/H-T6)F-|^ 
<4—V C57BL/6 and C57BL/6 4L—V DBA/1 mice. The composition of the hemo­
globin of the C57BL/6<—>A and C57BL/lOSn ^—>A mice was determined by 
comparison to separate standard curves established during their respective 
experiments. All hemoglobin analyses for a particular allophenic mouse 
were run simultaneously. A duplicate run was made at a later time. The 
standard curves were established by drawing the least-squares lines 
through the areas of the curves in the artificial mixtures versus the known 
amount of hemoglobin applied to the gels. For the (CBA x CBA/tI-T0)F]^*—? 
C57BL/6, C57BL/6<r->DBA/1, C57BL/6 ^ A, and C57BL/lOSn <r-> k, this 
plot was always in terms of the percentage of C57BL/6 or C57BL/lOSn hemo­
globin in the mixtures. For the C57BL/6<—> (A x SJL)Fi mice, this plot 
was always in terms of the percent A in the mixtures since C57BL/6 hemo­
globin and SJL hemoglobin are indistinguishable on isoelectric focusing 
(see Results). 
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4. Determination of isoelectric points 
The isoelectric point (pi) of hemoglobin samples, from six inbred 
strains of mice and (A x SJL)F^ hybrids, was determined before and after 
modification with cystamine dihydrochloride using an adaptation of the 
procedures of Righetti (1974). Untreated hemoglobins were prepared by 
diluting samples with distilled water to a concentration of 20 mg/ml to 
which an equal volume of buffer (0.2 M boric acid, 0.08 M NaOH and 0.01 M 
EDTA) was added. These samples were not treated with 2-ME or dry cysta­
mine dihydrochloride. Chemically modified hemoglobins were prepared 
using techniques previously described (Stephens et al., 1977; Warner, 
et al., 1977d). Both unmodified and modified hemoglobins were diluted to 
a final concentration of 5.0 mg/ml with an equal volume of sucrose-cyanide 
diluting buffer, pH 8.7 (see Table 3). To minimize differences between 
runs, the same preparations of ampholytes were used and samples were 
electrophoresized under identical conditions. After isoelectric focusing 
was complete, gels were removed from their tubes and their length and 
hemoglobin banding pattern were measured and recorded. Any slight varia­
tions between duplicates were corrected by correlating banding patterns 
with the actual pH gradients developed in experiments (Righetti, 1974). 
Gels were then quick frozen in liquid nitrogen and sliced into 5.0 
mm sections with an apparatus similar to the Biorad Model 190 Gel Slicer. 
Slices from duplicate gels were placed in 12 x 75 mm glass test tubes 
and ampholytes were eluted with 1.0 ml distilled water containing 1 mM 
sodium chloride. The water was boiled prior to its addition to tubes to 
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minimize absorption of atmospheric carbon dioxide (Righetti, 1974). 
After cooling to room temperature, the pH of the gel eluates was measured 
with a pH meter (The London Company, Cleveland, Ohio) equipped with a com­
bination electrode. 
Measured pH values from identical gel slices were averaged and a 
standard curve was established by drawing a least-squares line through 
the pH values which varied as a function of gel length. The constructed 
pH gradient then served as a standard curve from which isoelectric points 
of hemoglobin samples could be estimated. 
F. Preparation of Frozen Lymphocytes 
1. Cell preparation 
Spleen cells and thymocytes from allophenic and inbred mice were 
prepared for long-term storage using an adaptation of the freezing pro­
cedures of Fotino et al. (1967) and Bates and Sell (1970). Briefly, 
splssns and thymuscs wêrc pLëpâïëu Iulù sitiglë cell suspensions (Section 
D. Antibody Mediated Cytotoxicity Testing, Part 1. Cell preparation) 
and purified by Ficoll-Hypaque density gradient centrifugation (Boyum, 
1968). The white blood cell concentration was adjusted to 2.0 x 10^ 
cells/ml using L-15 medium with 10% heat-inactivated fetal calf serum and 
cells were maintained at 4° C in an ice bath. 
Cells were prepared for freezing as follows. To a 50 ml flask 
containing 2-15 ml of 2.0 x 10 cells/ml, an equal volume of 14% (w/v) 
dimethylsulfoxide solution (DMSO) (4° C) was added slowly to cells with 
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constant swirling of the flask. The DMSO was diluted with phosphate 
buffered saline, pH 7.0 prior to usage (see Table 3). All reagents 
were maintained at 4° C throughout the experiment to prevent temperature 
dependent cytotoxicity (Malinin and Perry, 1967). Ten minutes after the 
addition of the DMSO, the lymphocyte suspension was pipetted (1.0 ali-
quots) into either 2 ml-size glass ampoules or plastic 2 ml Provials 
(Cooke Laboratory Products) prechilled at 4° C. Ampoules and vials were 
color coded and labeled with a designated mouse number and cell type. 
The final cell concentration in a container was 1.0 x 10^ cells/ml 
in 7% DMSO (w/v). 
2. Cell freezing procedure 
The freezing of biological specimens was conducted with a Linde 4-2 
Biological Freezing System (Union Carbide, New York) composed of a BF-6 
controller, BF4-2 freezing chamber, liquid nitrogen tank (22 psig) and 
a Bristol Dynamaster Recorder, model IPH 560-51 (Waterbury, Connecticut) 
with an adjusted chart speed of one inch per minute. 
After a 15-30 minute warm-up period, the recorder was calibrated by 
placing the differential thermocouple probe into beakers containing 25 ml 
of distilled water at 25° C, 15° C, 10° C, and 5° C, respectively. Dur­
ing the experiments, actual cooling rates (degrees per minute) were cal­
culated by dividing AT, the differential temperature change, by AC, the 
chart speed. A typical change was one degree Celsius per one inch of paper. 
A control vial contaiuing 1.0 ml of 1.0 x 10^ cells/ml in 7% DMSO 
was connected to the differential thermocouple and inserted into the 
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freezing chamber. The controller was adjusted to a setting of 8 which 
roughly corresponded to a freezing rate of 1° C per minute. The chamber 
was cooled to 5° C, the samples were distributed evenly into the freezing 
chamber, and frozen at a controlled rate of 1° C per minute. When the 
specimens were 1® to 4° C above their freezing point (-12° C), liquid ni­
trogen was allowed to flow uninterrupted into the chamber for 30-40 seconds, 
thereby minimizing supercooling and the random freezing of samples (Bates 
and Sell, 1970). 
The freezing of biological samples was continued at a controlled rate 
of 1° C per minute to -30° C and then 10° C per minute to -70° C. Vials 
were then rapidly transferred to and stored in a cryogenic refrigerator, 
model LR-21 (Union Carbide) filled with liquid nitrogen. Samples were 
maintained in the refrigerator for a one to two year period. 
3. Thawing of lymphocytes 
Ampoules and vials containing lymphocytes were removed from the 
cryogenic refrigerator and rapidly thawed by agitation in a water bath 
at 40° C. The contents of the containers were gently transferred to a 
17 X 100 mm plastic test tube (Falcon) to which washing solution was added 
dropwise from a 25 ml buret, while constantly agitating. Washing solution 
was added in ratio of four parts to one part cell volume (see Table 3). 
After washing, cells were centrifuged at 1,100 rpm (180 g) for 10 minutes 
in a refrigerated International PR-2 centrifuge and resuspended to a con­
centration of 1-6,0 X 10^ cells/ml in supplemented RPMI 1640 (see Table 3). 
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Before using frozen-thawed cells in experiments, viability was 
evaluated by diluting a 10 pi aliquot of cells 1:3 with supplemented 
culture medium. To this was added 10 ul of a 0.4% filtered trypan blue 
solution. After five minutes a minimum of 200 cells were assessed micro­
scopically for viability. 
G. Testing for Chimeric Serum 
Blocking Factors 
1. Allophenlc mouse serum and 
allophenic spleen white blood cells 
The effectiveness of allophenic mouse sera in blocking antibody 
mediated complement dependent cytotoxicity was tested on frozen-thawed 
spleen white blood cells (Section F. Preparation of Frozen Lymphocytes). 
Both the cells and the allophenic sera had been frozen one to two years 
at the time of these experiments. Only target cells showing 70% or greater 
viability two hours following thawing were used for these experiments. 
Dead cells were not removed from the population. (Ficoll-Hypaque isola­
tion of dead cells used on human lymphocytes did not work on the mouse 
lymphocytes) (Davidson and Parish, 1975). 
In a preassay step, 25 ul of allophenic target cells (1-6.0 x 10^ 
cells/ml) were mixed with 25 pi of a dilution of heat-inactivated allo­
phenic mouse serum in a 12 x 75 mm glass test tube (Tube 1, Figure 7a). 
Simultaneously, 25 pi of a dilution of anti-spleen or antl-H-2 serum was 
mixed with 25 pi of a dilution of heat-inactivated allophenic mouse serum 
CTube 2, Figure 7a). Both sets of tubes were incubated at 37° C In 7% 
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COg in air for one hour. As a control (see Figure 7b), 25 yl of an equal 
mixture of the appropriate parental type normal sera were added to a 25 pi 
aliquot of target cells (Tube 4, Figure 7b) and a 25 Ul aliquot of anti­
serum (Tube 5, Figure 7b) and incubated as above. Both the allophenic 
mouse serum and mixed parental serum were filtered with a .45 pim dis­
posable millipore filter unit (Millipore Co., Bedford, Massachusetts) and 
diluted with supplemented RPMI 1640 prior to experiments. 
Following the one hour preincubation, blocking activity was evaluated 
using the trypan blue dye exclusion assay (Section D. Antibody Mediated 
Cytotoxicity Testing, Part 2. Trypan blue dye exclusion assay). 
Briefly, as shown in Figures 7a,b in each assay 20 pil of the serum 
treated target cell suspension (Tube 1 or Tube 4, Figures 7a,b) were mixed 
with 20 yl of serum treated antiserum (Tube 2 or Tube 5, Figures 7a,b) and 
20 yl of a dilution of allophenic mouse serum or control mixed parental 
serum were added. Then 20 yl of a 1:2 dilution of agarose absorbed guinea 
pig serum were added as a source of complement. The mixture (Tube 3 or 
Tube 6, Figures 7a,b) was allowed to incubate at 37° C for one hour in 7% CO2 
in air, after which 20 yl of a 0.4% filtered trypan blue solution was 
added to each tube. After five minutes a minimum of 200 cells were assessed 
microscopically for viability. Each assay was performed in duplicate 
and the percentage of dead cells calculated. Duplicate tubes containing 
only allophenic spleen cells and supplemented RPMI 1640 served as controls 
to monitor cell death resulting from thawing. 
For each allophenic mouse, samples of cells from the two parental 
strains comprising the particular mouse were included as controls. This 
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Experiment 
Tube 1 Tube 2 
25 yl allophenic mouse 
serum 
25 yl allophenic target 
cells 
1 hour preincubation as 
37° C (7% CO^ in air) 
25 yl allophenic mouse 
serum 
25 yl anti-spleen or 
anti-H-2 serum 
Tube 3 
u 
20 yl of 1:2 guinea pig serum 
20 yl of allophenic mouse serum 
20 yl from Tube 2 
?n u1 frnm TitV>o 1 
jr 1 hour incubation at 37° C (7% C0„ in air) 
Add 20 yl of 0.4% trypan blue dye solution and score 
microscopically. 
Figure 7a. The effect of allophenic mouse serum on allophenic target 
cells 
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Control 
Tube 4 Tube 5 
w 
25 ul mixed parental serum 
25 vil allophenic target 
cells 
1 hour preincubation at 
37° C (7% CO. in air) 
25 pi mixed parental 
serum 
25 yl allophenic target 
cells 
w 
Tube 6 
u 
h 
20 yl of 1:2 guinea pig serum 
20 yl of mixed parental serum 
20 pi from Tube 5 
20 pi from Tube 4 
1 hour incubation at 37° C (7% CO^ in air) 
Add 20 pi of 0.4% trypan blue dye solution and score 
microscopically. 
Figure 7b. The effect of mixed parental serum on allophenic target cells 
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occasionally resulted in values greater than 100%. For instance, if a 
sample of anti-C57BL/6 serum showed 95% killing of the C57BL/6 cells and 
99% killing of the allophenic mouse cells of unknown composition, this 
value would be corrected to give 104% C57BL/6 as the composition of the 
allophenic mouse. 
2. Allophenic mouse serum and 
allophenic thymocytes 
The blocking activity of allophenic mouse sera was evaluated against 
frozen-thawed allophenic thymocytes using the protocol described above 
(Figures 7a,b). Anti-thymocyte sera, prepared by the reciprocal immuni­
zation protocol were used to kill thymocytes. As before, data for each 
mouse were corrected to the killing of the fresh thymocyte control, which 
occasionally resulted in values exceeding 100%. 
3. Allophenic mouse serum and parental 
spleen white blood cells 
The possible blocking activity of allophenic mouse sera was tested 
with fresh parental spleen white blood cells in the RNA synthesis assay 
(Section D. Antibody Mediated Cytotoxicity Testing, Part 3. RNA synthesis 
assay) using a 50% cytotoxic dose of antisera. The protocol is described 
in Figures 8a,b. 
In the preincubation step, 25 p i  of a spleen cell population (6.0 x 
10" cells/ml) were mixed with 25 pi of a 1:5 dilution of heat-inactivated 
allophenic mouse serum in a 12 x 75 plastic culture tube (Falcon) (Tube 
1, Figure 8a). Simultaneously, 25 pi of a dilution of anti-spleen serum 
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was selected to give approximately 50% cytotoxic endpoint upon mixing 
with the allophenic mouse serum. The 50% endpoint was determined pre­
viously using the trypan blue dye exclusion assay. Both sets of tubes 
were incubated for one hour at 37° C in 7% CO^ in air. In the control 
experiments (Figure 8b), either 1:5 normal parental or mixed parental 
serum (mixed in an equal ratio) was mixed with target cells or anti-
spleen serum and incubated under identical conditions (Tubes 4 and 5, 
Figure 8b). Blocking activity was evaluated using RNA synthesis as 
a probe of antibody mediated cytotoxicity. In each tube (Tubes 3 and 6, 
Figures 8a,b) 20 jxl of a 1:5 dilution of allophenic mouse serum or normal 
parental mouse serum replaced the 1:4 dilution of fetal calf serum de­
scribed in the RNA synthesis assay protocol. The percentage of dead cells 
was calculated using the mathematical formula previously described (Section 
D. Antibody Mediated Cytotoxicity Testing, Part 3. RNA synthesis assay, 
Paragraph a. Cytotoxic quantitation). 
4. Statistical analysis of data 
To determine whether the various serum treatments, applied to target 
cells and antisera, were significantly effective, least significant dif­
ferences ("t" test) were performed on the appropriate paired samples at 
each serum dilution. Samples were evaluated at 0.05 and 0.01 levels of 
significance. To increase the degrees of freedom all paired samples of 
serum dilutions tested for a single mouse were pooled. Statistical anal­
ysis or some of the data was perfemeu by Drs. David Cox and Mike Hand, 
Department of Statistics, Iowa State University. 
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Experiment 
Tube 1 Tube 2 
W 
25 yl allophenic mouse serum 
25 yl parental spleen cells 
1 hour preincubation at 
37° C (7% CO2 in air) 
25 yl allophenic mouse serum 
25 yl anti-spleen or anti-
H-2 serum 
Tube 3 
U 
I 
20 yl guinea pig serum 
20 yl allophenic mouse serum 
20 yl from Tube 2 
20 yl from Tube 1 
Followed 
Step 2-6 in 
Figure 3 
Figure 8a. The effect of allophenic mouse serum on parental target cells 
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Control 
Tube 4 Tube 5 
25 pi normal mouse serum 
25 yl parental spleen cells 
25 yl normal mouse serum 
25 ul anti-spleen or anti-
H-2 serum 
1 hour incubation at 37% C 
(7% COg in air) 
Tube 6 
u 
ir 
20 yl guinea pig serum 
20 y1 normal mouse serum 
20 Ml from Tube 5 
20 pi from Tube .4 
1 hour incubation at 37° C (7% CO^ in air) 
Followed Steps 2-6 
in Figure 3 
Figure 8b. The effect of normal parental mouse serum on parental 
target cells 
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III. RESULTS 
A. Allophenic Mouse Production 
and Usage 
A total of 105 allophenic mice were produced in our laboratory for 
these studies. The mice included 9 different parental combinations as 
shown in Table 5. Of the 105 mice, 56 were phenotypic males and 39 were 
phenotypic females. In addition, 48 mice showed both parental coat colors, 
while 57 mice showed one or the other parental coat color. Data are shown 
in Table 6 for allophenic mouse descriptions and experimental usages. 
The experiments in which allophenic mice were examined include cytotox­
icity testing for spleen white blood cell, peripheral white blood cell 
and thymus cell compositions, hemoglobin analysis, chimeric drift, spleen-
thymus discordance, the effectiveness of long-term cryogenic storage of 
spleen white blood cells and thymocytes, and the evaluation of serum 
blocking factors as a possible mechanism of tolerance in theaê mice. 
Tables 5 and 6 utilize the current nomenclature used in our laboratory 
for describing particular combinations of allophenic mice. Reference to 
strain 1 is used to indicate the first embryo of the aggregate, while 
strain 2 refers to the second embryo to give a 1 i—^2 allophenic mouse. 
Table 5. Summary of allophenic mouse production (1974-1977) 
Mouse lype^ Total Number Mouse Numbers 
C57BL/6<-> (A X SJL)F, 34 00
 
w
 
00
 
00
 
Ln
 
00
 
ON
 
00
 
98, 108, 109, 
J. 110, 111, 112, 113, 114, 115, 116, 
117, 118, 132, 133, 134, 135, 137, 
138, 139, 140, 141, 142, 143, 148, 
149, 150 , 151, 152 , 153 
DBA/1 (A X SJL)F^ 3 94, 99, 100 
DBA/1 A 3 182, 183, 186 
(CBA X CBA/H-T6)F, DBA/1 17 97, 103, 104, 105, 106, 107, 144, 
145, 146, 154, 163, 164, 165, 166, 
174, 175, 184 
(CBA X CBA/H-T6)F, C57BL/6 15 74, 76, 80, 81, 82, 119, 120, 121, 
1 125, 126, 127, 128, 129, 130, 131 
(CBA X CBA/H-r6)F^<-^A 5 177, 178, 179, 180, 181 
C57BL/6<-^ DBA/1 4 101, 122, 123, 124 
C57BL/6<—> A 15 157, 158, 159, 160, 162, 167, 168, 
169, 170, 171, 172, 173, 187, 188, 
191 
C57BL/10Sn A 9 205, 206, 207, 210, 211, 212, 213, 
214, 215 
''Mouse type refers to allophen.Lc mice formed by the aggregation of a strain 1 embryo with 
a strain 2 embryo to give a 1 <-> 2 allophenic mouse. 
Table 6. Allophenlc mouse descriptions and experimental usages (1974-
1977) 
Cytotoxicity 
Mouse Parental Birth Coat® Testing^ 
Number Combination Sex Date Color SWBC PWBC TWBC 
74 CBA X CBA/H-T6 4—$ C57BL/6 fi. 7/15/74 S + +(2) 
76 CBA X CBA/H-T6 < —>C57BL/6 
1 
7/ 9/74 M + +(2) 
80 CBA X CBA/H-T6 « —^C57BL/6 7/ 7/74 S + +(2) 
81 CBA X CBA/H-T6 « —» C57BL/6 7/ 7/74 S + +(2) 
82 CBA X CBA/H-T6 « —» C57BL/6 (F 7/ 7/74 M + +(2) 
83 C57BL/6 <—t A X SJL 9/ 1/74 M + +(2) 
84 C57BL/6 *A X SJL 9/ 1/74 M + +(2) 
85 C57BL/6 «—> A X SJL 0 9/ 1/74 M + +(2) 
86 C57BL/6<—» A X SJL 0» 10/ 7/74 M + +(2) 
87 C57BL/6 4—»A x SJL 
4 
10/ 7/74 M + +(2) 
*Coat color was estimated at the time of weaning. (S) and (M) refer 
to single and multicolored mice, respectively. 
^Cytotoxicity testing was performed in duplicate at various times 
during the life of the mouse and at the time of sacrifice using the try­
pan blue dye exclusion assay. The abbreviations SWBC and PWBC refer to 
spleen white blood cells and peripheral white blood cells, respectively. 
TWBC refers to thymus white blood cells. (+) or (-) indicate whether the 
composition of the mouse was determined. The number following (+) refers 
to the frequency of sample collection during the lifetime of the mouse. 
^(+) or (-) Indicate whether the hemoglobin composition was deter­
mined. The number following (+) refers to the frequency of collection 
during the lifetime of the mouse. 
^Changes In hemoglobin (Hb) or peripheral white blood cells (PWBC) 
composition with time have been called chimeric drift. (+) or (-) indi­
cate whether the mouse was tested. 
^Difference between the relative proportions of the parental white 
blood cells in the spleen and thymus is called spleen-thymus discordance. 
(+) or (-) Indicate whether the mouse was tested. 
^(+) or (-) indicate whether spleen white blood cells (SWBC) or 
thymocytes were stored in liquid nitrogen for a one-two year period. 
"(+) or (-) indicate whether allophenlc mouse serum, spleen white 
blood cells (SWBC) and(or) thymocytes were employed in the examination of 
serum blocking factors. 
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+(2) + + — + + 
+ (2) + + + + 
+(2) + + + + 
+(2) + + + + 
+(2) + + + + 
+(2) + + + + 
+(2) + + + + 
+(2) + + — + + 
+(2) + + — + + 
+(2) + + + + 
Table 6. (continued) 
Cytotoxicity 
Mouse Parental Birth Coat Testing^ 
Number Combination Sex Date Color SWBC PWBC TWBC 
94 
97 
98 
99 
100 
101 
103 
104 
105 
106 
107 
108 
109 
110 
111 
112 
113 
114 
115 
116 
117 
118 
119 
120 
121 
122 
123 
124 
125 
126 
127 
128 
129 
130 
131 
DBA/1 A X SJL 
CBA X CBA/H-T64r—^DBA/1 
C57BL/6 4—»A X SJL 
DBA/1*—> A X SJL 
DBA/1 <—*A X SJL 
C57BL/6 <—> DBA/1 
CBA X CBA/H-T6 4—> DBA/1 
CBA X CBA/H-T6 f DBA/1 
CBA X CBA/H-T6 <—> DBA/1 
CBA X CBA/H-T6 <—> DBA/1 
CBA X CBA/H-T6 4—$DBA/1 
C57BL/6<—>A X SJL 
C57BL/6 <—> A X SJL 
C57BL/6 <—> A X SJL 
C57BL/6 t—» A X SJL 
C57BL/6<—»A X SJL 
C57BL/6 <-^A X SJL 
C57BL/6 4—>A x SJL 
C57BL/6 <—> A X SJL 
C57BL/6 4—> A X SJL 
C57BL/6 4—>A x SJL 
C57BL/6<—>A X SJL 
CBA X CBA/H-T6 <—> C57BL/6 
CBA X CBA/H-T6 <—> C57BL/6 
CBA X CBA/H-T6 V-> C57BL/6 
C57BL/6 DBA/1 
C57BL/6 ^ DBA/1 
C57BL/6 4—>DBA/1 
CBA X CBA/H-T6<—»C57BL/6 
CBA X CBA/H-T6<—»C57BL/6 
CBA X CBA/H-T6 <—> C57BL/6 
CBA X CBA/H-T6 <—> C57BL/6 
CBA X CBA/H-T6 > C57BL/6 
CBA X CBA/H-T6 4—> C57BL/6 
CBA X CBA/H-T6 » C57BL/6 
i 
10/27/74 M + - -
10/27/74 M + _ 
11/12/74 S + +(2) — 
11/ 9/74 M + — 
11/ 9/74 M + -
-
10/27/74 S + +(2) 
10/27/74 S + 
10/27/74 M + — 
10/27/74 M + — 
10/27/74 S + 
- -
10/27/74 S + _ 
10/27/74 M + +(2) — 
11/16/74 S + +(2) — 
11/16/74 S + +(2) — 
11/16/74 S + +(2) -
11/25/74 S + +(2) 
11/25/74 M + +C2) — 
11/25/74 S + +(2) — 
11/25/74 S + +(2) — 
12/ 1/74 M + +(2) -
12/ 1/74 S + +(2) 
12/ 8/74 S + +(.2) — 
12/ 8/74 M + +C2) -
12/ 8/74 S + +C2) -
12/ 8/74 M + +(2) -
10/12/75 S _ + 
10/12/75 S + +(3) + 
10/12/75 M + +(3) + 
10/12/75 M + +(3) + 
10/12/75 M + +(3) + 
10/12/73 M + +(3) + 
10/12/75 M + +(3) + 
10/12/75 M +(3) + 
10/12/75 S + +(3) + 
10/12/75 S + +(3) + 
76 
j Spleen- Cryogenic Chimeric Serum 
Hemoglobin^ Chimeric Drift Thymus Storage^ Blocking 
Analysis PWBC Hb Discordance SWBC Thymocytes Experiments 
- - + + + 
- - + + + 
+ - + + 
- - + + + 
- - + + + 
+ - + + + 
- - + + + 
- - + + + 
- - + + + 
- - + + + 
- - + + + 
+ - + + 
+ - + + 
+ - + + 
+ - + + 
+ - + + 
+ - + + 
+ - + + 
+ - + + 
+ - + + 
+ - + + 
+ - + + + 
+ - + + + 
+ - + + 
+ - + + 
+ - + + + 
+ + + + + 
+ + + + 
+ + + + 
+ + + + 
+ + + + + 
+ + + + 
+ + + + 
+ + + + 
+ + + + 
+(2) + 
+(2) + 
+(2) + 
+ (2) + 
+ (2) + 
+(2) + 
+(2) + 
+(2) + 
+(2) + 
+(2) + 
+(2) + 
+(2) + 
+(2) + 
+ (2) + 
+ C2) + 
+(2) + 
+ (4) + 
+(7) + 
+ (7) + 
+ (7) + 
+(7) + 
+(7) + 
+(7) + 
+(7) + 
+(7) + 
+(7) + 
Table 6. (continued) 
Cytotoxicity 
Mouse Parental Birth Coat Testing^ 
Number Combination Sex Date Color SWBC PWBC TWBC 
132 
133 
134 
135 
137 
138 
139 
140 
141 
142 
143 
144 
145 
146 
148 
149 
150 
151 
152 
153 
154 
157 
158 
159 
160 
162 
163 
164 
165 
166 
167 
168 
169 
170 
171 
C57BL/6 
C57BL/6 
C57BL/6 
C57BL/6 
C57BL/6 
A X 
A X 
A X 
A X 
A X 
SJL 
SJL 
SJL 
SJL 
SJL 
C57BL/6 4—^ A X SJL 
C57BL/6 <—> A X SJL 
C57BL/6 t A X SJL 
C57BL/6 <—> A X SJL 
C57BL/5V—^ A x SJL 
C57BL/6 4—> A x SJL 
CBA X CBA/H-T6 S—> DBA/l 
CBA X CBA/H-T6*—» DBA/l 
CBA X CBA/H-T6<—> DBA/l 
C57BL/6 4—» A X SJL 
SJL 
SJL 
SJL 
SJL 
SJL 
-r DBA/1 
C57BL/6 «—> A X 
C57BL/6 A x 
C57BL/6<—>A X 
C57BL/6 4—>A X 
C57BL/6 > A X 
CBA X UflÂ/ ti-ïb' 
C57BL/6<—>A 
C57BL/6 f A 
C57BL/6*—> A 
C57BL/6 e—» A 
C57BL/6t—>A 
CBA X CBA/H-T6 <—> DBA/l 
CBA X CBA/H-T6<—> DBA/l 
CBA X CBA/H-T6^—> DBA/l 
CBA X CBA/H-T6<—» DBA/l 
C57BL/6^—>A 
C57BL/6<—>A 
C57BL/6«—>A 
CS/BL/6<—f A 
C57BL/6t—>A 
10/21/75 S - + (2) 
10/21/75 S + +(3) + 
10/21/75 S + + (3) + 
10/21/75 S + + (3) + 
12/22/75 S + + (3) + 
12/22/75 M + + (3) + 
12/22/75 M + +(3) + 
12/22/75 M + + (3) + 
12/22/75 M + + (3) + 
12/22/75 M + +(3) + 
12/23/75 M + +(3) + 
12/23/75 M + + (2) + 
12/23/75 S + +(2) + 
12/23/75 S + + (2) + 
2/24/76 S + +(2) + 
2/24/76 S + + (2) + 
2/24/75 S + +(2) + 
2/24/75 S + + C2) + 
2/24/75 M + +(2) + 
2/24/75 M + +(2) + 
3/ 3/76 M 4- +(2) 
4/11/76 M + +(4) + 
4/11/76 M + + (4) + 
4/11/76 M + +(4) + 
4/19/76 S + +(4) + 
4/19/76 M + +(4) + 
4/26/76 S + +(2) + 
4/26/76 M + +C2) + 
4/26/76 M + +(2) + 
4/26/76 M + +(2) + 
4/26/76 S + +(4) + 
4/26/76 M + +(4) + 
4/26/76 M - +(4) 
5/ 9/76 5 + +(4) + 
5/ 9/75 M + +(4) 
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+(6) 
+(7) 
+(7) 
+(7) 
+(7) 
+(7) 
+ (7) 
+ (7) 
+(7) 
+(7) 
+(7) 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ (3) 
+(3) 
+(3) 
+(3) 
+ (3) 
+(3) 
+ (3) 
+(3) 
+ (3) 
+(3) 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
Table 6- (continued) 
Mouse 
Number 
Parental 
Combination 
Cytotoxicity 
Birth Coat Testing^ 
Sex Date Color SWBC PWBC TWBC 
172 
173 
174 
175 
177 
178 
179 
180 
181 
182 
183 
184 
186 
187 
188 
191 
205 
206 
207 
210 
211 
212 
213 
214 
215 
C57BL/6 A 
C57BL/6 > A 
CBA X CBA/H-T6 
CBA X CBA/H-T6 
CBA X CBA/H-T6 
DBA/1 
DBA/1 
A 
CBA X CBA/H-T6 > A 
CBA X CBA/H-T6 *—> A 
CBA X CBA/H-T6 A 
CBA X CBA/H-T6 <—» A 
DBA/1 ^ A 
DBA/1 4^ A 
CBA X CBA/H-T6 
DBA/1<—» A 
C57BL/6«—»A 
C57BL/6*—> A 
C57BL/10Sn » A 
C57BL/10Sn"t-4,A 
C57BL/10SnV->A 
C57BL/10Sn«—>A 
C57BL/10Sn4r->A 
C57BL/10Sn V 
C57BL/10Sn 
C57BL/10Sn 
C57BL/10Sn 
C57BL/10Sn 
DBA/I 
cr* 
% 
(f 
(f 
(P 
% 
? 
(f 
I 
I 
I 
(f 
5/ 9/76 M + +(4) + 
5/ 9/76 M + +(4) + 
51 9/76 S + + + 
5/ 9/76 M + + + 
5/11/76 M + + -
5/11/76 M + + _ 
5/11/76 S + + -
5/11/76 S + + -
5/11/76 S + + -
5/11/76 M + + + 
5/11/76 S + + + 
5/24/76 M + + + 
5/24/76 S + + + 
5/24/76 S + +(4) + 
5/24/76 s - +(4) -
5/24/76 M + +(4) + 
10/18/77 S - +(6) -
10/18/77 s - +(6) -
10/18/77 s - + (6) -
11/14/77 s - + (6) -
11/14/77 c +(6) 
11/14/77 M - +(6) -
11/14/77 M - +(6) -
11/14/77 M - +(6) -
11/14/77 M - +(6) -
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+ (3) + 4" 4- — — — 
+ (3) + + + - — + 
+(3) + + + - - + 
+ (3) + + - — - + 
+(3) + + + -
+(6) + + - - - -
+(6) + + - - -
+(6) + + -  -  -  -
+(6) + + -
+(6) + + -  -
+(6)  +  +  -  "  ~ -
+(6 )  +  +  -  -  — -
+(6 )  +  +  -  — -  -
+(6) + + -  -  -
81 
B. Evaluation of the Trypan Blue Dye 
Exclusion Assay 
1. Analysis of anti-spleen sera 
The antisera produced against spleen cells were found to show equal 
killing of spleen and peripheral white blood cells. This was to be ex­
pected since H-2 antigens are strongly expressed on both of these types 
of cells. In all cases, the killing of cells of the strain in which each 
antiserum sample was produced was less than 10% (Figure 9). 
As expected, the spleen antisera showed poor killing of thymocytes, 
since 80-90% of thymocytes show only a low concentration of H-2 antigens 
(Klein, 1975). The errors in the analysis of peripheral white blood cells 
and spleen white blood cells were determined by analyzing artificial mix­
tures of cells. As shown in Figure 9, anti-C57BL/6 prepared in A mice, 
gave the predicted killing of artificial mixtures of C57BL/6 and A peri­
pheral white blood cells, with no significant killing of A target cells. 
Based on many repeated deterininatlcriS, the naximum error in the «nleen 
white blood cell assays is estimated to be + 10%, while the error in the 
peripheral white blood cell data is + 20%. Depending upon the particular 
preparation being tested and the strength of the antiserum used, many 
errors were lower than the maximum value. No antiserum was used if it 
killed fewer than 50% of the target cells at a 1:2 dilution. 
2. Analysis of anti-thymocyte sera 
Unlike the spleen antisera, in which cross reactivity was no problem, 
some of the anti-thymocyte sera showed a high degree of cross reactivity 
82 
60 
r=0.99 
p<aooi 
0 20 40 60 80 100 
THEORETICAL %C57BL/6 PWBC 
Figure 9. A plot of the percentage of killing of known mixtures of 
C57BL/6 and A peripheral white blood cells (PWBC) with anti-
C57BL/6 serum. ^ ) is the theoretical line through the 
points for a perfect correlation; ( ) is the least squares 
line through the points^ 
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with the recipient strain. This wasprobably due to contamination of some 
of the serum samples. Fortunately, not all anti-thymocyte sera cross-
reacted and the composition of at least one parental type of thymocytes 
in allophenic mice or artificial mixtures could be tested without the 
cross reactivity problem. Based on repeated determinations of artificial 
mixtures, the maximum error in the thymocyte determinations is estimated 
to be + 10%. 
C. SNA Synthesis Assay 
1. Analysis of antisera 
Five antiserum samples obtained either from the National Institutes 
of Health or from whole spleen cell immunizations according to the method 
of Batchelor (1973) were initially titered against spleen cell suspensions 
using the trypan blue dye exclusion assay. 
Antiserum to CBA spleen cells was prepared by immunization of 
C57BL/6 mice. Reciprocal immunizations were used to produce antisera 
against C57BL/6 and A spleen cells, to eliminate cross reaction in cell 
mixing experiments. Thus, C57BL/6 mice were injected with A spleens, 
and A mice were injected with C57BL/6 spleens. Anti-H-2 sera for use on 
the DBA/1 mice (anti-H-2^) and on the SJL mice Cantl-H-2^) were obtained 
from Research Resources Branch, National Institutes of Health. 
All antisera were titered using a constant number of target cells 
(12 X 10^ spleen white blood cells) in each assay tube. At a 1:16 anti­
serum dilution, it was found that four of the antisera killed > 95% of the 
84 
correct target cells with less than 10% killing of control cells. The 
anti-H-2^ serum gave killing endpoint ranges of 70-90% in different exper­
iments. None of the serum samples showed anti-complementary effects 
when used with guinea pig serum as the source of complement. The five 
antiserum samples were used for all subsequent experiments described in 
this section. 
2. Conditions for RNA synthesis assay 
Figure 10 shows the counts per minute (cpm) in 12 x 10^ spleen cells 
3 (A strain) labeled for the five hours with varying amounts of [ H]urldine. 
Incorporation into high molecular weight product was linear in the ranges 
3 3 
2.5 to 15 y Ci [ H]uridine/assay. Cells labeled with amounts of [ H]-
uridine greater than 20 u Ci showed decreased counts incorporated. A 
3 
concentration of 12.5 p Ci [ H]uridine/assay was chosen for all subsequent 
experiments. 
The optimal labeling period for spleen cells was five hours, as is 
shown in Figure 11. The incorporation of label into total RNA was linear 
for the five-hour period. Longer periods of labeling were found to be 
toxic to the cells. Thus, a five-hour labeling period was used for all 
subsequent experiments. 
Figures 12a, 12b, 12c, 12d, and 12e represent counts incorporated into 
spleen cells following different times of preincubation with either appro­
priate antiserum or normal serum and complement. Cells were labeled for 
a five-hour period following the preincubation. In all five experiments, 
no detectable RNA synthesis was observed after a one hour preincubation 
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Figure 10. Optimal concentration of [ H]uridine. (Counts per minute 
incorporated into high molecular weight product as a function 
of concentration of [-"HJuridineJ 
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Figure 11. Optimal time of labeling. (Counts per minute incorporated into high molecular weight 
product as a function of time of labeling in the presence of [^Hjuridinelj 
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Figure 12a. Optimal time of incubation, jcounts per minute Incorporated 
into high molecular weight product by spleen cells, incubated 
five hours in the presence of 12.5 n Ci [%]uridine per assay, 
following different periods of preincubation with antiserum 
and complement. Cells treated with a 1:16 dilution of normal 
mouse serum ( ); cells treated with a 1:16 dilution of anti­
serum ( ) 3 (A spleen cells and anti-A serum) 
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12h. C57BL/6 spleen cells and anti-C57BL/6 serum 
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Figure 12c. CBA spleen cells and antl-CBA serum 
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Figure 12d. DBA/1 spleen cells and anti-DBA/1 serum 
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Figure 12e. SJL spleen cells and anti-SJL serum 
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of cells with antiserum and complement. Samples treated with normal 
serum and complement showed good viability for a two-hour period, after 
which counts decreased. This is to be expected since guinea pig serum is 
known to contain some cytolysins (Sanderson, 1964). This could potenti­
ally be overcome by substituting rabbit serum as the source of complement. 
Thus, a one-hour preincubation period, and a five-hour labeling period 
3 
with 12.5 y Ci/assay [ H]uridine were the final conditions chosen for the 
RNA. synthesis assay. 
3. Serum dilution experiments 
Figures 13a, 13b, 13c, 13d, and 13e demonstrate comparative changes in 
cytotoxicity in both the trypan blue dye exclusion and RNA synthesis 
assays as a result of increasing serum dilutions. The target cell number 
(12 X 10^ spleen white blood cells/assay) remained constant in these ex­
periments. The curves for all five strains were subjected to a computer­
ized probit analysis (Smith et al., 1977) to determine the 50% endpoint 
for both the RNA synthesis assay and the trypan blue dye exclusion assay. 
The 50% cytotoxic endpoints were examined because they represent the most 
sensitive part of the dilution curve (Brunner et al., 1968). The data 
in Table 7 clearly show that identical serum titers are obtained using 
the two different assay procedures. 
4. Cell dilution experiments 
Figures 14a, 14b, 14c, 14d, and 14e show the results of the RNA synthesis 
assay on various numbers of spleen cells of the five different mouse 
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Figure 13a. Analysis of serum titer. (The percentage of dead cells as a function of reciprocal 
dilutions of antiserum. Each assay was performed as described in the text using 
spleen cells as the target cells. Data are shown for the RNA synthesis assay 
( ) and the trypan blue dye exclusion assay ( )3 (A spleen cells and anti-A serum) 
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Figure 13b. C57BL/6 spleen cells and anti-C57BL/6 serum 
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Figure 13d. DBA/1 spleen cells and anti-DBA/1 serum 
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Table 7. Antiserum titers determined by RNA synthesis assay and by 
trypan blue dye exclusion assay^ 
Titer 
Antisera RNA Synthesis Assay Trypan Blue Dye Exclusion 
Assay 
Anti-A 71 71 
Anti-C57BL/6 537 468 
Anti-CBA 100 138 
Anti-DBA/1 209 166 
Anti-SJL 158 182 
^Data are the results of a probit analysis of the titration curves 
according to Smith et al. (1977). The values are the computer calculated 
reciprocal serum dilutions giving a 50% cytotoxic endpoint. 
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Figure 14a. Analysis of RNA synthesis assay. Ç'he counts per minute 
incorporated into high molecular weight product as a function 
of concentration of spleen cells. The least squares linear 
regression line through the points is shown. The correlation 
coefficient, r, and probability, P, that the points are not 
correlated, have been calculated according to Bevington 
(1969)J (A spleen cells) 
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Figure 14b. C57BL/6 spleen cells 
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Figure 14c. CBA spleen cells 
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Figure 14d. DBA/1 spleen cells 
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104 
strains. The cpm incorporated reflect the number of live cells in each 
sample, so that an unknown sample may be analyzed simultaneously by com­
parison with the standard curves. Differences observed in counts incor­
porated by identical numbers of cells from mice of different strains 
were found to reflect the uniqueness of each individual cell population, 
rather than to reflect consistent differences among mouse strains. Thus, 
the differences observed within one strain from day to day were as great 
as differences observed among strains. For this reason, control experi­
ments must be included every time an assay is performed. 
Similar samples were simultaneously evaluated using the trypan blue 
dye exclusion assay. Figures 15a, 15b^ 15c, 15d, and 15e represent the 
analysis of these samples. As described in Materials and Methods, these 
samples contained mixtures of two cell types, and were treated with anti-
sera directed to one of the cell types. The percentage of dead cells 
was a reflection of the total number of cells of that type in the popu­
lation. 
Table 8 shows a comparison of the data from the two assay procedures 
utilizing all the data collected from duplicate determinations on each of 
the five mouse strains (Figures 14a, 14b, 14c, 14d, I4e, and 15a, 15b, 15c, 15d, 
and 15^. The estimated error in both the RNA synthesis and the trypan 
blue dye exclusion assays is less than 10%, As can be observed, the RNA 
synthesis assay gives comparable or better accuracy than the trypan blue 
dye exclusion assay. 
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Figure 15a. Analysis of trypan blue dye exclusion assay. (The percentage of dead cells as a 
function of concentration of spleen cells of a particular strain. The least 
squares linear regression line through the points is shown. The correlation 
coefficient, r, and probability, P, that the points are not correlated, have been 
calculated according to Bevington (1969)] (A spleen cells mixed with C57BL/6 
cells, anti-A serum) 
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Figure 15b. C57BL/6 spleen cells (mixed with A cells), anti-C57BL/6 serum 
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Table 8. Comparison of RNA synthesis assay and trypan blue dye exclusion assay^ 
Experimental Cell Number 
X 10^ 
Theoretical Cell Number RNA Synthesis Trypan Blue Dye Exclusion 
Number x 10^ Determinations Assay Assay 
12.0 10 12.1 + 
0
0
 o
 11.7 + 0,6 
10.8 10 10.7 + 1.2 10.7 + 0.6 
9.6 10 9.5 + 1.1 9.6 + 0.9 
8.4 10 8.6 + 0.9 9.0 1 +
 
o
 
7.2 10 6.7 + 1.2 7,9 + 0.4 
6.0 10 6.1 + 1.0 6.3 + 1.0 
4.8 10 4.7 + 1.0 5.0 + 0.9 
3.6 10 3.7 + 0.9 3.1 + 0.9 
2.4 10 2.2 + 0.5 2.3 + 0.6 
1.2 10 1.2 + 0.4 2.1 
CM +
1
 
^Data are compiled from duplicate assays of the A, C57BL/6, CBA, DBA/1, and SJL strains. 
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D. Evaluation of Cryogenic Storage 
of Lymphocytes 
1. The effect of "freeze-thawing" on 
lymphocyte viability 
The possible lethal effects of controlled "freeze-thawing" on the 
composition of spleen white blood cells and thymus cells from allophenic 
mice were evaluated by testing for least significant differences prior 
to, and after, cryogenic storage. Analysis of organ compositions were 
made at the time of animal sacrifice and again one-two years later. Table 
9 summarizes the results from 26 allophenic mice of five combinations. 
These combinations included 10 C57BL/6 <—> (A x SJL)F^, 3 DBA/1 <—> 
(A X SJDF^, 6 (CBA X CBA/H-T6)F^ <—> DBA/1, 4 (CBA x CBA/H-T6)P^ 4—t 
C57BL/6, and 3 C57BL/6 DBA/1 mice. 
Data are shown in Table 10 for the analysis of thymus composition 
from 21 allophenic mice of similar combinations. All the numbers in Table 
9 and 10 are the average of duplicate determinations. The average per­
centages of nonspecific ceil death for apleëù whlCe blood cells and thymus 
cells were 16% and 9%, respectively. 
2. The effects of "freeze-thawing" on 
basal levels of RNA synthesis in 
lymphocytes 
Basal levels of RNA synthesis in normal serum treated, frozen-thawed 
C57BL/6 and (A x SJL)F^ spleen white blood cells were examined using the pre­
viously described RNA synthesis assays. Viability at the termination of 
the experiment was evaluated using the trypan blue dye exclusion assay. 
Table 9. The effects of freeze-thawing on allophenic mouse spleen white 
blood cell viability 
Spleen White Blood Cells^*^ 
Mouse % Nonspecific Freshly Prepared Frozen-Thawed 
Number Cell Death %C57BL/6 %AxSJL %C57BL/6 %AxSJL 
A. C57BL/6 <—> (A x SJL)F^ 
133 16 2 112 1 88 
134 5 2 106 7 98 
135 12 2 106 1 97 
137 22 5 85 1 83 
138 18 3 101 0 96 
139 17 1 96 0 99 
140 10 3 93 15* 91 
141 6 11 102 19* 91 
142 10 14 86 10 78 
143 10 23 61 18 76 
%DBA/1 %A X SJL %DBA/1 %A x SJL 
B. DBA/1 <—> (A X SJL)F^ 
94 21 7 — 0 98 
99 23 14 — 0* 92 
100 24 16 — 1** 90 
Nonspecific percent cell death is based on duplicate values 
determined by the trypan blue dye exclusion assay approximately 4-6 
hours after thawing cells. 
^Freshly prepared spleen white blood cells refers to the spleen 
composition of allophenic mouse determined at the time of sacrifice by 
duplicate trypan blue dye exclusion assays. 
^Significance was determined by testing for the probability of a 
least significant difference with a Student's "t" test. (*) significance 
at the 0.05 level, (**) significance at the 0.01 level. 
^CBA is an abbreviation for (CBA x CBA/H-T6)F^. 
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Table 9. (continued) 
Spleen White Blood Cells^»^ 
Mouse % Nonspecific Freshly Prepared Frozen-Thawed 
Number Cell Death %CBAd %DBA/1 BCBA* %DBA/1 
C. (CBA X CBA/H-T6)F^<—> DBA/1 
97 16 33 74 25 80 
103 16 89 4 93 8 
104 28 70 22 76 26 
105 14 54 48 50 46 
106 15 2 102 2 96 
107 14 16 85 14 81 
%CBA^ %C57BL/6 %CBA^ %C57BL/6 
). (CBA X CBA/H-T6)F^<—>C57BL/6 
119 23 18 58 40* 56 
120 25 83 16 48** 49** 
125 16 15 86 21 67** 
127 25 17 69 32 70 
%C57BL/6 %DBA/1 %C57BL/6 %DBA/1 
î. C57BL/6*—>DBA/1 
101 9 14 100 — 90 
123 9 69 7 — 9 
124 9 42 35 — 18* 
Table 10. The effects of freeze-thawing on allophenic mouse thymocyte 
viability 
b c 
Thymocytes * 
Mouse % Nonspecific Freshly Prepared Frozen-Thawed 
Number Cell Death %C57BL/6 %AxSJL %C57BL/6 %AxSJL 
A. C57BL/6 4—> (A x SJL)F^ 
133 10 —  —  99 12 94 
134 6 92 5 87 
135 12 97 9 84 
137 8 — — 105 22 93 
138 10 94 21 81 
139 12 — — 93 7 85 
140 9 105 4 94 
141 — —  100 
142 10 71 1 94** 
143 64 — —  — 
%DBA/1 %A X SJL %DBA/1 %A X S JL 
Î. DBA/1 4- (A X SJL)F^ 
94 6 — —  — —  50 49 
99 10 17 80 
100 13 31 56 
a 
Nonspecific percent cell death is based on duplicate values 
determined by the trypan blue exclusion assay approximately 4-6 hours 
after thawing cells. 
^Freshly prepared thymocytes refers to the thymus composition of an 
allophenic mouse determined at the time of sacrifice by duplicate trypan 
blue dye exclusion assays. 
^Significance was determined by testing for the probability of a 
least significant difference with a Student's "t" test. (*) significance 
at the 0.05 level, (**) significance at the 0.01 level. 
"^CBA is an abbreviation for (CBA x CBA/H-T6)F^. 
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Table 10. (continued) 
Thymocytes'»^ 
Mouse % Nonspecific Freshly Prepared Frozen-Thawed 
Number Cell Death %CBA^ %DBA/1 "%CBp %DBA/1 
C. (CBA X CBA/H-T6)F^<—» DBA/1 
97 11 — — — 63 
103 10 — — — 20 
105 11 — — — 42 
106 7 — — — 90 
107 16 — — — 96 
%C57BL/6 %DBA/1 %C57BL/6 %DBA/1 
D. C57BL/6<—> DBA/1 
101 9 — — — 105 
123 9 — 85 — 84 
124 9 — 71 — 81 
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Results indicated that in samples of spleen cell suspensions showing 
70-80% viability, only slightly significant levels of ENA synthesis were 
measured above background. Control samples containing freshly prepared 
spleen white blood cells gave counts per minutes four times greater than 
frozen-thawed cells. Repeated experiments, in which cells were thawed 
five hours before measuring basal levels of RNA synthesis, gave similar 
results. 
E. Polyacrylamide Gel Isoelectric 
Focusing (PAGIF) 
1. Hemoglobin resolution 
Figure 16 shows the isoelectric focusing gels of various inbred 
strains and F^ hybrids described in Table 2. These patterns are predicted 
from the electrophoretic studies of Button et al. (1962 a,b) and from 
the sequencing work of Oilman (1972), which have shown that some inbred 
strains of mice produce two hemoglobin g-chains in unequal amounts while 
other strains produce a single g-chain. None of the strains studied 
have any known electrophoretically distinct products in the hemoglobin 
a-chain. There are several interesting observations to be made from Figure 
16. First, the single type of hemoglobin and diffuse (double) types of 
hemoglobin migrate to different positions on the isoelectric focusing 
gels. Second, the two single hemoglobins migrate identically with each 
other, and the four double hemoglobins migrate identically with each other. 
Thus, mixtures of two single hemoglobins or two double hemoglobins cannot 
be resolved. Third, it is seen from the (A x SJL)F^ mice that the 
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Figure 16. Polyacrylamide gel isoelectric focusing patterns of 
hemoglobin samples from inbred and F^ mice 
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Figure 17. Polyacrylamide gel isoelectric focusing patterns of known 
mixtures of C57BL/6 and A hemoglobins 
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hemoglobins in mice are expressed in a codominant fashion. Each gel 
shown in Figure 16 had the same total amount of hemoglobin (350 pg) ap­
plied to the gel. Therefore, the concentration of both the A and SJL 
components of the (A x SJL)F^ hybrid are present at one-half the concen­
tration of the individual A and SJL standards. At this concentration 
the minor component of the A hemoglobin from the (A x SJL)F^ hybrid cannot 
be seen. 
Figure 17 shows the isoelectric focusing gels of various mixtures of 
C57BL/6 and A hemoglobins. It is seen that this technique resolves the 
diffuse (double) hemoglobin of the A mice into a major band and a minor 
band, and that under proper conditions both bands migrate to a different 
point than the single band from the C57BL/6 mice. This is a marked ad­
vantage of this isoelectric focusing technique compared to other electro-
phoretic techniques which have been used in the past. It is this separa­
tion of the diffuse (double) and single hemoglobins that has allowed the 
quantitation of miXLures of the two hemoglobin types. 
The analysis of artificial mixtures of C57BL/6 hemoglobin with 
(A X SJL)F^, (CBA X CBA/H-T6)F^, DBA/1, A and C57BL/10Sn hemoglobin with 
A is shown in Table 11. Each of the data forms a standard curve from 
which the unknown composition of an individual allophenic mouse may be 
calculated. Representative standard curves for C57BL/6 hemoglobin with 
A and C57BL/10Sn hemoglobin with A are shown in Figures 18 and 19, respec­
tively. These standard curves were formed after gels were scanned at a 
wavelength of 576 nm and the area under the C57BL/6 or C57BL/10Sn peak 
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Table 11. Analysis of artificial mixtures of hemoglobins 
A. C57BL/6 and A x SJL 
Theoretical Percentages Experimental 
Number Amount A 
% C57BL/6 %AxSJL % A of Total Determinations (Mean + S.D.) 
100 0 0 — — 
90 10 5 18 2 +6 
75 25 12.5 12 14 + 14 
50 50 25 16 27 + 10 
25 75 37.5 8 34+10 
1 0  9 0  4 5  4  4 3  + 4  
0 100 50 15 51 +7 
B. C57BL/6 and CBA 
Theoretical Percentages 
Number Experimental Amount 
% C57BL/6 % CBA Determinations C57BL/6 (Mean + S.D.) 
100 0 16 103 + 7 
90 10 14 87 + 5 
75 25 12 69 + 8 
6 0  4 0  6  5 8 + 3  
5 0  5 0  1 7  5 1 + 8  
2 5  7 5  1 6  2 8 + 8  
1 0  9 0  6  1 4 + 3  
0 100 — — 
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Table IL (continued) 
C. C57BL/6 and DBA/1 
Theoretical Percentages 
Number Experimental Amount 
% C57BL/6 %DBA/1 Determinations C57BL/6 (Mean + S.D.) 
100 0 6 102 + 3 
90 10 4 81 + 3 
75 25 5 69 + 3 
60 40 2 57 + 4 
50 50 6 52 + 6 
25 75 6 29 + 4 
10 90 2 17 + 3 
0 100 
D. C57BL/6 and A 
Theoretical Percentages 
Number Experimental Amount 
% C57BL/6 % A Determinations C57BL/6 (Mean + S.D.) 
100 0 2 100 + 13 
90 10 2 75 + 21 
80 20 2 86 + 10 
7 0  3 0  2  6 9  + 6  
6 0  4 0  2  6 6  + 8  
5 0  5 0  2  5 4 + 9  
40 60 2 48 + 13 
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Table 11. (continued) 
D. C57BL/6 and A 
Theoretical Percentages 
Number Experimental Amount 
% C57BL/6 % A Determinations C57BL/6 (Mean + S.D.) 
30 70 2 
20 80 2 
10 90 2 
0 100 
E. C57BL/10Sn and A 
Theoretical Percentages 
Number Experimental Amount 
% C57BL/10Sn % A Determinations C57BL/10Sn (Mean + S.D.) 
100 0 2 92 + 8 
90 10 2 91 + 2 
80 20 2 82 + 5 
70 30 2 69 + 1 
60 40 2 68 + 5 
50 50 2 48 + 1 
40 60 2 39 + 7 
30 70 2 29 + 1 
20 80 2 2 2 + 1  
10 90 2 7.5 + 1 
0 100 
25 + 4 
16 + 2 
6 + 2 
120 100 20 
%C57BL/6 HEMOGLOBIN 
Figure 18. The area under the C57BL/6 peak as a function of the percentage of C57BL/6 hemoglobin 
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Figure 19. The area under the C57BL/lOSn peak as a function of the percentage of C57BL/10Sn 
hemoglobin 
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was plotted as a function of the percentage of single type hemoglobin 
applied on the gel. The compositions of the unknown allophenic mice of 
these combinations were determined by comparing the area under the single 
type hemoglobin peak with the standard curve. 
It can be seen in Table 11 that for the C57BL/6 with CBA and C57BL/6 
with DBA/1 mixtures, there is a definite tendency for the amount of 
C57BL/6 hemoglobin to be overestimated when it is less than or equal to 
10% of the total mixture. The relatively large error in the C57BL/6 with 
(A X SJL)F^ mixtures is due to the fact that the C57BL/6 and SJL hemo­
globins comigrate in the gels. Thus, these gels must be quantitated for 
the percent A hemoglobin, and since this value can never be more than 
50% of the total, there is an increase in the error, especially at the 
points with a low percent of A hemoglobin compared to the total. 
2. Isoelectric points of murine 
hemoglobins 
Figure 20 illustrates the pH gradient formed during a four hour 
electrophoresis using a 7% polyacrylamide gel containing a total of 2% 
(3-10)(6-8) ampholytes and 5Z glycerol. The standard curve from which 
unknown isoelectric points could be estimated was established by drawing 
a least squares line through the measured pH values as a function of gel 
length. The good linearity observed in the pH range of 5.5-8.0 is attrib­
uted to the enrichment with ampholytes (6-8) in that part of the gel. 
Table 12 summarizes the isoelectric point values of hemoglobin samples 
from six inbred strains of mice and (A x SJL)F^ hybrids before and after 
Q. 
3 — 
10 8 6 9 0 4 1 2 7 3 5 
DISTANCECcm) 
Figure 20. pH gradient obtained in 10 cm polyacrylamide gel containing 2% ampholytes (3-10)(6-8) 
and 5% glycerol. jpH m&asurements were made at room temperature^ 
Table 12. Isoelectric points of hemoglobins from inbred and hybrid mice 
Isoelectric Points (pi) a 
Mouse 
Type 
Before Chemical Modification 
Hemoglobin Single Type Diffuse(double) Type 
Type Major Band Major Band Minor Band 
After Chemical Modification 
Single Type Diffuse(double) Type 
Major Band Major Band Minor Band 
Inbred Strains 
C57BL/6 
C57BL/10Sn 
SJL 
A 
CBA 
DBA/1 
Hybrid 
(A X SJL)F, 
Single 
Single 
Single 
Diffuse 
(double) 
Diffuse 
(double) 
Diffuse 
(double) 
Diffuse 
(double)-
Single 
7.33 + .02 
7.33 + .02 
7.30 
7.48 + .08 7.58 + .02 
7.45 + .05 7.60 
7.48 + .05 7.63 + .02 
7.52 + .02 
7.52 + .02 
7.55 
7.75 
7.75 
7.75 
7.86 
7.86 
7.86 
7.4 + .10 7.5 + .02 7.63 + .02 7.58 + .02 7.73 + .02 7.84 + .03 
^Isoelectric point estimations of hemoglobins are based on duplicate determinations and values 
are reported as pi + standard deviation. 
^This refers to the genetic polymorphism in Hbb (Hutton et al., 1962a,b; Oilman,1972). Electro­
phoresis shows Hbb either as a "single" or as a "diffuse" species. In this study, isoelectric focus­
ing further defines Hbb as two bands, which is referred to as double hemoglobin. 
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chemical modification with cystamine dihydrochloride. In Table 12, it 
can be seen that the single Hbb(C57BL/6, C57BL/10Sn, SJL) and diffuse 
Hbb(A, CBA, DBA/1) have different isoelectric points (pi) before and after 
chemical modification. However, after treatment with the cystamine de-
hydrochloride, the hemoglobin resolution of single and double mixtures, 
as shown in (A x SJL)F^ mice, are optimized. This is achieved by the 
addition of an S-ethylamine group to the cysteine at position 13 of the 
double Hbb type, while the glycine at the same position in the single 
Hbb type remains unchanged (see Figure 16) (Wegmann and Oilman, 1970). 
In addition, it can be seen that there are no significant differences in 
the pi values of hemoglobins of the single Hbb type among strains of mice. 
This observation is also true for the diffuse Hbb type mouse strains. 
This suggests that any possible substitutions existing between mouse 
strains of the same Hbb type are conserved, and therefore, hemoglobins 
of a type are electrophoretically identical, 
F. Analysis of Changes in Red Blood Cell and 
White Blood Cell Populations in 
Allophenic Mice 
The results of hemoglobin and peripheral white blood cell determinations 
on 28 C57BL/6t—> (A x SJL)F^, 15 (CBA x CBA/H-T6)F^ <—> C57BL/6, 4 
C57BL/6<—> DBA/1, 15 C57BL/6 t—) A, and 9 C57BL/10Sn <—> A allophenic 
mice are summarized in Tables 13, 14, 15, 16, and 17, and shown in Figures 
21 , 22 , 23, 24 , and 25, respectively. It is seen that Figures 21, 22, 
and 23 consist of two sets of data. In the first set, hemoglobin and 
peripheral white blood cell composition were tested twice, at an interval 
Table 13. Analysis of C57BL/6<—V (A x SJL)F^ allophenic mice 
Percentage of C57BL/6 PWBC or Hb^ 
First Second Third 
Mouse Determination Determination Determination 
umber PWBC Hb PWBC Hb PWBC Hb 
83 48 + 0 17 10 + 0 21 + 1 — — — 
84 63 + 0 4 0 + 9  16 + 2 0 + 0 — 
85 56 + 0 100 + 0 29 + 4 37 — 
86 10 ±0 31 + 2 6 + 1 7 — 
87 -6 + 0 14 +14 46 + 2 14 +14 — 
98 44 + 2 5 8 + 7  4 + 0 5 8 + 8  — 
108 40 + 8 52 7 + 1 34 —-
109 8 + 3  10 10 + 2 3 — 
110 84 + 5 100 + 0 79 + 2 100 + 0 — 
111 13 + 3 15 + 9 11 + 2 8 — 
112 46 + 5 54 +13 32 + 4 34 — 
113 -11 + 5 0 + 0 -5 + 4 34 +13 
— —  
114 27 + 6 1 + 1 16 + 3 58 + 3 —  —  — 
115 87 + 0 90 +10 94 + 4 87 +13 — —  
116 0 + 0 3 + 3 12 + 2 3 + 3 — 
117 -4 + 5 34 13 + 3 21 + 9 — 
118 91 + 4 92 93 + 1 90 
— —  
132 20 +18 — 21 + 4 9 + 1 
133 0 + 0 — 8 + 1 10 + 10 
134 27 + 6 — 18 +18 11 + 11 
135 0 + 0 — 1 + 1 0 + 0 
137 33 + 4 — 0 + 0 43 + 20 
138 39 + 2 — 39 +10 23 + 7 
139 37 + 0 — 35 + 8 35 + 1 
140 27 +11 14 + 13 24 + 1 
141 31 + 1 32 + 4 —• 30 + 11 
142 50 + 0 4 0 + 7  50 + 2 
143 — — 100 + 0 — — 47 + 1 — —  37 + 5 
^The percentage of C57BL/6 peripheral white blood cells (PWBC) or of 
hemoglobin (Hb) was determined as described in the Materials and Methods 
section. 
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Percentage of C57BL/6 PWBC or Hb^ 
Fourth Fifth Sixth Seventh 
Determination Determination Determination Determination 
PWBC Hb PWBC Hb PWBC Hb PWBC Hb 
1 + 0 
3 + 2 
1 + 1 
7 + 1 
3 
3 + 1 
6 + 6 
11 + 1 
11 + 1 
12 + 7 
24 + 5 
18 +12 
16 + 4 
21 + 4 
3 + 3 
23 + 3 
45 + 5 
29 + 6 
34 + 7 
22 + 3 
43 + 9 
50 + 2 
3 + 3  24 + 4 
1 + 1  
14 +10 
13 + 2 
20 + 0 
9 + 5 
26 + 3 
41 + 7 
29 + 1 
72 + 0 
42 + 3 
1 + 0 
3 + 0 
0 + 0 
2 + 1 
2 + 0 
1 + 1 
0 + 0 
0 + 0 
7 + 2 
19 + 3 
3 + 3 
0 + 0 
0 + 0 
7 + 0 
0 + 0 
27 + 2 
25 + 0 
21 
30 + 0 
50 + 0 
45 + 3 
1 + 0 
3 + 2 
2 + 2 
1 +1 
8 + 1 
6 + 1 
2 + 0 
1 
23 + 3 
24 + 5 
3 + 2  
1 0 + 5  
1 3 + 8  
11 + 7 
28 + 4 
10 + 5 
30 +10 
2 0 + 3  
46 + 0 
41 + 0 
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Table 14. Analysis of (CBA x CBA/H-T6)F^ <—>C57BL/6 allophenic mice 
Percentage of C57BL/6 PWBC or Hb^ 
First Second Third 
Mouse Determination Determination Determination 
Number PWBC Hb PWBC Hb PWBC Hb 
74 71 + 2 101 99 + 1 101 —— 
76 84 + 4 35 85 + 0 106 
80 74 + 3 79 103 + 1 101 
81 86 + 5 83 105 + 1 100 —— 
82 47 + 5 103 61 + 0 103 —— 
119 77 + 2 108 66 + 3 53 
120 27 + 3 45 41 + 2 33 
121 79 ± 2 113 62 ± 4 110 
125 — —  105 — 108 —— 103 + 5 
126 w 50 — 44 62 
127 —— 56 + 2 — 74 +13 59 + 2 
128 —— 83 + 3 — 83 83 + 8 
129 « 59 + 6 — 51 + 4 —— 66 + 2 
130 — 20 + 1 — 8 + 1 6 + 2 
131 23 — 15 + 2 13 
^The percentage of C57BL/6 peripheral white blood cells 
(PWBC) or of hemoglobin (Hb) was determined as described in the Mater­
ials and Methods section. 
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Percentage of C57BL/6 or Hb^ 
Fourth Fifth Sixth Seventh 
Determination Determination Determination Deterimantion 
PWBC Hb PWBC Hb PWBC Hb PWBC Hb 
— —  
— 
— 
— — 
— —  — MM 
— —  
— 
— — 
— —  
— —  MB 
— —  — 
— —  
— 
— —  — —  
— 
—— 
—-
mmmm 
— 
— — 
93 + 1 93 + 1 — —  98 + 1 74 + 2 87 + 4 83 + 1 90 
52 + 2 58 + 2 — —  74 + 3 48 + 0 69 + 2 72 + 0 82 + 5 
88 + 1 61 + 2 — —  56 60 +10 71 + 3 69 + 1 92 + 1 
93 + 5 94 + 6 — —  79 + 4 31 + 1 77 + 2 52 + 0 85 
8 + 2 53 + 3 — —  81 + 6 20+1 65 + 3 19 + 6 78 
0 9 + 1 — —  6 0 0 + 0 0 + 0 0 + 0 
0 12 •» 10 + 2 1 + 1 2 1 + 0 4 
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Figure 22, (continued) 
Table 15. Analysis of C57BL/6 <—) DBA/1 allophenic mice 
Percentage of C57BL/6 PWBC or Hb^ 
First Second Third 
Mouse Determination Determination Determination 
Number PWBC Hb PWBC Hb PWBC Hb 
101 15+0 6 13+0 10 
122 — 25 + 5 — 4 — 4 + 2 
123 — 91 — 108 + 2 — 96 + 3 
124 — 66 + 6 — 72 — 50 
*The percentage of C57BL/6 peripheral white blood cells (PWBC) or 
hemoglobin (Hb) was determined as described in the Materials and Methods 
section. 
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Percentage of C57BL/6 PWBC or Hb^ 
Fourth Fifth Sixth Seventh 
Determination Determination Determination Determination 
PWBC Hb PWBC Hb PWBC Hb PWBC Hb 
0  +  0  4 + 2  —  —  
7 0 + 3  1 0 1  +  1  —  1 1 0  +  7  
43 + 0 54 — 57 
43 +2 107 79 + 3 100 
3 4  +  3  5 2  +  1  6 9  +  2  5 5 + 3  
Figure 23. 
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Hemoglobin and peripheral white blood cells (PWBC) composition of C57BL/6 
DBA/1 mice as a function of age of mice. ]s and M refer to single- and multi 
colored mice, respectivelyQ 
Table 16. Analysis of C57BL/6 <—allophenic mice 
Percentage of C57BL/6 PWBC or Hb 
Mouse FiLrst Second Third 
Number Deteniinatlon Determination Determination 
PWBC Hb PWBC Hb PWBC Hb 
170 4 + 1 5 + 2 3 + 1 6 + 1  4 + 1 0 + 0 
159 32 + 7 49 + 5 48 + 2 33 + 0 14 + 3 82 
162 59 + 1 69 + 3 66 + 6 70 + 0 27 + 6 66 + 4 
171 28 + 1 41 + 5 32 + 1 15 + 3 8 + 1 12 
191 42 + 4 51 + 9 28 + 0 51 +21 11 + 3 7 + 2 
169 60 + 8 76 + 3 61 + 4 65 +10 62 + 2 58 
172 56 + 6 73 46 + 4 54 36 + 0 4 3 + 2  
173 71 + 1 76 + 4 58 + 4 79 + 1 25 + 0 57 
168 102 + 0 100 113 + 7 99 + 5 102 + 4 89 + 3 
158 99 + 9 95 + 2 44 + 4 72 + 3 107 + 1 98 + 3 
157 92 + 7 96 +18 91 + 2 97 + 1 97 + 4 89 
160 90 + 1 96 + 2 87 + 1 83 + 8 57 + 1 88 
167 80 + 6 93 +11 106 + 1 92 + 7 77 + 1 102 +25 
187 96 + 1 80 + 5 58 + 1 95 +12 56 + 5 103 + 0 
188 119 + 5 67 79 + 1 93 + 25 84 + 6 93 + 0 
'^The percentage of C57BL/6 peripheral white blood cells (PWBC) or of hemoglobin (Hb) was 
determined as described in the Materials and Methods section. 
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Figure 24. Hemoglobin and peripheral white blood calls (PWBC) composition of C57BL/6 <—>A 
mice as a function of age of mice, js and M refer to single- and multicolored 
mice, respectively!] 
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Figure 24. (continued) 
Table 17. Analysis of C57BL/10Sn4—^ A allophenic mice 
Percentage of C57BL/10Sn PWBC or Hb^ 
First Second Third 
Mouse Determination Determination Determination 
Number PWBC Hb PWBC Hb PWBC Hb 
205 0 + 0 2 + 0 6 + 2 2 + 3 3 + 1 3 + 2 
206 97 + 0 107 + 4 91 + 5 77 + 2 111 + 0 91 + 5 
207 97 + 2 82 + 0 94 + 2 82 + 0 99 + 2 83 + 1 
210 3 + 3 48 + 0 10 + 7 54 + 6 9 + 2 22 + 5 
211 0 + 0 45 + 1 6 + 3 35 + 1 3 + 1 3 0 + 3  
212 2 + 1 25 + 0 38 + 5 27 + 0 21 + 6 33 + 1 
213 103 + 5 66 + 1 90 + 2 67 + 1 103 + 2 49 + 4 
214 91 + 5 65 + 1 67 + 4 58 + 3 45 + 0 68 + 5 
215 105 + 3 9 0 + 1  94 + 3 105 + 0 103 + 6 74 + 6 
*The percentage of C57BL/10Sn white blood cells (PWBC) or of 
hemoglobin (Hb) was determined as described in the Materials and Methods 
section. 
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Percentage of C57BL/10Sn PWBC or Hb^ 
Fourth Fifth Sixth 
Determination Determination Determination 
PWBC Hb PWBC Hb PWBC Hb 
2 + 5 0 + 0 15 + 6 1 + 1 0 + 0 2 + 0 
104 + 0 101 + 2 95 + 1 75 + 0 100 + 2 100 + 0 
103 + 1 78 + 9 94 + 0 63 + 3 96 + 2 74 + 2 
2 + 1 49 + 1 0 + 0 3 7 + 2  1 + 1 36 + 1 
9 + 8  41 + 1 0 + 0 25 + 1 2 + 1 27 + 4 
23 + 5 32 + 1 43 + 9 40 + 2 65 + 5 56 + 0 
67 +14 52 + 4 58 + 8 68 + 1 66 +14 49 + 1 
7 1 + 2  75 + 7 28 + 5 62 + 7 65 +11 54 + 1 
106 + 4 67 + 4 91 + 0 70 + 0 9 8 + 3  72 + 1 
#205(5)(f «206 (S) (f #2% (5)6" 
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Figure 25. Hemoglobin and peripheral white blood cell (PWBC) composition of C57BL/10Sn4—>A 
mice as a function of age of mice, (s and M refer to single- and multicolored mice, 
respectivelyj 
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Table 18. Analysis of C57BL/10Sn <—> A allophenic mice 
Mouse 
Number 
Percentage of C57BL/10Sn or A PWBC" 
First 
Determination 
C57BL/ A 
lOSn 
Second 
Determination 
C57BL/ A 
lOSn 
Third 
Determination 
C57BL/ A 
lOSn 
205 o
 
1+
 
0 99 + 1 6 + 2 99 + 1 3 + 1 104 + 5 
206 97 + 0 0 + 0 91 + 5 2 + 2 111 + 0 0 
207 97 + 2 7 + 1 94 + 2 2 + 1 99 + 2 9 + 1 
210 3 + 3 100 + 2 10 + 7 96 + 8 9 + 2 98 + 3 
211 0 + 0 106 + 2 6 + 3 101 + 2 3 + 1 102 + 4 
212 2 + 1 92 + 1 38 + 5 80 + 2 21 + 6 74 + 1 
213 103 + 5 18 + 0 90 + 2 21 + 1 103 + 2 5 + 2 
214 91 + 5 24 + 5 67 + 4 27 + 4 45 + 0 56 + 3 
215 105 + 3 1 + 0 94 + 3 1 + 1 103 + 6 8 + 1 
*The percentage of C57BL/10Sn or A peripheral white blood cells 
(PWBC) was determined as described in the Materials and Methods sec­
tion. 
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Percentage of C57BL/10Sn or A PWBC^ 
Fourth Fifth Sixth 
Determination Determination Determination 
C57BL/ A C57BL/ A C57BL/ A 
lOSn lOSn lOSn 
2 + 5 105 + 2 15 + 6 7 8 + 0  0 + 0 101 + 2 
104 + 0 2 + 1 95 + 1 8 + 4 100 + 2 3 + 1 
103 + 1 4 + 1 94 + 1 4 + 1 96 + 2 6 + 1 
2 + 1  104 + 2 0 + 0 95 + 0 1 + 1 9 2 + 7  
9 + 8 99 + 5 0 + 0 97 + 6 2 + 1 98 + 3 
23 + 5 87 + 6 43 + 0 61 +10 6 5 + 5  56 + 4 
67 +14 44 + 0 58 + 8 6 8 + 7  66 +14 5 2 + 6  
7 1 + 2  53 + 0 28 + 5 74 + 2 65 +11 4 1 + 2  
106 + 4 15 + 3 91 + 0 7 + 1 98 + 3 1 + 1 
#205(5)6" #;206(S)(? #207 (S) d" 
0 40-
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Figure 26. Peripheral white blood cell (PWBC) composition of C57BL/10Sn<—>A mice as a function 
of age of mice. S and M refer to single- and multicolored mice, respectively. 
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of from two to five months apart. In the second set, hemoglobin 
composition was tested monthly for six to eight months, and the peripheral 
white blood cell composition was tested three times at two-month inter­
vals. It is seen from Figures 21, 22, and 23 that the allophenic mice 
were between two and sixteen months of age for all of the determinations. 
The peripheral white blood cell and hemoglobin compositions of 15 
C57BL/6 <—mice as shown in Figure 24 were measured at either two or 
three months of age (first determination), one month later (second deter­
mination) and then three months after that (third determination). For 
all three determinations, the peripheral white blood cell and hemoglobin 
were collected within one day of each other. 
Data shown in Figure 25 summarizes the peripheral white blood cell 
and hemoglobin composition of 9 C57BL/10Sn4—mice. Six weekly samples 
were collected from mice either 11 or 15 weeks of age at the beginning of 
the experiment. Data presented in Table 18 and Figure 26 show in detail 
the changes in both parental types peripheral white blood cells during 
the same time period. Almost all of the data presented in Tables 13, 14, 15, 
16, 17, 18, and Figures 21, 22, 23, 24, 25, and 26 are the average of 
duplicate determinations. The number of each mouse, its sex, and whether 
or not it was single (S)-colored or multi (M)-colored are shown in each 
graph. 
Data are shown in Table 19 for the analysis of the parental types 
peripheral white blood cells at time 0 (two months before sacrifice) and 
time 0+2 (time of sacrifice) for 33 allophenic mice. The mice included 
Table ISL Analysis of peripheral white blood cell changes in allophenic mice^ 
Peripheral Peripheral 
Age at White Blood White Blood 
Mouse Coat Color Phenotype Sacrifice Cells-Time 0^ Cells-Time (0+2) 
Number Sex %C57BL/6 %AxSJL (Months) %C57BL/6 %AxSJL %C57BL/6 %A X SJL 
A. C57BL/6<—» (A x SJL)F^ 
133 a" 0 100 11 1 + 0 109 + 1 1 + 0 91 + 4 
134 9. 0 100 11 3 + 1 100 + 3 3 + 2 93 + 3 
135 & 0 100 11 0 + 0 105 + 3 2 + 1 89 + 4 
137 5 0 100 9 2 + 1 100 + 0 1 + 1 96 + 3 
138 Q 15 85 9 2 + 1 73 + 1 8 + 2 110 + 5 
139 (f 20 80 9 1 + 1 70 + 3 6 + 5 74 + 4 
140 0 25 75 9 0 + 0 82 + 5 2 + 2 98 + 3 
141 30 70 9 0 + 0 61 + 4 1 + 0 120 + 20 
142 (f 85 15 9 7 + 6 57 + 4 23 + 1 73 + 1 
143 (f 95 5 9 19 + 2 70 + 1 24 + 5 80 + 1 
148 Q 0 100 11 5 + 1 102 + 3 11 + 2 96 + 2 
149 0 100 11 5 + 0 100 + 0 11 + 3 98 + 0 
150 0 0 100 11 3 + 1 94 + 1 9 + 5 107 + 2 
151 T 5 95 11 7 + 1 97 + 2 4 + 5 107 + 2 
152 Q 15 85 11 4 + 3 97 + 3 6 + 0 97 + 1 
153 9 80 20 11 22 + 1 71 + 4 10 + 1 103 + 5 
^All values are the average of duplicate determinations. 
^Coat color was estimated visually at the time of weaning. 
^Time 0 Is two months before sacrifice. Time (0+2) is the time of sacrifice. 
Table 19. (continued) 
Peripheral Peripheral 
U Age at White Blood White Blood 
Mouse Coat Color Phenotype Sacrifice Cells-Time 0^ Cells-Time (0+2) 
Number Sex %CBA<1 %DBA/1 (Months) %CBAd %DBA/1 % CBAÛ % DBA/1 
B. (CBA X CBA/H-T6)F^ t— >DBA/1 
144 (F 50 50 13 Haw 32 + 2 62 + 1 
145 CT' 100 0 13 —— 3 + 0 —— 3 + 0 
146 Î 100 0 13 — 14 + 3 —— 3 + 0 
154 60 40 10 17 + 1 —— 6 + 0 
163 a 0 100 9 100 + 2 —— 93 + 0 
164 & 5 95 9 64 + 4 —— 67 + 0 
165 2' 
50 50 9 — — 2 + 2 —— 3 6 + 5  
166 ? 40 60 9 20 + 2 
" 
38 + 3 
ZCBA^ %C57BL/6 %CBAD %C57BL/6 %CBAD %C57BL/6 
C. (CBA X CBA/H-T6)F^ <— > C57BL/6 
125 (f 15 85 11 0 + 0 74 + 2 1 + 0 83 + 4 
126 CF 60 40 11 42 + 2 48 + 1 58 + 5 72 + 1 
127 Cf 90 10 11 19 + 1 69 + 2 17 + 1 6 9 + 7  
128 CF 95 5 11 20 + 3 31 + 1 32 +3 52 + 2 
129 Q 98 2 11 95 + 1 20 + 3 67 + 4 19 + 0 
130 & 100 0 11 108 + 2 0 + 1 78 + 3 0 + 0 
131 Cf 100 0 11 105 + 3 1 + 0 100 + 0 1 + 2 
"^CBA is an abbreviation for (CBA x CBA/H-T6)F^. 
Table 19. (continued) 
y Age at 
Peripheral 
White Blood 
Peripheral 
White Blood 
Mouse Coat Color Phenotype Sacrifice Cells-Time 0^ Cells-Time (0+2) 
Number Sex %C57BL/6 %DBA/1 (Months) %C57BL/6 %DBA/1 %C57BL/6 %DBA/1 
D. C57BL/6<—» DBA/1 
123 d* 100 0 16 34 + 1 2 + 2 79 + 2 15 + 3 
124 (f 50 50 16 43 + 2 18 + 2 69 + 4 39 + 1 
159 
16 C57BL/6 <—> (A x SJL)F^ (10 mice previously characterized in Table 13, 
plus 6 additional mice), 8 (CBA x CBA/H-T6)F^ 4—> DBA/1, 7 (CBA x CBA/ 
H-T6)F^<—>C57BL/6 (all mice previously characterized in Table 14). Of 
the mice, 20 were phenotypic males and 13 were phenotypic females. In 
addition, 20 of the mice showed both parental coat colors, which 13 of 
the mice showing one or the other parental coat color. All the experi­
mental values in Table 19are the average of duplicate determinations. 
Changes in hemoglobin or peripheral white blood cell composition with 
time have been called chimeric drift. A summary of the mice which have 
shown chimeric drift is shown in Table 20. 
Table 21 summarizes the statistical analysis of the correlation of 
hemoglobin and peripheral white blood cell composition of allophenic mice 
at all time points. Data were taken from Tables 13, 14, 15, 16, and 17 
for Table 21. Unstable mice refers to allophenic mice showing marked 
changes in their red blood cell or white blood cell populations with time. 
Stable aies show no change= Figure 27 shows a plot of the hemoglobin 
composition of 15 C57BL/6 <—> A mice as a function of their peripheral 
white blood cell composition at any given time point. Data for Figure 27 
were taken from Table 16. 
G. Composition of the Immune System 
of Allophenic Mice 
The characterization of the 93 allophenic mice used in this study 
is shown in Table 22. The mice included 34 C57BL/6 <—> (A x SJL)F^ 
mice, 3 DBA/1^—> (A x SJL)F^ mice, 3 DBA/1<—^ A 
Table 20. List of allophenic mice showing chimeric drift 
Mouse Type 
Number Mice 
Tested 
Hemoglobin PWBC 
Hemoglobin Drift 
Total Num- Mouse 
ber Mice Number 
PWBC Drift 
Total Num­
ber Mice 
Mouse 
Number 
A. C57BL/6 (AxSJL)F^ 28 34 
B. (CBA X CBA/H-T6)F^ <->DBA/1 0 8 
C. (CBA X CBA/H-T6)F^<—>C57BL/6 15 15 
D. C57BL/6^> DBA/1 4 4 
E. C57BL/6^>A 15 15 
F. C57BL/lOSn<r->A 9 9 
5 84, 85, 114, 
137, 143 
2 76, 119 
0 — 
2 159, 191 
0 — 
3 
0 
1 
1 
5 
3 
83,84,141 
128 
123 
158,162, 173 
187, 188 
212, 213, 
214 
A significant change in hemoglobin content was considered to be > 40% of total. 
A significant change in PWBC content was considered to be > 40% of total. 
161 
Table 21. Statistical analysis of the correlation of hemoglobin and 
PWBC composition of allophenic mice 
Number Correlation 
Mouse Type Data Points Coefficient Probability 
A. C57BL/6 (A x SJL)F^ 
All Mice 66 0.82 <0.001 
Stable Mice 52 0.87 <0.001 
Unstable Mice 14 0.56 <0.05 
B. (CBA X CBA/H-T6)P 
C57BL/6 
All Mice 37 0.77 <0.001 
Stable Mice 30 0.83 <0.001 
Unstable Mice 7 0.12 >0.1 
C. C57BL/6 *-» DBA/1 
All Mice 9 0.75 <0.05 
Stable Mice 6 0.95 <0.01 
Unstable Mice 3 -0.80 70.1 
D. C57BL/6«-»A 
All Mice 45 0.80 <0.001 
Stable Mice 24 0.94 <0.001 
Unstable Mice 21 0.58 <0.01 
E. C57BL/10Sn*-»A 
All Mice 54 0.84 <0.001 
Stable Mice 36 0.88 <0.001 
Unstable Mice 18 0.64 <0.01 
^This is the probability that the variables are not correlated, as 
determined by Bevington (1969). 
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Figure 27. Percent C57BL/6 hemoglobin as a function of the percent 
C57BL/6 peripheral white blood cells (PWBC). }(—-) is the 
theoretical line for a perfect correlation; ( ) is the 
least squares line through the points!] 
Table 22. Composition of the Immune system of allophenlc mice at time 
of sacrifice* 
Mouse 
Number Sex 
Coat Color Phenotype 
%C57BL/6 %(A X SJL)F^ 
Age at Sacrifice 
(Months) 
A. C57BL/6 
—53 
84 
85 
86 
87 
(A X SJpF 
cl»  ^ 75 
40 
85 
10 
15 
25 
60 
15 
90 
85 
12 
12 
12 
11 
11 
98 
108 
109 
110 
111 
0 
50 
0 
100 
0 
100 
50 
100 
0 
100 
10 
10 
10 
10 
10 
112 
113 
114 
115 
116 
90 
0 
0 
100 
50 
10 
100 
100 
0 
50 
10 
10 
10 
10 
10 
117 
118 
132 
133 
134 
0 
100 
0 
0 
0 
100 
0 
100 
100 
100 
10 
10 
11 
11 
11 
XJ3 
137 
138 
139 
140 
u 
0 
15 
20 
25 
100 
85 
80 
75 
XX 
9 
9 
9 
9 
All values are the average of duplicate determinations. 
Coat color phenotype was estimated visually at the time of weaning. 
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Table 22. (continued) 
Mouse Coat Color Phenotype^ Age at Sacrifice 
Number Sex %C57BL/6 %(A X SJL)Fj^ (Months) 
141 Q 30 70 9 
142 5» 85 15 9 
143 (f 95 5 9 
148 & 0 100 11 
149 5* 0 100 11 
150 Q 0 100 11 
151 (f 5 95 11 
152 0 15 85 11 
153 9 
80 20 11 
%DBA/1 %(A X SJL)F^ 
B. DBA/1 « (—> (A X SJL)F^ 
94 (f 30 70 10 
99 (f 60 40 10 
100 d* 80 20 10 
% DBA/1 %A 
,C. DBA/14 :—^ A 
182 (f 75 25 12 
183 100 0 12 
186 ff 98 2 12 
%CBA^ %DBA/1 
D. (CBA X CBA/H-T6)F^4~4 DBA/1 
97 g 5 95 10 
103 100 0 10 
104 d* 50 50 10 
105 5* 50 50 10 
105 g 0 100 10 
107 (f 0 100 10 
144 50 50 13 
145 5* 100 0 13 
146 (f 100 0 13 
154 d' 60 40 10 
'^CBA is an abbreviation for (CBA x CBA/H-T6)F^. 
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Peripheral White Blood Cells Spleen White Blood Cells Thymocytes 
%C57BL/6 %(A X SJL)F^ %C57BL/6 %(A X SJL)F^ %C57BL/6 %(AxSJL)F^ 
1 + 0 120 +20 1 1 + 1  102 + 2 100 +15 
23 + 1 73 + 1 1 4 + 1  86 + 1 71 + 9 
24 + 5 80 + 1 2 3 + 5  61 + 1 64 + 4 
1 1 + 2  96 + 2 2 + 2 102 + 2 5 + 2 90 + 3 
11 + 3 98 + 0 4 + 1  102 + 1 7 + 2 92 + 7 
9 + 5 107 + 2 8 + 1  102 + 2 0 + 0 9 7 + 2  
4 + 5 107 + 2 9 + 5 103 + 15 0 + 0 99 + 1 
6 + 0 97 + 1 6 + 0 107 + 0 0 + 0 95 + 1 
10 + 1 103 + 5 9 + 5 95 + 2 49 + 4 46 + 2 
%DBA/1 %(A X SJL)F, %DBA/1 %(A X SJL)F, %DBA/1 %(AxSJL)F, 
22 + 1 
1 
7 + 2 
1 —' '—1 
41 + 1 14 + 2 — — — 
62 + 0 16 + 1 — 
— — 
%DBA/1 %A %DBA/1 %A %DBA/1 %A 
44 + 1 89 + 1 35 + 1 87 + 0 15 + 0 91 + 1 
67 + 2 18 + 3 93 + 1 16 + 0 110 + 1 7 + 1 
67 + 1 18 + 2 95 + 1 15 + 0 86 + 0 18 +13 
%CBA'^ %DBA/1 %CBA^ %DBA/1 BCBA^ %DBA/1 
33 + 2 7 4 + 6  
92 + 1 9 + 0 89 + 2 4 + 1 — 
85 + 0 27 + 2 7 0 + 2  22 + 2 — — 
83 + 4 4 3 + 2  54 + 1 48 + 2 — 
8 + 3 92 + 0 2 + 1  102 + 1 — — 
20 + 4 64 + 4 16 + 4 85 + 2 
62 + 1 — 60 + 1 — 95 + 4 
3 + 0 — 2 + 0 — 3 + 5 
3 + 0 100 + 1 2 + 0 — 3 + 2 
— —  6 + 0 104 + 2 7 + 2 — 8 + 3 
Table 22 , (continued) 
Mouse Coat Color Phenotype^ Age at Sacrifice 
Number Sex %CBAC %DBA/1 (Months) 
163 $ 0 100 9 
164 Ï 5 95 9 
165 y 50 50 9 
166 40 60 9 
174 ? 100 0 9 
175 $ 40 60 9 
%CBA^ %C57BL/6 
E. (CBA X CBA/H-T6)Fj^<r ->C57BL/6 
74 0 100 14 
76 
1 
20 80 14 
80 y 0 100 14 
81 (f 0 100 14 
82 20 80 14 
119 S 10 90 9 
120 $ 100 0 9 
121 95 5 9 
125 15 85 12 
126 60 40 12 
127 (f 90 10 12 
128 95 5 12 
129 98 2 12 
130 5 100 0 12 
131 100 0 12 
184 5* 98 2 10 
%CBA^ %A 
F. (CBA X CBA/H-T6)F^4 -^A 
177 (? 35 65 10 
178 cr 40 60 10 
179 & 100 10 
180 (f 100 — —  10 
181 Q 100 —— 10 T* 
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Thymocytes 
BCBAf %DBA/1 %CBAC %DBA/1 %CBAC %DBA/1 
93 + 0 7 + 1 104 + 0 „ 84 + 2 
— 67 + 0 1 6 + 2  93 + 0 — 109 + 5 
— 35 + 5 106 + 1 8 + 1 — 25 + 4 
— 38 + 3 81 + 0 40 + 3 — 0 + 0 
106 + 0 0 + 0 101 + 0 7 + 1 94 + 0 0 + 0 
4 107 4 83 24 75 
ZCBA^ %C57BL/6 %CBA^ %C57BL/6 %CBAC ZC57BL/6 
7 + 1 99 + 2 8 + 2 9 4 + 2  
27 + 0 85 + 4 12 + 4 80 + 3 — — 
1 1 + 1  103 + 3 4 + 1 94 + 0 — — 
5 + 1 105 + 5 5 + 2 101 + 5 — — 
33 + 0 61 + 1 22 + 2 9 0 + 1  — — 
33 + 3 6 6 + 2  18 + 3 58 + 2 
70 + 2 4 1 + 3  8 3 + 3  1 6 + 3  — — 
46 + 4 62 + 2 32 + 1 6 2 + 1  — —  
1 + 0 8 3 + 4  17 + 1 86 + 3 25 +10 — 
58 + 5 72 + 1 58 + 2 52 + 0 26 + 0 — 
17 + 1 69 + 7 3 2 + 2  69 + 1 17 + 3 
32 + 3 52 -r 2 51 + 1 55 + 0 19 + 4 — 
67 + 4 19 + 0 6 1 + 3  26 + 0 45 + 2 — 
7 8 + 3  0 + 0 102 + 1 5 + 5 71 +13 — 
100 + 0 1 + 2  102 + 1 3 + 0 104 +10 — 
13 + 1 — 5 6 + 3  38 + 2 65 + 1 
%CBAC %A %CBA^ %A %CBAC %A 
15 + 0 60 + 4 
42 + 2 — 21 + 0 — — — 
100 + 0 — 104 + 1 — — 
98 + 2 
— 104 + 1 — — 
95 + 1 
— 100 + 2 — 
— 
Table 22. (continued) 
Mouse 
Number Sex 
Coat Color Phenotype 
%C57BL/6 %DBA/1 
Age at Sacrifice 
(Months) 
G. C57BL/6 f—> DBA/1 
101 
123 
124 
(f 
Of 
(T 
0 
100 
50 
100 
0 
50 
10 
16 
16 
H. C57BL/6 <-> A 
157 
158 
159 
160 
162 
167 
168 
170 
171 
172 
173 
187 
191 
0 
O" 
(f 
(T 
% 
$ 
(f 
%C57BL/6 
2 
95 
40 
100 
50 
100 
85 
0 
50 
60 
75 
100 
50 
%A 
98 
5 
60 
0 
50 
0 
15 
100 
50 
40 
25 
0 
50 
10 
10 
10 
9 
9 
9 
9 
9 
9 
9 
9 
8 
8 
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Peripheral White Blood Cells 
%C57BL/6 %DBA/1 
Spleen White Blood Cells 
%C57BL/6 %DBA/1 
Thymocytes 
%C57BL/6 %DBA/1 
13 + 0 
79 + 2 
69 + 4 
100 + 1 
15 + 3 
39 + 1 
14 
69 + 
42 + 
100 + 1 
7 + 0 
35 + 0 
85 
71 
± 1 
+ 1 
%C57BL/6 %A %C57BL/6 %A %C57BL/6 %A 
100 + 0 0 + 0 95 + 0 16 + 2 90 +16 5 + 1 
98 + 3 11 + 2 97 + 2 20 + 0 107 + 4 0 + 0 
16 + 2 68 + 4 11 + 1 85 + 5 57 + 2 110 + 2 
98 + 2 0 + 0 72 + 5 26 + 1 111 + 2 0 + 0 
54 + 2 39 + 3 63 + 4 46 + 0 73 + 4 47 + 0 
79 + 1 15 + 1 106 + 1 13 + 2 102 + 1 8 + 0 
91 + 1 12 + 3 95 + 3 29 + 4 93 + 3 13 + 2 
0 + 0 109 + 4 1 + 0 99 + 0 2 + 0 100 + 1 
3 + 3 97 + 1 3 + 1 98 + 1 1 + 1 97 + 1 
76 + 1 32 + 2 52 + 1 61 + 1 71 + 4 30 + 2 
71 + 1 44 + 2 59 + 1 55 + 0 32 + 2 73 + 2 
103 + 0 2 + 3 84 + 1 8 + 1 105 + 0 0 + 0 
35 + 2 60 + 1 12 + 2 92 + 0 12 + 2 96 + 2 
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mice, 16 (CBA x CBA/H-T6)Fj^<->DBA/l mice, 16 (CBA x CBA/H-T6)F^ <—> 
C57BL/6 mice, 5 (CBA x CBA/H-T6)F^ f—>A mice, 3 C57BL/64—> DBA/1 mice, 
and 13 C57BL/6 4—^ A mice. Of the 93 mice, 57 were phenotypic males and 
36 were phenotypic females. In addition, 53 of the mice showed both 
parental coat colors, while 40 of the mice showed one or the other paren­
tal coat color. Data are shown in Table 22 for the analysis of the paren­
tal types of peripheral white blood cells, spleen white blood cells and 
thymocytes (when possible) at the time of sacrifice. All the experimental 
values in Table 22 are the average of duplicate determinations. Table 23 
shows the additivity of peripheral white blood cells, spleen white blood 
cells, and thymocytes of various combinations of allophenic mice. The 
data used for these calculations are from Table 22 . Table 24 shows the 
correlation of the various cell types determined at the time of sacrifice. 
Differences between the relative proportion of the parental white 
blood cells in the spleen and thymus has been called spleen-thymus dis­
cordance. A summary of the mice which have shown chimeric drift and 
spleen-thymus discordance is shown in Table 25. The data for chimeric 
drift and spleen-thymus discordance were taken from Tables 13, 14, 15, 16, 
17, 18, 19, and 22, respectively. 
H. Analysis of Chimeric Serum 
Blocking Factors 
1. Allophenic mouse sera and allophenic 
mouse spleen white blood cells 
In Tables 26 and 27 are shown the results of 26 allophenic mouse serum 
samples examined for serum blocking activity using the trypan blue dye 
Table 23. Additlvity of cell types in allophenlc mice* 
Mean ^  S.D. 
Mouse Number of Peripheral White Spleen White Thymocytes 
Type Mice Blood Cells Blood Cells 
A. C57BL/6 <—> (A X SJL)F 
1 
34 102 + 14 102 + 8 97 + 2 
B. DBA/1 « >• (A X SJL)F^ 3 — — 
C. D B A / 1 )  A  3 101 + 23 107 + 5 109 + 6 
D. (CBA X CBA/E-T6)F^ <—5 • DBA/1 16 107 + 13 104 + 10 97 + 3 
E. (CBA X CBA/H-T6)F^< 3 •C57BL/6 16 101 + 16 101 + 9 103 
F. (CBA X CBA/H-T6)F^<—) • A 5 — —  — 
G. C57BL/6 DBA/1 3 105 + 8 89 + 18 
H. C57BL/6<—> A 13 101 + 8 108 + 9 110 +18 
^The data used for these calculations were taken from Table 22. 
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Table 24. Correlation analysis of cell types In allophenic mice* 
Comparison of Parental Cell Types^ 
Cell Typesc C57BL/6 A x SJL 
N r P N r 
A. C57BL/6 <r—> (A x SJL)F^ 
SWBC versus PWBC 33 0.90 <0.001 33 0.83 <0.001 
SWBC versus TWBC 6 0.35 >0.1 16 0.52 <0.05 
PWBC versus TWBC 6 0.35 >0.1 16 0.29 >0.1 
(A X SJL)F, 
N r ? 
B. DBA/1 <—» (A X SJL)F^ 
SWBC versus PWBC 3 0.95 >0.1 
SWBC versus TWBC — — — — — — 
PWBC versus TWBC 
DBA/1 
N r P 
DBA/1 A 
N r P N r P 
DBA/1 A 
SWBC versus 
SWBC VèïâUS 
PWBC versus 
PWBC 
TSSC 
TWBC 
3 
O J 
3 
0.99 
0.99 
0.97 
<0.1 
^0 1 
70.1 
3 
3 
3 
0.99 
0.99 
0.99 
<0.1 
<0 = 1 
<0.1 
*Data taken from Table 22 collected at the time of sacrifice. 
^Parental cell types refers to the composition of al allophenic 
mouse as determined by cytotoxicity testing. N • sample size, r » 
correlation coefficien, P = probability that the variables are not cor­
related, as determined by Bevington (1969). 
Spleen white blood cells (SWBC), peripheral white blood cells 
(PWBC), and thymocytes (TWBC). 
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Table 24. (continued) 
Comparison of Parental Cell Types^ 
Cell TypesC CBA"^ DBA/1 
N r P N r 
D. (CBA X CBA/H-T6)F^ DBA/1 
SWBC versus PWBC 13 0.97 <0.001 15 0.94 <0.001 
SWBC versus TWBC 2 1.00 >0.1 10 0.90 <0.001 
PWBC versus TWBC 2 1.00 >0.1 10 0.85 <0.001 
CBA^ C57BL/6 
N r P N r 
E. (CBA X CBA/H-T6)F^ 4—> C57BL/6 
SWBC versus PWBC 16 0.83 <0.001 15 0.93 <0.001 
SWBC versus TWBC 8 0.87 <0.01 1 
PWBC versus TWBC 8 0.78 <0*05 1 — —— 
CBA^ A 
N r P N r P 
F. (CBA X CBA/H-T6)F^<—» A 
SWBC versus PWBC 5 0.80 >0.1 
SWBC versus TWBC 
PWBC versus TWBC 
G. C57BL/6 4—»DBA/1 
C57BL/6 DBA/1 
N r P N r 
SWBC versus PWBC 3 0.93 >0.1 3 0.99 >0.1 
SWBC versus TWBC — — — 2 -1.00 >0.1 
PWBC versus TWBC —— — — 2 —1,00 >0.1 
'^CBA is an abbreviation for (CBA x CBA/H-T6)F^. 
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Table 24. (continued) 
Comparison of Parental Cell Types 
Cell Types^ C57BL/6 A_ 
N r P N r P 
E. C57BL/6 4—> A 
SWBC versus PWBC 13 0. 93 <0. 001 13 0. 94 <0.001 
SWBC versus TWBC 13 0. 88 <0. 001 13 0. 95 <0.001 
PWBC versus TWBC 13 0. 87 <0. 001 13 0. 92 <0.001 
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Table 25. Analysis of chimeric drift and spleen-thymus discordance in 
allophenic mice 
ci b 
Mouse Chimeric Drift Spleen-Thymus 
Number Hemoglobin PWBC Discordance 
A. C57BL/6 4r-^ (A x SJL)F^ 
83 +f 4- NT 
84 -H-+ 444- NT 
85 +++ 
-H- NT 
86 44- 4- NT 
87 - 444- NT 
98 - 444- NT 
108 + 44- NT 
109 4- 4- NT 
110 - 4- NT 
111 4- + NT 
112 4- 4* NT 
113 44- - NT 
114 444- 4- NT 
115 4- 4- NT 
ii6 
-
•f NT 
117 4- 4- NT 
118 4- 4- NT 
^Chimeric drift refers to time-dependent changes in the peripheral 
white blood cells (PWBC) or hemoglobin (Hb). (+) <20% change, (+f) 
3120% but <40% change, (+44-) Z40% change, (-) no change, (KT) not tested. 
Data were taken from Tables 13, 14, 15, 16, 17, 18, and 19. 
^Spleen-thymus discordance refers to the difference between the 
relative proportions of the parental white blood cells in the spleen 
and thymus, (+) <20% discordance, (++) 2.20% but <40% dlscordanee, 
(fH-) k40% discordance, (-) no change, (NT) not tested. Data were 
taken from Table 22. 
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Table 25. (continued) 
Mouse Chimeric Drift* Spleen-Thymus** 
Number Hemoglobin PWBC Discordance 
132 4- 4-
133 + 4- 4-
134 + 4- 4-
135 + 4- 4-
137 +++ 4- 4-
138 + 4- 4-
139 4+ 4- 4-
140 44- 4- 4-
141 4- - 4-
142 44- 4- 4-
143 444- 4- 4-
148 NT 4- 4-
149 NT 4- 4-
150 NT -1- 4-
151 NT 4- + 
152 NT 4- + 
153 NT +4- 4-
B. DBA/14—> 
94 
99 
100 
C. DBA/t—^ A 
182 
183 
186 
(A X SJL)F^ 
NT 
NT 
NT 
NT 
NT 
NT 
NT 
NT 
NT 
NT 
NT 
NT 
NT 
NT 
NT 
+ 
+ 
+ 
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Table 25. (continued) 
Mouse Chimeric Drift* Spleen-Thymus^ 
Number Hemoglobin . PWBC Discordance 
D. (CBA X CBA/H-T6)F^ 4-^ DBA/1 
97 NT NT NT 
103 NT NT NT 
104 NT NT NT 
105 NT NT NT 
106 NT NT NT 
107 NT NT NT 
144 NT -H- -H-
145 NT - + 
146 NT + + 
154 NT + + 
163 NT + •H-
164 NT + + 
165 NT 44- + 
166 NT + -H-
174 NT NT + 
175 NT NT + 
E. (CBA X CBA/H-T6)F^ > C57BL/6 
74 - 4- NT 
76 ++H- + NT 
80 44- 44- NT 
81 + 4- NT 
82 - 4- NT 
119 444- 4- NT 
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Table 25. (continued) 
Mouse Chimeric Drift* Spleen-Thymus^ 
Number Hemoglobin PWBC Discordance 
121 + + NT 
125 + + + 
126 - -H- ++ 
127 ++ -H- + 
128 + -H- -H-
129 + ++ + 
130 + ++ ++• 
131 + + + 
184 NT NT + 
F. (CBA X CBA/H-T6)F^ I > 
177 NT NT NT 
178 NT NT NT 
179 NT NT NT 
180 NT NT NT 
181 NT NT NT 
G. C57BL/1 <-> DBA/1 
101 + + NT 
122 + + NT 
123 + +44- •HH 
124 + ++ ++ 
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Table 25. (continued) 
a b 
Mouse Chimeric Drift Spleen-Thymus 
Number Hemoglobin PWBC Discordance 
H. C57BL/6 4->A 
157 + + 4-
158 ++ 4-H- 444 
159 +++ + 44-
160 + ++ 44-
162 + +¥+ 4-
167 + ++ 4-
168 + + 4-
169 + + NT 
170 + + 4-
171 + + + 
172 4+ 44- 44-
173 + 444- 44-
187 - 444- 4-
188 4+ 
-H4- NT 
191 +++ 444- 4-
I. C57BL/lOSn4—>A 
205 + + NT 
206 44- 4- NT 
207 44- + NT 
210 4- 4- NT 
211 4- NT 
212 44- 444- NT 
213 4- 444- NT 
214 4- 444- NT 
215 44- 4- NT 
Table 26. Analysis of serum blockin# factors using allophenic mouse sera and allophenic mouse 
spleen white blood cells 
Blocking Treatment^ 
Mouse Reciprocal Mixed Parental Serum Allophenic Mouse Serum 
Number Dilution ' ZC57BL/6 %A x SJL %C57BL/6 %A x SJL 
A^ C57BL/6 <—> (A x SJL)F^ 
133 2 0 + 0 89 + 4 0 ± 0 76 + 2* 
4 0 + 0 84 + 3 1 ± 1 82 + 5 
8 0 + 0 92 + 1 1± 1 82 + 0 
16 0 + 0 95 + 4 1± 1 90 + 1 
32 0 + 0 90 + 5 1± 1 93 + 1 
134 2 12 + 1 86 + 6 5± 3* 108 + 3* 
4 7 + 0 96 + 2 3 ± 2 103 + 5 
8 8 + 1 102 + 4 6 ± 0 92 ± 3 
135 4 0 + 0 99 + 1 1 + 1 97 + 1 
8 0 + 0 93 + 2 1 + 1 96 + 1 
16 0 + 0 96 + 6 7 ± 5* 98 ± 0 
137 2 2 + 2 85 + 4 o± 0 87 + 3 
4 0 + 0 81 + 1 o± 0 84 + 3 
8 0 + 0 82 + 1 Q± 0 81 + 2 
16 0 + 0 73 + 3 Q± 0 91 + 0** 
138 2 0 + 0 94 + 2 0 + 0 96 + 2 
4 0 + 0 90 + 1 Q + 0 96 + 1** 
8 0 + 0 106 + 1 0 + 0 98 + 1** 
16 0 + 0 100 + 1 1- + 1 87 + 1** 
^Significance was determined by testing for the probability of a least significant difference 
using a Student's "t" test: (*) significance at the 0.05 level, (**) significance at the 0.01 
level. 
Table 26. (continued) 
Blocking Treatment^ 
Mouse Reciprocal Mixed Parental Serum Allophenic Mouse Serum 
Number Dilution %C57BL/6 %A x SJL %C57BL/6 %A x SJL 
139 2 0 + 0 100 + 3 0 + 0 100 + 1 
4 0 + 0 97 + 2 0 + 0 99 + 1 
8 0 + 0 95 + 0 0 + 0 96 + 4 
16 0 + 0 99 + 1 0 + 0 103 + 2 
140 2 20 + 2 70 + 6 26 + 8 76 + 12 
4 0 + 0 91 + 11 16 + 2* 109 + 9 
8 14 + 1 90 + 10 14 + 2 105 + 11 
16 20 + 4 103 ± 3 11 + 6 84 + 6 
141 2 14 + 4 101 + 15 21 + 3 85 + 10 
4 27 + 0 77 + 3 17 + 4* 88 + 2 
8 24 + 3 89 + 9 14 + 3* 117 + 5* 
16 16 + 3 86 + 2 20 + 2 82 + 2 
142 2 5 + 3 67 + 5 12 + 1 72 + 2 
4 13 + 7 76 + 4 15 + 0 80 + 0 
8 7 + 5 87 + 9 8 + 3 78 + 0 
16 13 + 0 72 ± 4 9 + 0 85 + 3 
143 2 6 + 1 64 + 2 0 + 0 72 + 4* 
4 15 + 7 74 + 1 17 + 0 74 + 4 
8 21 + 5 70 + 1 30 + 0 74 + 4 
16 23 + 5 91 + 2 30 + 5 83 + 5 
Table 26. (continued) 
Blocking Treatment^ 
Mouse Reciprocal Mixed Parental Serum Allophenic Mouse Serum 
Number Dilution %DBA/1 %A x SJL %DBA/1 %A x SJL 
B. DBA/1 (A X SJpF, 
94 2 0 + 0  9 0 + 3  0 + 0 8 8 + 8  
4 0 + 0 101 + 1 0 + 0 103 + 2 
8 0 + 0 100 + 0 0 + 0  105 + 4 
99 2 0 + 0  89 + 4 0 + 0 95 + 6 
4 0 + 0 92 + 6 0 + 0 94 + 1 
8 0 + 0 100 + 1 0 + 0 86 + 5 
100 2 4 + 4 8 5 + 7  0 + 0  94 + 0 
4 0 + 0 85 + 1 0 + 0  95 + 1 
8 0 + 0 94 + 1 0 + 0 86 + 1 
%CBA %DBA %CBA^ %DBA 
CCBA X CBA/H-T6)F. DBA/1 
97 2 31 + 4 86 + 1 17 + 2 83 + 11 
4 15 + 5 87 + 0 2 4 + 7  76 + 8 
8 35 + 0 72 + 1 29 + 5 77 + 9 
103 2 86 + 1 2 + 2 93 + 2 9 + 1  
4 9 3 + 2  19 +14 95 + 5 8 + 8  
8 100 + 5 2 + 2 91 + 5 5 + 5 
104 2 73 + 0 26 +11 84 + 0 2 3 + 3  
4 7 2 + 7  30 +10 83 +10 27 + 1 
8 72 + 7 25 +10 73 + 2 21 +10 
CBA is an abbreviation for (CBA x CBA/H-T6)F 
1' 
Table 26. (continued) 
Blocking Treatment* 
Mouse Reciprocal Mixed Parental Serum Allophenlc Mouse Serum 
Number Dilution %CBA'> %DBA %CBAt> %DBA 
C. (CBA X CBA/H-T6)F, DBA/1 
105 2 45 + 4 44 + 2 56 + 2 31 + 1** 
4 47 + 4 45 + 3 51 + 7 57 + 3** 
8 59 + 1 40 + 0 35 + 2 60 + 2** 
106 2 4 + 3 80 + 3 0 + 0 113 + 0* 
4 0 + 0 83 + 11 1 + 0 103 + 6 
8 0 + 0 90 + 6 4 + 4 95 ± 9 
107 2 5 5 87 + 4 24 + 5** 81 + 7 
4 1 1 87 + 3 27 + 4** 67 + 9 
8 35 + 0 72 + 10 16 + 1** 93 + 0 
%CBA^ %C57BL/6 %CBAB %C57BL/7 
). CC:BA X CBA/H-T6)F^ T- C57BL/6 
119 2 37 + 1 56 + 4 38 + 8 56 + 4 
4 48 + 4 53 + 5 36 + 9 64 + 0 
8 44 + 0 49 + 2 40 + 8 60 + 6 
16 38 + 1 56 ±12 36 + 3 58 + 6 
120 4 40 + 1 58 + 8 55 + 1** 40 + 2 
8 39 + 1 48 + 1 55 + 1** 44 + 6 
125 2 13 + 2 69 + 5 7 + 3 63 + 8 
4 42 + 5 72 + 1 25 + 1* 53 + 3* 
8 21 + 3 75 + 5 20 + 3 69 + 5 
127 4 34 + 0 69 + 3 31 + 2 85 + 2* 
8 26 + 0 66 + 5 38 + 21 61 + 4 
Table 26. (continued) 
Blocking Treatment^ 
Mouse Reciprocal Mixed Parental Serum Allophenlc Mouse Serum 
Number Dilution %C57BL/6 %DBA/1 %C57BL/6 %DBA/1 
E. C57BL/6 4—» DBA/1 
101 2 —— 93 + 3 — 93 +10 
4 —— 80 + 7 88 + 5 
123 2 16 +13 —— 6 + 3 
4 —  —  30 + 2 —• 15 +13 
8 18 + 9 7 + 6 
124 2 26 +10 •• —• 17 + 5 
4 — —  14 + 2 — —  18 + 0 
8 17 + 2 —— 20 + 3 
Table 27. Summary of the analysis of serum blocking factors using 
allophenic mouse sera and allophenic mouse spleen white blood 
cells* 
Spleen Thymus 
Mouse Composition Composition 
Number Sex %C57BL/6 U x SJL %C57BL/6 %A x SJL 
A. C57BL/6 4—» (A x SJL)F^ 
133 (f 2 112 99 
134 % 2 106 92 
135 & 2 106 97 
137 5 89 105 
138 2 3 101 94 
139 (f 1 96 93 
140 3 93 105 
141 » 11 102 100 
142 (T 14 86 71 
143 (f 23 61 — 64 
^Spleen and thymus composition of allophenic mice are based on 
duplicate values determined at the time of sacrifice using the trypan 
blue dye exclusion assay. Data were taken from Table 22. 
^ Significance was determined by testing for the probability of a 
least significant difference using a Student's "t" test. (*) signifi­
cance at the 0.05 level, (**) significance at the 0.01 level. 
^Chimeric drift refers to time-dependent changes in either 
peripheral white blood cells (PWBC) or hemoglobin (Hb). (+)<20% change, 
(++) &20% but <40% change, (+++) >40% change, (-) no change, (NT) not 
tested. Data were taken from Tables 13, 14, 15, 16, 17, 18, and 19. 
^Spleen-thymus discordance refers to the difference between the 
relative proportions of the parental white blood cells in the spleen 
and thymus. (+) <20% discordance, (++) >20% but <40% discordance, (+++) 
J^40% discordance, (-) no discordance, (NT) not tested. Data were taken 
from Tables 22 and 25. 
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Blocking Treatement^ 
Spleen- Mixed Parental Allophenic Mouse 
Chimeric DriftT h y m u s  Serum Serum 
Hemoglobin PWBC Discordance %C57BL/6 %AxSJL %C57BL/6 %AxSJL 
+ + + 0 + 0 90 + 4 1 + 1  85 + 6 
+ + + 9 + 3 9 4 + 7  4 + 2  101 + 7 
+ + + 0 + 0  96 + 3 1 + 3 97 + 1 
+++ + + 1 + 1 80 + 5 0 + 0 86 + 4 
+ + + 0 + 0 97 + 5 0 + 1  94 + 4 
++ + + 0 + 0 98 + 2 0 + 0 99 + 3 
++ + + 14 + 8 88 +12 17 + 5 94 +11 
+ - + 20 + 5 88 + 9 18 + 7 93 +14 
•H" + + 9 + 4 7 6 + 7  11 + 3 79 + 5 
+++ + + 16 + 7 75 +10 20 +11 77 + 5 
Table 27. (continued) 
Spleen Thymus 
Mouse Composition Composition 
Number Sex %DBA/1 %A X SJL %DBA/1 %A X SJL 
B. DBA/1 (A X SJL)F, 
94 cT 7 — —  — —  —— 
99 (f 14 — —— 
100 (f 16 — — 
%CBA® %DBA/1 %CBA® %DBA/1 
C. (CBA X CBA/E-T6)F, «r-H •DBA/1 
97 
X 
33 74 —— —— 
103 d* 89 4 —— 
104 (f 70 22 
105 (f 54 48 — 
106 
î 
2 102 — 
107 d* 16 85 —— 
%CBA® %C57BL/6 %CBA® %C57BL/6 
D. (CBA X CBA/H-T6)F^<--* C57BL/6 
119 18 58 — 
120 $ 83 16 — 
125 (f 17 86 25 — 
127 (f 17 69 17 
%C57BL/6 %DBA/1 %C57BL/6 %DBA/1 
E. C57BL/6 4—»DBA/1 
101 (f 14 100 — — 
123 (f 69 7 — 85 
124 (? 42 35 71 
®CBA is an abbreviation for (CBA x CBA/H-T6)F^. 
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exclusion cytotoxicity assay. Allophenic spleen white blood cells were 
used as the source of target cells. The mice included 10 C57BL/6<—> 
(A X SJL)F^ mice, 3 DBA/1 > (A x SJL)F^ mice, 6 (CBA x CBA/H-T6)F^<—> 
DBA/1 mice, 4 (CBA x CBA/H-T6)F^ <—>C57BL/6 mice, and 3 C57BL/64^ 
DBA/1 mice. Of the 26 mice examined, 4 mice showed evidence of chimeric 
drift in either their peripheral white blood cell or hemoglobin composi­
tions using a + 40% criterion, while 22 mice were classified as being 
stable chimeras. Only 2 mice showed evidence of spleen-thymus discor­
dance. Chimeric drift and spleen-thymus discordance analyses were not 
done on 14 mice. Mouse serum samples were examined for blocking activity 
using from 3-5 different serum dilutions with a constant number of target 
cells (1-6 X 10^ cells/ml). All the values in Table26 are the average 
of duplicate determinations at each serum dilution tested. Table27 sum­
marizes the data from Table 26 with each value representing the geometric 
mean, calculated across serum dilutions. Significant differences between 
the blocking activity of mixed parental serum and allophenic mouse serum 
are indicated in both Tables 26 and 27. 
2. Allophenic mouse sera and allophenic 
mouse thymocyte's" 
The analyses of the serum blocking activity of allophenic mouse serum 
samples on antibody mediated cytotoxicity of allophenic mouse thymocytes 
(1-6 X 10^ cells/ml) are shown in Tables 28 and 29. A total of 19 mice of 
the same combinations as in the previous section were analyzed for block­
ing activity using from 2-3 different serum dilutions. All the values 
Table 28. Analysis of serum blocking factors using allophenlc mouse sera and allophenlc mouse 
thymocytes 
Blocking Treatment* 
Mouse Reciprocal Mixed Parental Serum Allophenlc Mouse Serum 
Number Dilution %C57BL/6 %A x SJL %C57BL/6 %A x SJL 
A. C57BL/6*—»(A x SJL)F^ 
133 2 17 + 0 100 + 4 10 + 3 8 8 + 7  
4 15 + 0 99 + 4 6 + 3 87 + 5 
8 20 + 4 98 + 1 5 + 1 9 2 + 3  
134 4 0 + 0 77 + 1 6 + 6 8 9 + 2  
8 0 + 0 88 + 1 13 + 5 93 + 1 
135 2 12 + 4 63 + 7 8 + 5 86 + 2 * 
4 11 ± 0 82 +12 1 + 0 96 + 0 
8 21 +10 86 + 6 0 + 0 90 + 0 
137 2 4 + 4 92 + 1 23 + 3** 93 + 1 
4 20 + 0 90 + 0 29 + 5 94 + 0* 
8 18 + 0 98 + 2 34 + 3* 91 + 1** 
138 2 29 + 0 71 + 7 19 +10 74 + 1 
4 5 + 4 87 + 2 32 + 2* 9 1 + 3  
139 2 10 + 1 86 + 1 7 + 8 87 + 5 
4 9 + 6 86 + 2 0 + 0 8 8 + 1  
3 19 + 2 32 + 4 0 + 0* 80 + 4 
140 4 0 + 0 94 + 2 1 + 1 9 5 + 1  
3 0 + 0 93 + 1 14 +10 9 4 + 1  
142 4 1 + 0 92 + 3 0 + 0* 9 1 + 2  
S 0 + Q 93 + 1 0 + 0 97 + 2 
Significance was determined by testing for the probability of a least significant difference 
using a student's "t" test: (*) significance at the 0.05 level, (**) significance at the 0.01 
level. 
Table 28- (continued) 
Blocking Treatment^ 
Mouse Reciprocal Mixed Parental Serum Allophenic Mouse Serum 
Number Dilution %DBA/1 %A x SJL %DBA/1 %A x SJL 
B. DBA<—» (A X SJpFj^ 
94 4 4 9 + 1  47 + 2 57 + 2* 5 3 + 7  
8 4 6 + 2  49 + 2 4 9 + 2  46 + 3 
99 4 11 + 1 90 + 1 19 + 1 68 + 8* 
8 1 3 + 2  84 + 6 23 +10 79 + 5 
100 4 22 +13 69 + 4 3 0 + 1  50 + 6* 
8 4 1 + 0  55 + 5 32 +10 52 + 3 
aiCBA^ %DBA/1 %CBA^ %DBA/1 
(CBA X CBA/H-T6)F^ 4- DBA/1 
97 4 53 + 1 — —  58 + 3 
8 76 + 5 
— 65 + 4 
103 4 — —  15 + 14 — —  29 + 0 
8 10 + 10 — 27 + 3 
105 4 — —  37 + 1 — —  37 +10 
8 — —  44 + 8 49 + 2 
106 4 —  —  97 + 10 — —  92 + 7 
8 —— 85 + 1 — —  86 + 4 
107 4 — —  93 + 0 — —  100 + 1 
8 —  —  97 + 3 — —  93 + 3 
^CBA is an abbreviation for (CBA x CBA/H-T6)F^. 
Table 28. (continued) 
Mouse 
Number 
Reciprocal 
Dilution 
Mixed Parental Serum 
Blocking Treatment' 
%C57BL/6 %DBA/1 
Allophenlc Mouse Serum 
%C57BL/6 %DBA/1 
D. C57BL/6 
101 
123 
124 
DBA/1 
4 
8 
4 
8 
4 
8 
106 + 1 
104 + 4 
73 + 4 
81 + 5 
76 + 2 
85 +10 
104 + 1 
104 +12 
95 + 1 
71 + 9 
81 + 2 
79 +10 
Table 29. Summary of the analysis of serum blocking factors using 
allophenic mouse sera and allophenic mouse thymocytes 
Spleen Thymus 
Mouse Composition Composition 
Number Sex %C57BL/6 %A x SJL %C57BL/6 %A x SJL 
A. C57BL/6<—> (A x SJL)F. 
1 IQ fW# J-133 0^ ^ 2 112 99 
134 2 106 92 
135 2 106 97 
137 A. 5 89 105 
138 4L 3 101 94 
139 0^ 1 96 93 
140 & 3 93 105 
142 (F» 14 86 71 
^Spleen and thymus composition of allophenic mice are based on 
duplicate values determined at the time of sacrifice using the trypan 
blue dye exclusion assay. Data were taken from Table 22. 
^Significance was determined by testing for the probability of a 
least significant difference using a Student's "t" test. (*) signifi­
cance at the 0.05 level. (**) significance at the 0.01 level. 
^Chimeric drift refers to time dependent changes in the peripheral 
white blood cells (PWBC) or hemoglobin (Hb). (+) <20% change, (++) Z20% 
but <40% change, (+++) >40% change, (-) no change, (NT) not tested. 
Data were taken from Tables 13, 14, 15, 16, 17, 18, and 19. 
'^Spleen-thymus discordance refers to the difference between the 
relative proportions of the parental white blood cells in the spleen and 
thymus. (+) <20% discordance, (++) 220% but <40% discordance, (+++) > 
40% discordance, (-) no discordance, (NT) not tested. Data were taken 
from Tables 22 and 25. 
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5" 
Blocking Treatment 
Spleen- Mixed Parental Âllophenic Mouse 
Chimeric Drift^ Thymus'^ Serum Serum 
Hemoglobin PWBC Discordance %C57BL/6 %ÂxSJL %C57BL/6 %AxSJL 
+ + + 17 + 2 98 + 1 7 + 2 89 + 3 
+ + + 0 + 0 82 + 6 9 + 4 91 + 2 
+ + + 15 + 4 77 +10 3 + 1 91 + 5 
+++ + + 14 + 7 93 + 4 29 + 5* 9 3 + 1  
+ + + 17 +12 7 9 + 8  25 + 7 82 + 8 
+f + 13 + 5 85 + 1 3 + 4 85 + 4 
4+ + + 0 + 0 9 3 + 1  7 + 7 94 + 1 
+f + + 1 + 1  9 3 + 1  0 + 0 94 + 2 
Table 29. (continued) 
Mouse 
Spleen 
Composition 
Thymus 
Composition 
Number Sex %DBA/1 %A X SJL %DBA/1 %A X SJL 
B. DBA/1 4—i  (A X SJL)F, 
94 (f ^ 7 —— —— —— 
99 (f 14 — —— 
100 (f 16 —— — —— 
%CBA® %DBA/1 %CBA® %DBA/1 
C. CBA X CBA/H-T6)F, 
1—
1 1
 
I 
97 
X 
5 33 74 —— —— 
103 (f 89 4 —• 
105 (? 54 48 —— — 
106 5 2 102 
107 (f 16 85 —— —— 
%C57BL/6 %DBA/1 %C57BL/6 %DBA/1 
D. C57BL/6 i r->DBA/l 
101 (? 14 100 — —— 
123 d" 65 7 — 85 
124 (? 42 35 71 
®CBA is an abbreviation for (CBA x CBA/H-Tô)?^. 
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Blocking Treatment^ 
Chimeric 
Hemoglobin 
Drift^ 
PWBC 
Spleen-
Thymus 
Discordance 
Mixed Parental 
Serum 
Allophenlc Mouse 
Serum 
%DBA/1 %A X SJL %DBA/1 %A X SJL 
NT 
NT 
NT 
NT 
NT 
NT 
NT 
NT 
NT 
47 + 1 
1 2 + 1  
31 +10 
48 + 1 
87 + 3 
62 + 7 
53 + 5 
2 1 + 6  
3 1 + 1  
50 + 4 
73 + 2 
51 + 1 
%CBA® %DBA/1 %CBA® %DBA/1 
NT 
NT 
NT 
NT 
NT 
NT 
NT 
NT 
NT 
NT 
NT 
NT 
NT 
NT 
NT 
— 
65 +10 
13 + 3 
4 1 + 1  
91 + 6 
95 + 2 
62 + 3 
28 + 1 
43 + 7 
89 + 3 
97 + 4 
%C57BL/6 %DBA/1 %C57BL/6 %DBA/1 
+ + NT 105 + 1 104 + 1 
+ 
+ 
44+ 
++ 
+H-
+++ 
77 + 4 
81 + 5 
S3 T 2 
80 + 1 
198 
in Table 28 are the average of duplicate determinations at each serum 
dilution tested. Table 29 summarizes the data from Table 28 with each value 
representing the geometric mean calculated across serum dilutions. Sig­
nificant differences between the blocking activity of mixed parental 
serum and allophenic mouse serum are indicated in both Tables 28 and 29. 
3. Allophenic mouse sera and parental 
spleen white blood cells 
The analyses of serum blocking activity of allophenic mouse serum 
samples on antibody mediated cytotoxicity of parental spleen white blood 
cells for 45 mice of combinations— 16 C57BL/6<—> (A x SJL)F^, 13 
(CBA X CBA/H-T6)F^«—>DBA/1, 1 (CBA x CBA/H-T6)F^<—»C57BL/6, 3 C57BL/6 
<—^ DBA/1, and 12 C57BL/6<—? A mice—are shown in Tables 31, 32, 33, 
and 34, respectively. An initial serum dilution of 1:5 was used for all 
experiments. All the values in Tables30, 31, 32, 33, and34 are the average 
of duplicate determinations. 
Table 30. Analysis of serum blocking activity using C57BL/6<—> ^ 
(A X SJL)F^ mouse sera and parental spleen white blood cells 
Spleen Thymus 
Mouse Composition Composition 
Number Sex %C57BL/6 %AxSJL %C57BL/6 %AxSJL 
133 cf 2 112 99 
134 I 2 106 — —  92 
135 & 2 106 — —  97 
137 ; 5 89 — —  105 
138 3 101 — —  94 
139 1 96 — —  93 
140 g 3 93 — —  105 
141 5 11 102 100 
142 (f 14 86 — —  71 
143 0Î» 23 61 64 
148 0 2 102 5 90 
149 y 4 102 7 92 
150 Q 8 102 0 97 
151 (f 4 103 0 99 
152 & 6 107 0 95 
153 I 9 95 49 46 
^Spleen and thymus composition of allophenic mice are based are 
duplicate values determined at the time of sacrifice. Data were taken 
from Table 22. 
^Control samples preincubated with a 1:3 dilution of either type of 
parental serum or an equal ratio of mixed parental serum gave average 
cytotoxicity values of 53 + 10% and 51 + 8% for C57BL/6 and (A x SJL)F-
target cells respectively. 
'^Significance was determined by testing for least significant differ­
ences between normal mouse serum controls and allophenic mouse serum samples 
at a 50% cytotoxic dose of antiserum using Cochran's approximate t-test 
(Snedecor and Cochran, 1967). (*) significant at the 0,05 level, (**) 
sienificant at the 0.01 level. 
Chimeric drift refers to time-dependent changes in the peripheral 
white blood cells (PWBC) or hemoglobin (Hb). (+) 420% change, (++) >20% 
change but <40% change, (+++) >40% change, (-) no change, and (NT) not 
tested. Data were taken from Tables 13, 14, 15, 16, 17, 18, and 19. 
"Spleen-thymus discordance refers to the difference bêtwên relative 
proportions of the parental blood cells in the spleen and thymus. <+) 
<20% discordance, (++) 220% but <40% discordance, (+++) 240% discord­
ance, (-) no discordance, (NT) not tested. Data were taken from 
Tables 11 and 25. 
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b c j Spleen- Blocking Treatment * 
Chimeric Drift Thymus® Allophenic Mouse Sera 
Hemoglobin PWBC Discordance %C57BL/6 %AxSJL 
+ + + 73 + 10* 42 + 12 
+ + + 68 + 1* 42 + 8 
+ + + 43 + 2 51 + 17 
H+ + + 47 + 5 62 + 10* 
+ + + 64 + 1 5 1 + 7  
++ + + 67 + 2 62 + 0* 
H- + + 49 + 1 5 7 + 2  
+ - + 47 + 6 5 7 + 3  
++ + + 47 + 2 61 + 5* 
H-H + + 46 + 9 5 6 + 3  
NT + + 57 + 4 4 9 + 3  
NT + + 57 + 2 4 9 + 2  
NT + + 58 + 2 5 9 + 2  
NT + + 60 + 6 5 3 + 2  
NT + + 53 + 4 5 1 + 0  
NT + +++ 52 + 1 5 3 + 1  
Table 31. Analysis of serum blocking activity using (CBA x CBA/H-T6)F, 
<—> DBA/1 mouse sera and parental spleen white blood cells 
/ 
Spleen Thymus 
Mouse Composition Composition 
Number Sex %CBA: %DBA/1 %CBAt %DBA/1 
97 Q 33 74 
103 (f 
(f 
89 4 —— — 
104 70 22 —— —— 
105 Cf 54 48 —— — 
107 (f 16 85 — 
144 —— 60 — 95 
146 d* 100 2 3 
154 (T 104 7 8 
163 7 104 84 
164 0 16 93 109 
166 S 81 40 0 
174 101 7 0 
175 2 83 24 7 
^Spleen and thymus composition of allophenic mice are based on 
duplicate values determined at the time of sacrifice using the trypan 
blue dye exclusion assay. Data were taken from Table 22. 
^Control samples preincubated with a 1:5 dilution of either type 
of parental serum or an equal ratio of mixed parental serum gave mean 
cytofo*icitv values of 53 + 10% and 49 + 10% for (CBA x CBA/H—T6)F^ 
and DBA/1 target cells, respectively. 
Q 
Significance was determined by testing for least significant dif­
ferences between normal mouse serum controls and allophenic mouse serum 
samples at a 50% cytotoxic dose of antiserum, using Cochrarfs approximate 
t-test (Snedecor and Cochran, 1967). (*) significant at the 0.05 level. 
(**) significance at the 0.01 level. 
^Chimeric drift refers to time-dependent changes in the oerioheral 
white blood cells (PWBC) or hemoglobin (Hb). (+) <.20% change, (++) 6 
20% but <40% change, (-H4-) 2.40% change, (-) no change, (NT) not tested. 
Data were taken from Tables 13, 14, 15, 16, 17, 18, and 19. 
^Spleen-thymus dicordance refers to the difference between the 
relative proportions of the parental white blood cells in the spleen 
and thymus. (+) <20% discordance, (++) >20% but<40% discordance, (+++) 
240% discordance, (-) no discordance, (NT) not cested. Data were taken 
from Tables 22 and 25. 
^CBA is an abbreviation for (CBA x CBA/H-T6)F^. 
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_ — —— — - t) ,c 
J Spleen- BlocklnR Treatment 
Chimeric Drift Thymus® Allophenic Mouse Sera 
Hemoglobin PWBC Discordance %CBAf %DBA/l 
NT NT NT 60 4- 8 43 + 2 
NT NT NT 52 + 4 70 4- 0** 
NT NT NT 50 4-17 43 4- 5 
NT NT NT 49 + 5 44 4- 7 
NT NT NT 74 4- 9 46 4- 1 
NT 44- 44- 46 4- 2 64 4- 2* 
NT - 4- 56 4- 1 54 4- 8 
NT 4- 4- 54 + 8 51 4- 3 
NT 4- 4- 52 4-10 49 4- 6 
NT. 4- 4- 65 4- 2 70 4- 2** 
NT 4- 444- 60 4- 3 49 + 2 
NT NT 4- 51 4- 3 52 4- 0 
NT NT 4- 50 4-21 55 4- 6 
Table 32. Analysis of serum blocking activity using (CBA x CBA/H-T6)F^ <—> C57BL/6 mouse sera 
and parental spleen white blood cells^ 
Spleen 
Mouse Composition 
Number Sex ZCBA^ %C57BL/6 
Chimeric 
Thymus Drift 
Composition Hemo-
%CBA£ %C57BL/6 globin PWBC 
Spleen-
Thymus^ 
Discord­
ance 
Blocking 
Treatment 
Allophenic Mouse 
Sera 
%CBAt %C57BL/6 
127 (F 32 69 17 - ++ ++ + 41 + 11 60 + 1 
^Spleen and thymus composition of allophenic mice are based on duplicate values determined 
at the time of sacrifice using the tirypan blue dye exclusion assay. Data were taken from Table 
22.  
^Control samples preincubated with a 1:5 dilution of either type of parental serum or an 
equal ratio of mixed parental serum gave mean cytotoxicity values of 71 + 11% and 67 + 10% for 
(CBA X CBA/H-T6)F^ and C57BL/6 target cells, respectively. 
^Significance was determined by testing for least significant differences between normal 
mouse serum controls and allophenic mouse serum samples at a 50% cytotoxic dose of antiserum, using 
CochratJs approximate t-test (Snedecor and Cochran, 1967). (*) significance at the 0.05 level, (**) 
significance at the 0.01 level. 
^Chimeric drift refers to time-dependent changes in the peripheral white blood cells (PWBC) 
or hemoglobin (Hb). (+) <20% change, (++) >20% but <40% change, (4-H-) >40%, (-) no change, (NT) 
not tested. Data were taken from Tables 13, 14, 15, 16, 17, 18, and 19. 
®Spleen-thymus discordance refers to the difference between the relative proportions of 
parental white blood cells in the spleen and thymus. (+)<20% discordance, (++) *20% but <40% 
discordance, (+++) Z 40% discordance, (—) no discordance,(NT) not tested. Data were taken from 
Tables 22 and 25. 
CBA is an abbreviation for (CBA x CBA/H-T6)F^. 
Table 33. Analysis of serum blocking activity using C57BL/6 <—> DBA/1 mouse sera and parental 
spleen white blood cells^ 
Chimeric 
Drift" 
Hemo­
Spleen-
Blocking 
Treatment '^ 
Mouse 
Spleen 
Composition 
Thymus 
Composition 
Thymus® 
Discord­
Allophenic Mouse 
Sera 
Number Sex %C57BL/6 %DBA/1 %C:57BL/6 %DBA/1 globin PWBC ance %C57BL/6 %DBA/1 
101 
123 
124 0* 
14 
69 
42 
100 
7 
35 
—— 85 
71 
+ — 
+ -H-4-
+ ++ 
NT 
444-
++ 
69 + 4 57 + 9 
69 + 4 51 + 4 
58 + 8 41 + 8 
^Spleen and thymus composition of allophenic mice are based on duplicate values determined 
at the time of sacrifice using the trypan blue dye exclusion assay. Data were taken from Table 
22 .  
^Control samples preincubated with 1:5 dilution of either type of parental serum or an equal 
ratio of mixed parental serum gave mean cytotoxicity values of 71 + 10% and 52 + 12% for C57BL/6 
and DBA/1 target cells, respectively., 
"^Significance was determined by testing for least significant differences between normal 
mouse aerum controls and allophenic mouse serum samples at a 50% cytotoxic dose of antiserum, using 
Cochran's approximate t-test (Snedecor and Cochran, 1967). (*) significance at the 0.05 level, (**) 
significance at the 0.01 level. 
^Chimeric drift refers to time-dependent changes in either the peripheral white blood cells 
(PWBC) or hemoglobin (Hb). (+) <20% change, (-H-) >20% but <40% change, (+++) >.40% change, (-) 
no change, (NT) not tested. Data were taken from Tables 13, 14, 15, 16, 17, 18, and 19. 
®Spleen-thymus discordance refers to the difference between relative proportions of the 
parental white blood cells in the spleen and thymus. (+) <20% discordance, (++) 3Ç,20% but <40% 
discordance, (+++) i40% discordance, (-) no discordance, (NT) not tested. Data were taken from 
Tables 22 and 25. 
Table 34. Analysis of serum blocking activity using C57BL/6 <—>A mouse 
sera and parental spleen white blood cells® 
Spleen Thymus 
Mouse Composition Composition 
Number Sex %C57BL/6 %A %C57BL/6 %A 
157 (J 95 16 90 5 
158 $ 97 20 107 0 
159 a 11 86 57 110 
160 72 26 111 0 
162 g 63 46 73 47 
167 106 13 102 8 
168 95 29 93 13 
170 Q 1 99 2 100 
171 Ï 1 98 8 97 
173 (f 59 53 32 73 
187 9 84 8 105 0 
188 ? 
^Spleen and thymus composition of allophenic mice are based on 
duplicate values determined at the time of sacrifice using the trypan 
blue dye exclusion assay. Data were taken from Table 22. 
Control samples preincubated with a 1:5 dilution of either type of 
parental serum or an equal ratio of mixed parental serum gave average 
cytotoxocity values of 55 + 12% and 56 + 8% for C57BL/6 and A target cells, 
respectively. 
Significance was determined by testing for least significant differences 
between normal nouse serum controls and allophenic mouse serum samples at a 
50% cytotoxic dose of antiserum using Cochran's approximate t-test (Snedecor 
and Cochran, 1967). (*) significance at the 0.5 level, (**) significance at 
the .01 IPVPI. 
^Chimeric drift refers to time-dependent changes in the peripheral 
white blood cells (PWBC) or hemoglobin (Hb). (+) <20% change, (++) 220% 
but <40% change, (+++) 240% change, (-) no change, (NT) not tested. 
Data were taken from Tables 13, 14, 15, 16, 17, 18, and 19. 
®Spleen-thymus discordance refers to the difference between the 
relative proportions of the parental white blood cells in the spleen and 
thymus. (+) <20% discordance, (++) 120% but <40% discordance, (+++) 
$l40% discordance, (-) no discordance, (NT) not tested. Data were taken 
from Tables 22 and 25. 
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Spleen- Blocking Treatment^ 
Chimeric Drift" Thymus® Allophenic Mouse Sera 
Hemoglobin PWBC Discordance %C57BL/6 %A 
+ + 4- 52 4- 1 59 4-10 
+f + 44- 55 4- 4 49 4- 1 
+++ + 4-44- 57 4- 3 48 4- 1 
+ ++ 44- 60 4- 5 44 4- 2 
+ 444- 4- 50 4- 1 47 4- 5 
+ 44- 4- 46 4- 9 48 4- 4 
+ + 4- 44 4- 3 33 4- 1* 
+ 4- 4- 44 4- 3 43 4- 2 
+ 4- 4- 52 4- 5 40 4- 3 
+ 444- 44- 46 4- 1 43 4- 3 
- 444- 4- 49 4- 1 51 4- 9 
+ 444- NT 45 4- 4 52 4- 9 
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IV. DISCUSSION 
A. Chimeric Drift 
1. Murine hemoglobin 
The adult mouse hemoglobin is a molecule (65,000 daltons, M.W.) of 
four globin chains (two a chains and two g chains) each of which is bound 
to a heme residue in noncovalent linkage (Russell and Bernstein, 1966). 
In 1962, Hutton and his colleagues using starch gel electrophoresis showed 
that some inbred strains of mice have an adult 3-chain doublet producing 
two S-chains in unequal amounts, designated Hbb*^. Other strains of mice 
have an adult 6-chain singlet designated Hbb® (Hutton et al., 1962a, b). 
Morton (1966) reported a third allele at the 3-chain locus of mice, desig­
nated Hbb^ with the p hemolysate bearing some resemblance to the d hemo­
lysate. In 1972, Oilman isolated and sequenced the two g-chains from the 
d hemolysate and demonstrated that each possesses a structurally differenL 
3-chain. In the d hemolysate, represents approximately 20% of the 
total, while 3^^^^ accounts for the remaining 80%. He further demonstrated 
that Hbb^ was a variant form of the Hbb^ allele, since it produces a 
slightly different minor g-chaln, 3^ . The difference was seen at two 
positions in the minor 3-chalns (Oilman, 1972). Figure 28 summarizes the 
differences in amino acid sequences between the three different types of 
3-chalns in laboratory mice. Hemoglobins Hbb^, Hbb^ and Hbb^ are coded 
for by three separate loci; two (Hbb®, Hbb^ or Hbb°) of the three segregate 
0 
3dmaj < > Bpmaj 
3dmin 
2 
9 13 16 20 22 23 58 76 76 77 80 104 139 
Bs Ala Gly Gly Ala Glu Val Ala Asp Asn His * Met Ala 
Bdmaj Ala Cys Gly Ser Glx Val Ala Asp Asn His * Met (Thr) 
Bdmin Ser (Cys) Ala Pro Glx Val Pro Glu Lys Asn Asn Alx (Thr) 
Bpmin Syr Cys Ala Pro Ala Ile Pro Glx Lys Asn Asn ? (Thr) 
Uncommon symbols are Syr, serine or cysteine; Alx, probably alanine, 
possibly valine; ?, an unknown residue; *, probably serine; **, not ar-
ginine; ***, not methionine. Standard abbreviations are: A, Ala, alanine; 
R, Arg, arginine; N, Asn, asparagine; D, Asp, aspartic acid; C, Cys, 
cysteine; E, Glu, glutamic acid; Z, Glx, glutamic acid or giutamine; G, 
Gly, glycine; H, His, histidine; I, lie, isoleucine; L, Leu, leucine; K, 
Lys, lysine; M, Met, methionine; F, Phe, phenylalanine; P, Pro, proline; 
S, Ser, serine; T, Thr, threonine; W, Trp, tryptophan; Y, Tyr, tyrosine; 
V, Val, valine. Parentheses around a residue mean that tryptic peptide 
composition data are all that are available, and that the position in the 
sequence has been inferred by homology. 
Figure 28, A comparison of Mus musculus musculus 6 chains 
gdmin ^ gPmin positions where differences are found 
(Oilman, 1972) 
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as separate units in breeding experiments (Oilman, 1974). It has been 
suggested that Rbb*^ or Hbb^ loci may actually contain two almost identical 
DNA sequences that may code for the two slightly different hemoglobin g-
chains (Oilman, 1974). The breeding unit alleles coding for the hemoglobin 
6-chain in mice have been mapped to a segment of chromosome 7 near the 
albino locus (Russell and McFarland, 1974). 
Some laboratory mice have also been shown to have hemoglobin a-chains 
that can exist in polymorphic forms (Oilman, 1974). The locus coding for 
genetic polymorphism seen in the a-chains has been designated, Hba 
(Russell and Bernstein, 1966). This locus has been mapped to a region 
of chromosome 11 (Russell and McFarland, 1974). Despite the polymorphic 
forms of Hba no electrophoretically distinct products are known to exist 
in laboratory mice (Oilman, 1974). 
Russell and Bernstein (1966) have summarized the techniques used to 
separate and characterize mouse hemoglobin. Diffuse hemoglobins (Hbb*^ 
or Hfab°) are more soluble in buffered salt solutions, over a wider pH and 
molarity range than any of the single hemoglobins (Hbb^). Associated 
with this difference in solubility is a difference in crystal formation. 
Typically, homogenous single hemoglobin precipitates from buffered salt 
solutions as large hexagonal crystals, while the diffuse hemoglobin ap­
pears as a flocculent amorphorous precipitate. During column chroma­
tography over Amberlite, the single hemoglobin appears as a single major 
peak, while the major band of the diffuse appears as a major single peak 
in the same regions as the single hemoglobin, plus an additional minor 
component. 
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In order to quantitate mixtures of Hbb and Hbb we developed the 
technique of polyacrylamide gel isoelectric focusing in our laboratory. 
The technique proved to be simple, rapid, and quantitative. Complete sepa-
S d 
ration of Hbb and Hbb was achieved by chemically modifying the cysteine 
d s 
at position 13 of the Hbb , leaving the Hbb glycine at position 13 un­
altered (Wegmann and Gilman, 1970). The technique we developed now seems 
to be the method of choice in analyzing murine hemoglobins. 
2. Analysis of changes in red blood cell 
and white blood cell populations in 
allophenic mice 
This study demonstrates that allophenic mice can show marked changes 
in their red blood cell and white blood cell populations with time. The 
results of the analysis of 85 allophenic mice, shown in Tables 13, 14, 15, 
16, 17, 18, and 19 are depicted in Figures 21, 22, 23, 24, 23, and 26. A 
summary of the results of the analysis of all mice is shown in Table 20. 
First of all, it is seen that at least some of the mice of parental types 
C57BL/6(—> (A X SJL)F^, (CBA x CBA/H-T6)F^<—>C57BL/6, C57BL/6<—> DBA/1 
and C57BL/6 4—^ A,but not C57BL/10Sn 4—^ A mice,showed significant changes 
in their hemoglobin compositions. Some mice of all six types showed sig­
nificant changes in their peripheral white blood cells. Second, it is 
seen that 9 of 71 or 13% of the mice showed significant changes in their 
hemoglobin compositions, whereas 13 of 85 or 15% of the mice showed sig­
nificant changes in their peripheral white blood cell composition. Only 
one mouse (84) showed a change in both hemoglobin and peripheral white 
blood cell composition. Thus, a total of 21 of 84 or 25% of the total 
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number of allophenic mice tested showed a significant change in their 
hemoglobin composition, their peripheral white blood cell composition, or 
both. These changes have been termed chimeric drift. Allophenic mice 
have been classified as "stable" or "unstable" depending on whether or not 
they show significant chimeric drift. 
It should be noted that the number of mice showing significant 
chimeric drift as shown in Table 20, is a minimum number, since signifi­
cant differences were considered to be + 40%. Deciding what constitutes 
chimeric drift in this system is not a simple problem, since the error 
in individual determinations varies between + 10% and + 20%. If the error 
in each determination was closer to + 10% than + 20%, so that significant 
drift might be considered to be changes greater than + 20%, then 24 of 71 
or 34% of the mice showed significant changes in their hemoglobin compo­
sition, 28 of 85 or 33% showed significant changes in their peripheral 
white blood cell composition and 51 of 85 or 60% showed changes in both. 
However, for the purpose of discussion, the + 40% criterion will be used, 
since the overall conclusions are the same and the significance of the 
drift is more certain. Using changes of + 40% as the criterion for the 
definition of chimeric drift, there is no question that any observed drift 
is not simply because of experimental error. 
From Figures 21. 22, 23, 24, and 25, and Table 19, it is seen that 
chimeric drift is independent of the age, sex, and coat color of a mouse. 
Mice may show significant drift at any age, with apparently no more likeli­
hood of drift in young mice than in old mice. Of the 21 mice with 
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significant drift, 10 were phenotypic males and 11 were phenotypic females. 
Of the total number of mice, there were 50 males and 35 females. Among 
all of the mice there were 46 multicolored mice and 39 single-colored mice. 
This confirms a number of earlier studies (Mintz, 1969b; Mintz and Palm, 
1969; Wegmann, 1973) which have suggested that the coat color and organ 
composition of individual allophenic mice are subjected to different 
selective pressures and may be independent. This is especially true of 
coat color compared with blood cell composition, since the former, with 
the possible exception of agouti versus nonagouti chimeras, is of ecto­
dermal origin whereas the latter is of mesodermal origin (Wegmann and 
Oilman, 1970). The drift in peripheral white blood cell composition was 
found in 13 mice. Of the 13 mice, 12 showed significant decreases in the 
number of C57BL/6 or C57BL/10Sn peripheral white blood cells. One of 
the mice (212) showed a significant increase in C57BL/10Sn cells, while 
three mice (123, 158 and 214) showed a significant increase followed by 
a uecireaae at a later Lime. Tlius, the shift in the peripheral white blood 
cell population is not unidirectional. 
This is demonstrated more dramatically in Figure 26, with the tissue 
typing of nine C57BL/10 Sn <—>A mice using two types of antisera. These 
observations confirm an early study (Warner et al., 1976) on chimeric drift 
of the peripheral white blood cell populations In C57BL/6 4—) (A x SJL)F^ 
allophenic mice. 
The results on drift in the hemoglobin composition of the mice can 
be similarly analyzed. It is seen that five of the mice (84, 85, 119, 
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143, and 191) showed a significant decrease in the amount of C57BL/6 
hemoglobin, three of the mice (76, 114, and 159) showed a significant 
increase in the amount of C57BL/6 hemoglobin and one mouse (137) showed 
a significant increase and then a significant decrease in the amount of 
C57BL/6 hemoglobin. Thus, there is no apparent preference for one cell 
type or the other, and there is no evidence for unidirectional shifts in 
hemoglobin composition. This result is somewhat at odds with those of 
Mintz and Palm (1969), who studied H-2 antigens on the surface of ery­
throcytes of 34 C3H(f) <—>C57BL/6 allophenic mice. Their data suggested 
that all shifts were in the direction of the C57BL/6 parental type. How­
ever, only a limited number of determinations were made, so that shifts 
In the opposite direction from C57BL/6 may not have been present in their 
sample or else could have easily escaped detection. Similarly, West 
(1977) reported preferential shifts in the hemoglobin of 6 out of 8 
C3H/BlMcL<—> C57BL/McL mice in the direction of the C57BL/McL parental 
type. He concludcd that time dependent changes in erythropoietic tissue 
may be the result of differential rates of mitotic activity that contrib­
utes to strain-dependent, tissue-specific selective pressures in allophenic 
mice. In contrast to West's findings is the present study, which has 
shown that chimeric drift in the five combinations of allophenic mice may 
occur In either parental direction and fluctuate back and forth between 
the two parental cell types. 
Shifts in the erythrocyte composition of chimeras in other species 
have been documented in the past. In both cattle (Stone et al., 1964) 
214 
and marmoset (Gengozian et al., 1969) chimeras, there is a spontaneous 
change in the proportion of each cell population with age. It must be 
remembered that the cattle and marmoset chimeras are different from allo-
phenic mice in that they are secondary chimeras, and therefore, chimeric 
only in their blood systems. The allophenic mice, on the other hand, are 
primary chimeras, and may be chimeric in any or all of their tissues. 
The random shifts in the erythrocyte population of allophenic mice very 
closely resemble the random shifts seen in cattle chimeras; both twins 
usually shift in the same direction, even though two sets of twins may 
shift in opposite directions. Thus, there is an apparent genetic influence 
on the direction of drift in secondary chimeras, which may or may not 
apply to the shifts seen in allophenic mice. 
Table 21 summarizes the statistical analysis of the correlation of 
hemoglobin and peripheral white blood cell composition of 71 allophenic 
mice. It is seen that there is a good correlation of hemoglobin and peri­
pheral white blood ceil composition when all of Lhe mice are considered 
in each of the five allophenic combinations. When only the stable mice 
are considered, this correlation becomes even better. However, when the 
unstable mice are considered separately, the five combinations of allo­
phenic mice show poor or no correlation of the two parameters. Figure 27 
shows Che distribution of the hemoglobin composition of the 15 C57BL/6 
<—>A mice as a function of their peripheral white blood cell composition 
at any give time point. As previously demonstrated in Table 21, there is 
a good statistical correlation of the data. Thus, there is strong support 
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for the concept that erythrocytes and white blood cells arise from the 
same pluripotent hematopoietic stem cell during embryogenesis (Till et al., 
1975). However, the mechanism for the maintenance of the two cell popu­
lations in the adult may not be coordinated (Gandini et al., 1968; Mintz 
and Palm, 1969; Wegmann and Oilman, 1970). In another study (Berntson, 
1978) in which the IgG2a allotype composition was compared to the hemoglobin 
composition of eight (CBA x CBA/H-T6)F^^—&C57BL/6 mice, only a slight 
correlation of these two parameters was observed, thus further supporting 
the concept of separate control mechanisms of red blood cell and white 
blood cell populations. 
The lack of concordance of drift in the hemoglobin and peripheral 
white blood cell population leads to some speculations about the mechan­
isms of chimeric drift in allophenic mice. One might wonder whether 
chimeric drift can be taken as evidence for the breakdown of the tolerance 
mechanism in the allophenic mice. If this were true, there might be a 
difference in the ability to detect serum-blocking factors or suppressor 
cells in unstable versus stable allophenic mice. However, it has been 
shown that blocking factors were not detected in allophenic mouse sera 
regardless of whether the source of serum was from a stable or unstable 
mouse (see Discussion, Section C). 
Finally, it seems apparent from these data that there Is no simple 
cause and effect mechanism to account for the differential drift in the 
peripheral white blood cell and erythrocyte populations. For instance, 
if the amount of C57BL/6 or C57BL/10Sn hemoglobin had always gone down 
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as the number of C57BL/6 or C57BL/10Sn white blood cells went up, a cause 
and effect relationship might be postulated. This is obviously not the 
case among the unstable mice since some of them show a coordinate decrease 
in both C57BL/6 hemoglobin and peripheral white blood cells, whereas others 
show either one or the other parameter rising while the other is falling. 
No periodicity of these markers could be detected by analyzing mice at a 
weekly interval for six weeks (Figures 25 and 2Q, However, it is possible 
that a undetected periodicity of the data might have been detected by 
analyzing the mice weekly for 6-12 months. On the other hand, it is 
strongly suggested that drift in the two cell populations in adult mice 
is independently determined by the environment and the mechanisms involved 
in drift are not the same as those responsible for the maintenance of 
tolerance. 
B. Composition of the Immune System 
of Allophenic Mice 
This study describes the ccTTtpcsiitcn of the iitsnune system of eight 
different types of allophenic mice, based on the presence of different 
surface antigens on the two types of parental cells, as detected by anti­
body mediated cytotoxicity. As is seen in Table 22, the 93 mice studied 
covered the entire range of possible chimeric mixtures. This probably 
reflects the chance differential death of one parental cell type or other 
during early embryogenesis (Mullen and Whitten, 1971). It is seen that 
chimerism for coat color does not necessarily predict the internal compo­
sition of any given mouse; this is in agreement with the earlier 
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observations of Mintz and Palm (1969). In fact, the internal composition 
of the mice seems to be independent of the coat color, sex or age of the 
mice at the time of sacrifice. 
Table 23 demonstrates the additivity of the different parental cell 
types in the eight combinations of allophenic mice. In no case do the 
figures add up to significantly more than 100%. This may be evidence 
for a small percentage of cells that might be hybrids. The possibility 
of transfer of genetic information or spontaneous fusion of a small num­
ber of parental cells in allophenic mice has never been vigorously excluded 
(Munro et al., 1974a). One previous study suggests that there is no fusion 
of cells in allophenic mice (Bona et al., 1974). However, it is clear 
from these data that the vast majority of cells in these chimeric animals 
have one or the other parental type of cell surface antigens. In no case 
do the values add up to significantly less than 100%. This can be inter­
preted to mean that allophenic mice do not have a specific factor in their 
spleens which prevents complete killing with the antisera. This is con­
sistent with the observations of the absence of serum blocking factors 
previously reported in allophenic mice (Meo et al., 1973; Festenstein 
et al., 1975; von Boehmer et al., 1975a)(see Discussion, Section C). 
Table 24 summarizes the correlation of the peripheral blood, spleen 
and thymus cells of the eight different combinations of mice. It is seen 
in Table 24 that there is an excellent correlation of the peripheral blood 
composition with the spleen composition of all mice of a parental combina­
tion. Since blood contains 70% T cells while spleen contains 35% T cells 
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(Gornish et al., 1972), one might speculate that the relative proportion 
of the two parental types of T cells is the same in the blood and spleen. 
Furthermore, the correlation of the thymus composition with the peripheral 
blood cell or the spleen compositions is not statistically significant in 
most allophenic mice and does not correlate well as the peripheral blood 
and spleen composition, with the exception of the (CBA x CBA/H-T6)F^4:—^ 
DBA/1 mice and C57BL/6<—>A mice. These two combinations of mice have an 
excellent correlation between these markers. The explanation for this 
discrepancy is not clear. It is possible that all of the lymphomyeloid 
cells have a common origin during embryogenesis and then diverge due to 
differential proliferation of one cell type or the other in the adult 
allophenic animal. Thus, it would be likely that the particular strains 
of mice used in the allophenic combinations would determine the degree 
of concordance of the various cell populations in the adult mice. This 
conclusion would explain the data reported and those of Gornish (Gornish 
et al., 1972) and Ford (Ford et al., 1975) (see Introduction). 
Figures 29, 30 and 31, respectively, show the distribution of the 
parental strain peripheral white blood cells, spleen white blood cells, 
and thymocytes in allophenic mice. As can be seen, the parental lymphoid 
cells approximate an uniform distribution with the ratio of a parental 
type occurring at an almost equal frequency, with the exceptions the two 
ends. Similar results are also seen with respect to coat color. These 
distributions are consistent with and predicted from the work of Falconer 
and Avery (1968) who similarly observed an approximately flat distribution 
Figure 29. Distribution of parental strain 1 peripheral white blood cells 
(top) and coat color (bottom) in 92 allophenic mice of parental 
strain combinations (33) C57BL/6<—> (A x SJL)F-, (3) DBA/1 
^(A X SJL)F , (3) DBA/14—>A, (16) (CBA x CBA/H-T6) F^ <—> 
DBA/1, (16) (CBA X CBA/H-T6)F *—»C57BL/6, (5) (CBA x CBA/ 
H-T6)F <f—»A, (3) C57BL/6^—» DBA/1, and (13) C57BL/6 4—* A 
mice, peripheral white blood cell (PWBC) composition was de­
termined at the time of sacrifice using the trypan blue dye 
exclusion assay. Coat color phenotype was estimated visually 
at weaning. Data were taken from Table 22.2 
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Figure 30. Distribution of parental strain 1 spleen white blood cells 
(top) and coat color (bottom) in 92 allophenic mice of 
parental strain combinations (33) C57BL/6<:—> (A x SJL)F., 
(3) DBA/1 4—t (A X SJL)F , (3) DBA/1<—>A, (16) (CBA x CBA/ 
H-T6)F^ «—>DBA/1, (16) "^(CBA x CBA/H-T6)F <r^C57BL/6, (5) 
(CBA X CBA/H-T6)F <—>A, (3) C57BL/6^—> DBA/1, and (13) 
C57BL/6<—VA mice, ^pleen white blood cell composition 
was determined at the time of sacrifice using the trypan blue 
dye exclusion assay. Coat color phenotype was estimated 
visually at weaning. Data were taken from Table 22^ 
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Figure 31. Distribution of parental strain 1 thymocytes (top) and 
coat color (bottom) in 52 allophenic mice of parental strain 
combinations (16) C57BL/6a—> (A x SJL)F., (3) DBA/1 <—>A, 
(10) (CBA X CBA/H-T6)F. > DBA/1, (8) (CBA x CBA/H-T6)F 
»C57BL/6, (2) C57BL^/6<—» DBA/1, and (13) C57BL/6<—> A 
mice, ^hymus composition was determined at the time of 
sacrifice using the trypan blue dye exclusion assay. Coat 
color phenotype was estimated visually at weaning. Data 
were taken from Table 22^ 
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of coat pigmentation in mouse aggregation chimeras, with the exception of 
solid color mice which form a peak at each end of the distribution. 
Table 25 summarizes the data collected on the mice which have been 
analyzed for chimeric drift and spleen-thymus discordance. As stated 
earlier (see Discussion, Section A) deciding what constitutes chimeric 
drift is not a simple problem since the error of individual determina­
tions can vary between + 10-20%. Even though most of the data on chimeric 
drift was good enough to meet the + 20% criterion, a + 40% criterion was 
chosen to be absolutely sure of the results. 
The situation with respect to spleen-thymus discordance is much 
simpler, since the error in these two types of determination is always 
< 10%. Therefore, only one criterion, >20% difference in the spleen and 
thymocyte compositions has been used to enumerate the mice with spleen-
thymocyte discordance in Table 25. 
The most interesting aspect of the data shown in Table 25 is that 
11 out of 14 mice or 79% which show mpTeen-thymus discordance also showed 
chimeric drift of their peripheral white blood cells earlier in their lives, 
when using a > 20% criterion. However, using y 40% criterion, 4 out of 
14 mice or 29% showed the same phenomenon. Only one mouse (159) showing 
spleen-thymus discordance also showed a significant change in hemoglobin 
composition. Allophenic mice, therefore, apparently fall into two sep­
arate classes: those with stable immune and hematopoietic systems and 
those with unstable immune and hematopoietic systems. The spleen-thymus 
discordance in these mice could be either the cause or the result of the 
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chimeric drift of peripheral white blood cells. It is doubtful this 
relationship extends to the red blood cell population since only 1 out of 
14 mice which showed spleen-thymus discordance also showed significant 
drift of hemoglobin. If this were true, then it would be highly probable 
that drift in the two cell populations in adult mice is under the influence 
of independent mechanisms. However, more mice would have to be examined 
to verify this observation since a number of mice showing hemoglobin drift 
were not analyzed for spleen-thymus discordance. 
The apparent lack of relationship between hemoglobin drift and spleen-
thymus discordance does not exclude the possible influence of the thymus 
on red blood cell formation and development. Experiments performed by 
Wiktor-Jedrzejczak et al. (1977) have shown the required presence of a 
theta-sensititve cell in bone marrow, thymus and spleen for the normal 
differentiation of stem cells along the erythroid pathway. Their studies 
indicate that the theta-sensitive regulatory cell (TSRC), shown not to be 
of hematopoietic stem cell nriein. confers a stimulatory action on hema­
topoietic stem cells resulting in their differentiation into red blood 
cells. This suggests that deficiencies in either the hematopoietic stem 
cell or TSRC or both might be one of the mechanisms responsible for some 
of the genetically determined anemias and stem cell deficiencies seen in 
certain mouse strains and man. 
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C. Immunological Tolerance in 
Allophenic Mice 
1. RNA synthesis in mouse spleen cells 
as a probe of antibody mediated 
cytotoxicity 
Assays for antibody mediated cytotoxicity can be categorized into 
five classes based upon the method used to distinguish live cells from 
dead cells. In the dye exclusion assay (Gorer and 0'Gorman, 1956; 
Terasaki and McClelland, 1964; Walford, et al., 1964; Mittal et al., 
1968; Amos et al., 1969) the cytotoxic effects of antibody and comple­
ment are measured by the failure of dead cells to exclude vital dyes 
such as trypan blue or eosin Y. Quantitation of cells is determined by 
microscopic examination of test samples. A variation of the dye exclu­
sion assay is the use of a fluorescent marker (Edidin, 1970; Brawn et al., 
1975). In this assay, ethidium bromide is excluded from viable cells 
but rapidly enters damaged cells, in which it fluoresces. Cytotoxicity 
is evaluated using a commercially available fluorometer. 
A second class of cytotoxic assay is the dye inclusion assay. In 
the procedure of Filman et al. (1975), target cells, sensitive to antibody-
dependent complement-mediated cytotoxicity, undergo an intracellular de-
localization of the supravital stain, neutral red. The results are 
determined by visual enumeration of cells which have accumulated the dye. 
A similar marker inclusion assay is the fluorochromasia cytotoxicity 
assay (Rotman and Papermaster, 1966; Bodmer et al., 1967; Watanabe et 
al,, 1971). This assay is based upon the observation that free 
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fluorescein, produced by intracellular esterase mediated hydrolysis of 
fluorescein diacetate, is retained by live cells but released from dead 
cells. Cell viability is determined by counting the number of fluores­
cent cells in a sample. 
In the third category, the colony inhibition assay (Hellstrom and 
Sjogren, 1965; Hellstrom and Hellstrom, 1971) target cells are grown in 
petri dishes or microtest plates prior to treatment with antibody and 
complement. Cells showing no sensitivity to the antiserum are enumer­
ated by visual examination of cells or groups of cells forming colonies. 
The fourth category, represented by radioactive marker release 
assays, involves a pre-assay incubation step in which the radioisotope 
is concentrated intracellularly. ^^Cr-chromate (Sanderson, 1964; Wigzell, 
ft A 
1965; Holm and Perlmann, 1967; Brunner et al., 1968) or Rb-chloride 
(Chollet et al., 1974) are the most commonly used labeling materials. 
Target cells are then incubated with antibody and complement, and a 
cytotoxic index determined by the activity released by the test sample 
divided by total activity released by control cells. 
We have developed a new cytotoxicity assay for use on samples of 
resting mouse spleen cells which contain a large proportion of dead 
cells due to previous biochemical and immunological treatments. The 
assay was developed so that it would be refractory to interference by 
large numbers of dead cells, not require the prelabeling of target ceils, 
be reasonably rapid, be independent of operator subjectivity, and be 
subject to automation. The dye exclusion and dye inclusion assays could 
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not be used because of the interference by large numbers of dead cells. 
The colony formation assay could not be used because it requires a 
lengthy culturing period. The radioactive marker release assays were 
not suitable because of the requirement for the prelabeling of the tar­
get cells. 
The assay developed falls into a fifth category of cytotoxic assays 
which takes advantage of the fact that live cells will incorporate small 
molecular weight radioactive precursors into high molecular weight 
products, whereas dead cells will not. One such assay, which measures 
3 
the incorporation of [ H] thymidine into DNA was first reported by Klein 
and Ferlmann (1963), and later automated, using a MASH (multiple auto­
mated sample harvester) by Knudsen et al. (1974). This DNA synthesis 
assay procedure meets all the criteria set forth above, except the 
length of time required. In order to measure DNA synthesis the cells 
must be undergoing mitosis, and this requires mitogenic stimulation of 
the bpleeri cell culture, followed by a several day culture period. In 
our assay procedure, the basal level of RNA synthetic activity was high 
3 
enough in resting mouse spleen cells to use the incorporation of [ H]-
uridine into RNA as an index of the viability of a given cell population. 
Cooper and Rubin (1965), in a series of experiments with resting 
3 
lymphocytes, have demonstrated that incorporation of [ Hjuridine increases 
over a period of 4-6 hours and then reaches a stable state beyond which 
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incorporation decreases. Incorporation into high molecular weight product 
in their studies was linear up to a 5-hour period with no change in the 
RNA content of the culture during this time. This observation is in 
agreement with our findings (Figures 10 and 11). 
The different classes of RNA synthesized by resting lymphocytes 
have been previously summarized by Cooper (1971). Briefly, ribosomal 
RNA, which constitutes the largest pool of RNA in the cell, is turned 
over quite slowly with a half life on the order of days. It has been 
estimated that rRNA represents only 2-4% of the total RNA synthesized 
in the resting cell at any one time. A nonmethylated heterogenous 
nuclear RNA with a half life in minutes represents 90% of the RNA syn­
thetic activity of the resting cell. The majority of the heterogenous 
RNA is, in fact, not used but is turned over by the cell (Jelinek et al., 
1974). It has been suggested that a portion of the heterogenous RNA 
is a precursor of messenger RNA. This conclusion is based on its DNA-
like base cOuipoaiLiou, whicu coûLalris a poly(A) sequence at its 3' end. 
Heterogenous RNA also shares sequences with mRNA which codes for poly­
peptide chains (Jelinek et al., 1974). Messenger RNA is thought to 
represent the processed form of heterogenous nuclear RNA which is trans­
ported to the cytoplasm. Cytoplasmic transfer RNA and small molecular 
weight precursor molecules are turned over at moderately rapid rates and 
have a half life on the order of 1-2 hours. The types of RNA synthesized 
during the 5-hour labeling period in our system will have to be confirmed. 
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Each of the currently available methods for evaluating antibody-
mediated cytotoxicity has advantages and disadvantages. Among the com­
monly used assays, the trypan blue assay has the advantages that it is 
inexpensive, fast, and requires few manipulations. The disadvantages 
are the possibility of operator subjectivity, a limit to the number of 
samples that can be analyzed by a single operator, and the impossibility 
of evaluating samples when a large percentage of dead cells are present. 
The ^^Cr release assay has the advantage of being objective, but has 
the disadvantages of requiring the prelabeling and washing of cells. 
The DNA synthesis assay has the disadvantage of requiring mitogenic 
stimulation of the culture, and a long culturing period. Even though 
a large number of cytotoxicity assays have been described previously, 
none of the known cytotoxicity assays met all the requirements for our 
work; no interference by large numbers of dead cells, no prelabeling of 
target cells, no long culturing periods, and no mitogen stimulation of 
the cultures. 
The presently described RNA synthesis assay does meet all the 
criteria set forth previously. First, there is no interference by dead 
cells, so that there is no need to separate dead cells nor red blood 
cells from the live spleen cell population, since neither of these have 
measurable levels of RNA synthesis. The RNA synthesis assay works as 
well as FLcoll-Hypaque isolated lymphocytes, and on thymocytes, as on 
whole spleen cell suspensions. Second, the procedure does not require 
the extra manipulation of prelabeling the target cells. Third, the 
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the procedure can be done in hours instead of days as is required in the 
3 
DNA synthesis assay. By increasing the specific activity of the [ H]-
uridine, the assay time could be cut down even further. Fourth, the 
assay relies on the counting of radioactively labeled material, so it is 
independent of operator subjectivity. And finally, the procedure could 
be easily automated using microtiter plates and an automated cell har­
vester such as the MASH II (Microbiological Associates) or Titertek 
(Scatron, Flow Laboratories). The RNA synthesis cytotoxicity assay pro­
cedure should be applicable to any resting cells with a high basal level 
of RNA synthetic activity. 
2. Cryogenic storage of lymphocytes 
Since 1950, several classes of biological materials have been 
successfully preserved for experimental and clinical usage. This in­
cludes spermatozoa (Sadleir, 1966), mouse embryos (Leibo et al., 1975), 
cornea (Muller et al., 1964), skin (Lehr et al., 1964), and lymphocytes 
for immunological studies and antibody mediated cytotoxicity testing 
(Fotino et al., 1967; Bates and Sell, 1970). This success was largely 
the result of a group of cryoprotective additives that are mixed with 
cells prior to freezing. The cryoprotective additives are classified 
as to whether they permeate the cell (intracellular) or remain outside 
of the cell (extracellular)(Rowe,1966). Examples of a few extracellular 
additives include such chemicals as polyvinylpyrrolidone (PVP), polyglycol, 
dextran, lactose, and sucrose. These cryophylactics work most effectively 
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with cells that require rapid rates of cooling such as red blood cells. 
They provide their greatest protection by minimizing the effects of ice 
nucleation by moderating ice crystal growth (Doebbler, 1966). Intra­
cellular additives include glycerol and dimethylsulfoxide (DMSO). These 
additives are employed with nucleated cells such as lymphocytes that 
require slow rates of cooling. It is generally believed that penetrating 
compounds work by minimizing cell dehydration by acting as solvent (H^O) 
substitutes, thereby reducing the hypertonicity of the extracellular 
fluid that often accompanies freezing (Doebbler, 1966). 
Procedures for freezing macro- and micro-quantities of lymphocytes 
for extended periods of time followed by thawing with a minimum loss of 
viability have been described elsewhere (Fotino et al., 1967; Bates and 
Sell, 1970). The procedures generally include adding DMSO at a final 
concentration of 7% (w/v) to cells prior to freezing at 1° C per minute, 
followed by rapid thawing and washing of cells with culture medium con-
Our study was undertaken to compare the effects of cryogenic 
storage on allophenic mousespleen white blood cells and thymus cells 
that are used as target cells in an antibody-mediated cytotoxicity assay 
before and after freeze-thawing. Also the effects of freeze-thawing on 
the basal levels of RNA synthesis in spleen white blood cells were examined. 
Data summarized in Tables 9 and 10 show the results of the typing 
of allophenic spleen white blood cells and thymus cells before and after 
long term freezing and thawing. First of all, it is seen that there is 
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no significant difference in the percentage of parental cell types 
comprising the allophenic mice as determined by antibody-mediated cyto­
toxicity prior to and after long term storage (1-2 years). This was 
true for all five combinations of allophenic mice. However, spleen 
white blood cells from individual allophenic mice (120, 125) occasionally 
did show a significant difference after the freeze-thawing process. 
This difference probably reflects cell injury during the thawing cycle 
of those samples, since large groups of cells were frozen simultaneously 
under identical conditions. Second, it is seen there is no differential 
susceptibility of any inbred mouse strain or selective advantage of 
hybrids over inbred strains, to the detrimental effects of the freeze-
thawing process, since the proportions of cell types remained the same, 
before and after freezing. Therefore, the percentage of cells nonspecif-
ically dead, probably comprises an approximately equal mixture of both 
parental cell types, with the exception of two mice (120, 125). Third, 
thymus cells shc^'sd fev:er nonspecific dead cells than spleen white 
blood cells, but differences are not statistically significant. Although 
no one mechanism can account for the nonspecific cell death in the freez­
ing and storage of lymphocytes, a number of factors have been implicated 
in cell injury. These include the rates of cooling of specimens before 
and after the initiation of freezing, the formation of ice crystals, 
their size, location and rate of growth, cellular dehydration as a re­
sult of poor distribution of cryoprotective additive, the concentration 
of solutes, particularly electrolytes, and membrane damage during the 
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thawing process. The type of vial, whether glass or plastic, had no 
effect on cell viability. However, the plastic Provials (Cooke Labora­
tory Products) had an added advantage over glass containers, during cell 
thawing, in that aerosol formation was minimized and the shatterproof 
property prevented leakage of the contents of the vials. 
No significant levels of RNA synthesis were detected in frozen-
thawed lymphocytes. As a result, these cells were unsuitable for usage 
in assays measuring basal levels of RNA or DNA synthesis (e. g., RNA 
synthesis assay) as an index of cell viability. Similar results for bone 
marrow cells slowly frozen in liquid nitrogen have been reported by 
Rowe (1966). Therefore, frozen cells were found to work best as target 
cells in dye exclusion assays (E.g., trypan blue dye exclusion assay). 
Whether this low detectable level of RNA synthesis is the result of the 
freeze-thawing process or a function of the length of time in storage 
is not known. 
3. The absence of serum blocking 
factors in allophenic mice 
Whether self tolerance in allophenic mice is the result of a central 
failure of the immune system (Billingham et al., 1954; Burnet, 1959; 
Jerne, 1971) or is due to some active peripheral mechanisms (Hellstrom 
et al., 1971; Allison, 1971; Voisin et al., 1972), has been a subject 
of long unresolved debate. Mintz and Silvers (1967) first designated 
tolerance in allophenic mice as being "intrinsic" rather than being 
"acquired" and proposed that during development reactive clones to the 
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composite chimera's own tissue were eliminated. Similar observations 
supporting "clonal elimination" have been reported by other investiga­
tors (Meo et al., 1973; Festenstein et al., 1975; von Boehmer et al., 
1975a; Barnes, 1976). Contrary to these observations, other workers in 
the field have presented evidence in favor of serum blocking factors 
and suppressor cells (Wegmann et al., 1971; Phillips et al., 1971; 
Phillips and Wegmann, 1973). 
Our study fails to confirm the presence of blocking factors in the 
serum of allophenic mice. A summary of the results can be seen in Tables 
26, 27, 28, 29, 30, 31, 32, 33, and 34. The criterion for evaluating 
blocking activity in the antibody-mediated cytotoxicity assay was de­
fined as a significant difference, at a minimum of two serum dilutions 
between samples, pretreated with allophenic mouse serum or normal mouse 
serum, as determined by a Student's "t" test. It can be seen in Table 
26, that five serum samples from allophenic mice 105, 107, 120, 138, and 141 
showed a significant difference from normal mixed parental serum when 
tested with their own spleen cells in the trypan blue dye exclusion assay. 
However, only two serum samples (138, 141) out of 26 samples tested or 
8% give serum blocking activity at two serum dilutions. Serum samples 
from mice 105, 107, and 120 showed significantly higher killing than normal 
serum controls. This difference was not seen in any of the five mice 
when the source of the target cells were thymocytes (Table 28). Further­
more, it can be seen in Tables 27 and 29 that serum blocking activity was 
completely eliminated by testing the same samples across serum dilutions. 
These data demonstrate that allophenic mouse serum has no blocking effect 
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of antibody-mediated cytotoxicity on allophenic spleen white blood cells. 
This was true for mice showing a wide range of chimerism of the immune 
system (Tables 27and 29). In addition, no relationship was seen between 
the absence of serum blocking activity and the phenomena of chimeric 
drift and spleen-thymus discordance. 
Analysis of serum blocking activity using allophenic mouse serum 
and parental type spleen white blood cells gave similar results (Tables 
30, 31, 32, 33, and 34). Of the 90 duplicate cytotoxicity tests per­
formed on 45 allophenic mouse serum samples, 7/90 or 8% were significant 
at the 0.05 level while 2/90 or 2% were significant at the 0.01 level. 
It could be argued that serum blocking may have been present but repeated 
freeze-thawing and heat inactivation of allophenic serum samples destroyed 
their protective properties. However, in other studies (Wegmann et al., 
1971; Phillips et al., 1971) where allophenic mouse sera received similar 
treatment, serum blocking activity was reported. 
This reported absence of serum blocking activity is not in 
accordance with the studies of Hellstrom (Hellstrom et al., 1971) and 
Wegmann and Phillips (Wegmann et al,, 1971; Phillips et al., 1971). In 
the studies of Hellstrom, mice made tolerant by the neonatal transfer 
of generation cells were reported to possess self-reactive clones 
whose sera could block the killing of donor strain fibroblasts in the 
microcytotoxicity (MC) test. However, in subsequent studies by Beverley 
(Beverley et al., 1973) such mice have been shown to be characterized 
as being partially tolerant, due to Insufficient dosage of cells in 
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the Hellstrom tolerance inducing procedure. As a result, only partially 
tolerant states have been characterized by the presence of blocking fac­
tors. On the other hand, allophenic mice have been shown to be healthy 
and long-lived and readily accept skin grafts from either of the two 
component strains indicating full tolerance (Mintz and Silvers, 1967). 
Wegmann and his colleagues (Wegmann et al., 1971) demonstrated that lymph 
node cells from C57BL/6 C3H/He or (CBA x C57BL/6)F^<—^ SJL mice 
could react against parental cell lines in the (MC) test. Phillips et 
al. (1971) similarly showed that C57BL/10<—^SJL lymphoid cells could 
react against cells with the corresponding parental strain antigens in 
mixed lymphocyte culture (MLC). Furthermore, this in vitro reactivity 
of chimeric cells to parental cells could be blocked by sera from such 
mice (Wegmann, et al., 1971; Phillips et al,, 1971). Serum blocking 
factor was characterized as an antibody molecule with specificity for 
the allelic products of the H-2 region (Phillips et al., 1971). However, 
in this study, sera from allophenic mice did not protect target cells 
from the toxic action of antiserum and complement. Unlike prior tolerance 
studies on allophenic mice (Wegmann et al, 1971; Phillips et al., 1971), 
where serum samples from three or four mice of one or two parental com­
binations were pooled, our study tested 52 different unpooled serum samples 
from six different parental combinations on a variety of target cells. In 
addition, unlike the Wegmann and Oilman studies, the immune system com­
position of individual mice was characterized at the time of serum 
collection. 
239 
Other investigations failing to show evidence of serum blocking 
factors in allophenic mice include Meo (Meo et al., 1973), Festenstein 
(Festenstein et al., 1975) and von Boehmer (von Boehmer et al., 1975a). 
Meo and Festenstein in separate studies demonstrated allophenic mouse 
serum or cells could not prevent reactivity of parental cells in one 
way MLC. Similar results were reported by Ceppellini (1971) and his 
associates in the case of tetragametic human chimeras, von Boehmer 
(1975a) and his group working with tetraparental bone marrow chimeras 
produced by injecting lethally irradiated F^, hybrid mice with relatively 
high numbers of T cell depleted bone marrow from two allogeneic parental 
strains reported the absence of any reactive cells in MLC and cell-
mediated lympholysis (CML) of chimeric origin to host cells. In addi­
tion, no suppressor cells could be demonstrated in either system and 
serum blocking factors could not be found. These results are in direct 
conflict with the previous studies of Phillips and Wegmann (1973). They 
suggested that chimeric spleen cells insensitive to antitheta serum 
could block MLR between the two parental cell types, but not between un­
related strains. 
In summary, our study fails to confirm the presence of serum 
blocking factors in the sera of allophenic mice as detected by antibody-
mediated cytotoxicity. Likewise, other investigators have failed to de­
tect any blocking activity of chimeric serum in MLR and CML (Meo et al., 
1973; Festenstein et al., 1975; and von Boehmer et al., 1975a) or in 
the in vivo local graft-versus-host assay (Barnes and Graham, 1976). 
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Presumably, the presence of serum blocking factors could be detected in 
any or all of the assays. In their experiments, Phillips and Wegmann 
(1973) suggested the levels of serum blocking factor varied between dif­
ferent strain combinations of allophenic mice. In this study, no blocking 
activity was detected from 52 different serum samples from six different 
parental combinations. Likewise, the possible role of suppressor cells 
has not been substantiated (Barnes, 1976). Although no interpretation 
of tolerance in allophenic mice can be absolute, collectively these ob­
servations are in strong agreement with the concept of a central failure 
of the immune system. 
D. Conclusion 
A basic goal of this research was to explain the phenomena of chimeric 
drift and spleen-thymus discordance in terms of the presence of serum block­
ing factors which are characteristic of "graft versus host" reactions and 
incomplete states of tolerance. The results presented in this dissertation 
are unequivocable. Neither stable nor unstable allophenic mice have detect­
able serum blocking activity as determined by antibody mediated cytotoxi­
city testing. This observation is consistent with the results of other 
workers (Meo et al., 1973; Festenstein et al., 1975; von Boehmer et al., 
1975a; Barnes and Graham, 1976) who similarly have failed to detect serum 
blocking activlEy Oif suppressor' cells in allophenic mice. Thus, the 
overall picture that emerges from these observations is that chimeric 
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drift in the two cell populations is probably the response of two 
independent control mechanisms and the mechanisms involved are not the 
same as those responsibile for maintenance of tolerance. This conclusion 
is supported by three independent studies. First, it was seen in this 
study that significant changes in the red blood cell populations of allo-
phenic mice occurred independently of changes in the white blood cell 
populations and that 79% of the mice showing spleen-thymus discordance 
also showed peripheral white blood cell drift. These observations are 
consistent with the investigations of Berntson (1978) who observed only 
a slight correlation of the IgG2a allotype marker with hemoglobin compo­
sition of allophenic mice and, therefore, concluded that the red blood 
cell and white blood cell populations must be under separate regulatory 
mechanisms. Second, it was seen in both cattle (Stone et al., 1964) and 
marmoset (Genozian et al., 1969) chimeras, that spontaneous change in 
the proportion of the red blood cell populations with time could occur 
with no apparent breakdown of tolerance in these animals. This closely 
resembles the results seen here with primary chimeras. Finally, Gandini 
(Gandini et al., 1968) and his colleagues investingating x-inactivated 
mosaics, observed that granulocytes and erythrocytes appear to be derived 
from a common pool of precursor cells while lymphocytes were derived from 
a different precursor pool. Both precursor pools appeared to be regulated 
by separate controls. Although chimeric drift in the peripheral white 
blood cell population appears to be the cause or the result of spleen-
thymus discordance, it is still possible that both phenomena are independent 
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of each other. An important question which remains to be answered is 
whether the lymphomyeloid tissues arise from a common stem cell (Cornish 
et al., 1972) or whether certain groups of immune tissues are derived 
independently (Ford et al., 1975). ' 
The value of the investigation of tolerance in allophenic mice is 
great. Understanding the mechanism by which genetically distinct cells 
coexist in an allophenic animal may help us understand the normal mechanism 
of tumor development and regression. It is the hope of the author that 
the data collected and presented herewithin. may directly or indirectly 
help in the future understanding of how cells interact with each other. 
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V. SUMMARY 
One hundred five allophenic mice of nine different types 
[C57BL/6 4—i (A x SJL)F^, DBA/1 4—) (A x SJL)F^, DBA/1 *—> A, (CBA x CBA/ 
H-T6)F^<—^ DBA/1, (CBA x CBA/H-T6)F^ ^ C57BL/6, (CBA x CBA/H-T6)F^ 
<—> A, C57BL/6 DBA/1, C57BL/6 A, and C57BL/10 Sn 4—> A] were 
produced for characterization and quantitation of their hematopoietic 
and(or) immune systems and for tolerance studies. Techniques were de­
veloped to examine erythrocyte, peripheral white blood cell, spleen white 
blood cell, and thymocyte compositions of the mice. This approach was 
achieved by using chemical modification with cystamine dihydrochloride 
and polyacrylamide gel isoelectric focusing (PAGIF) for the separation of 
the different hemoglobin types, and antibody-mediated cytotoxicity for 
quantitation of spleen white blood cells, peripheral white blood cells 
and thymocytes. Mice were analyzed for changes in their peripheral white 
blood cell and hemoglobin compositions at several time points in their 
lives. Spleen white blood cells, peripheral white blood cells and thymo­
cytes were analyzed at the time of sacrifice. It was found that the red 
blood cell and white blood cell populations of 21 of the 85 mice examined 
showed significant changes termed "chimeric drift" in one or the other 
or both of these parameters. These 21 mice were classified as unstable 
chimeras, as opposed to the 64 stable chimeras which showed no apparent 
drift. There was an excellent correlation of the peripheral white blood 
cell and hemoglobin composition of the stable chimeras. However, the 
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unstable chimeras showed little or no correlation of these two markers. 
At the time of sacrifice, the iimntine system of 93 allophenic mice was 
studied. All eight types of mice which were characterized [C57BL/6 4^ 
(A X SJL)F^ , DBA/1 4—» (A x SJL)F^ , DBA/1 ^ —>A, (CBA x CBA/H-T6)F^  4-} 
DBA/1, (CBA X CBA/H-T6)F^<—>C57BL/6, (CBAxCBA/H-T6)F^4r-4»A, C57BL/6 <—> 
DBA/1, and C57BL/6<—> A] were found to be true chimeras since the vast 
majority of cells in these chimeric animals had only one or the other 
parental types of surface antigens. It was seen that the proportions 
of the parental thymocytes (and coat color, spleen white blood cells and 
peripheral white blood cells) in all eight types of allophenic mice 
approximates an uniform distribution, with each proportion almost occur­
ring at an equal frequency. The correlation of the blood with the spleen 
composition for each of the eight types was excellent for all mice. 
However, only two types of mice, (CBA x CBA/H-T6)F^4—) DBA and C57BL/6 
<—^A, showed a good correlation of the thymus composition with either 
the blood or the spleen composition. Further analysis of individual 
mice of the eight types revealed that 11 out of 14 mice which showed 
spleen-thymus discordance also showed chimeric drift of their peripheral 
white blood cells (+ 20% criterion) earlier in their lives. On the other 
hand, only 1 out of 14 mice with spleen-thymus discordance also showed 
chimeric drift of the red blood cell population. 
In tolerance studies, serum samples from 52 unstable and stable 
allophenic mice of similar combinations were analyzed for serum blocking 
activity using an antibody-mediated cytotoxicity assay. The target cells 
consisted of frozen-thawed allophenic mouse spleen white blood cells, or 
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thymocytes and freshly collected parental strain spleen white blood cells. 
Serum treated frozen-thawed cells were typed using the trypan blue dye 
exclusion assay while serum treated freshly collected cells were typed by 
measuring basal levels of RNA synthesis in live cells as a probe of 
antibody-mediated cytotoxicity. It was found that neither 14 unstable 
or 38 stable allophenic mice had serum blocking activity as detected in 
these assays. In addition, 10 mice which showed spleen-thymus discordance 
also failed to show the presence of blocking factors in their serum. Al­
though no interpretation of tolerance in allophenic mice can be absolute, 
these observations are in agreement with the concept of a central failure 
of the immune system. 
In conclusion, chimeric drift in the red blood cell and white blood 
cell populations is probably the result of two independent control mech­
anisms and the mechanisms involved are not the same as those responsible 
for the maintenance of tolerance. The spleen-thymus discordance in these 
same mice could either be the cause or the result of chimeric drift or 
be totally independent of this phenomenon. Explanation of the immune 
system of allophenic mice suggests that all the lymphcmyeloid cells could 
have a common origin in embryogenesis, and then diverge due to the dif­
ferential proliferation of one cell type or the other in the adult allo­
phenic animal. These studies have laid the groundwork for further exper­
iments aimed at the elucidation of the mechanism of tolerance in allophenic 
mice. 
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